<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3497036</article-id><article-id pub-id-type="doi">10.3390/v4101950</article-id><article-id pub-id-type="publisher-id">viruses-04-01950</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Enhanced Heterosexual Transmission Hypothesis for the Origin of Pandemic HIV-1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>de Sousa</surname><given-names>Jo&#x000e3;o Dinis</given-names></name><xref ref-type="aff" rid="af1-viruses-04-01950">1</xref><xref rid="c1-viruses-04-01950" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Alvarez</surname><given-names>Carolina</given-names></name><xref ref-type="aff" rid="af1-viruses-04-01950">1</xref><xref ref-type="aff" rid="af2-viruses-04-01950">2</xref></contrib><contrib contrib-type="author"><name><surname>Vandamme</surname><given-names>Anne-Mieke</given-names></name><xref ref-type="aff" rid="af1-viruses-04-01950">1</xref><xref ref-type="aff" rid="af3-viruses-04-01950">3</xref></contrib><contrib contrib-type="author"><name><surname>M&#x000fc;ller</surname><given-names>Viktor</given-names></name><xref ref-type="aff" rid="af4-viruses-04-01950">4</xref></contrib></contrib-group><aff id="af1-viruses-04-01950"><label>1 </label>Laboratory for Clinical and Epidemiological Virology, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven B-3000, Belgium; Email: <email>joao.sousa@rega.kuleuven.be</email> (J.D.S.); <email>annemie.vandamme@uz.kuleuven.be</email> (A.-M.V.)</aff><aff id="af2-viruses-04-01950"><label>2 </label>Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima 31, Peru; Email: <email>carolina.alvarez@upch.pe</email> (C.A.) </aff><aff id="af3-viruses-04-01950"><label>3 </label>Centro de Mal&#x000e1;ria e Outras Doen&#x000e7;as Tropicais, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa 1349-008, Portugal</aff><aff id="af4-viruses-04-01950"><label>4 </label>Research Group of Theoretical Biology and Evolutionary Ecology, E&#x000f6;tv&#x000f6;s Lor&#x000e1;nd University and the Hungarian Academy of Sciences, Budapest 1117, Hungary; Email: <email>mueller.viktor@gmail.com</email></aff><author-notes><corresp id="c1-viruses-04-01950"><label>*</label> Author to whom correspondence should be addressed; Email: <email>joao.sousa@rega.kuleuven.be</email>; Tel.: +32-16332180; Fax: +32-16332131.</corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>10</month><year>2012</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2012</year></pub-date><volume>4</volume><issue>10</issue><fpage>1950</fpage><lpage>1983</lpage><history><date date-type="received"><day>06</day><month>9</month><year>2012</year></date><date date-type="rev-recd"><day>15</day><month>9</month><year>2012</year></date><date date-type="accepted"><day>17</day><month>9</month><year>2012</year></date></history><permissions><copyright-statement>&#x000a9; 2012 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p><!--CREATIVE COMMONS-->This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>).</license-p></license></permissions><abstract><p>HIV-1 M originated from SIVcpz endemic in chimpanzees from southeast Cameroon or neighboring areas, and it started to spread in the early 20th century. Here we examine the factors that may have contributed to simian-to-human transmission, local transmission between humans, and export to a city. The region had intense ape hunting, social disruption, commercial sex work, STDs, and traffic to/from Kinshasa in the period 1899&#x02013;1923. Injection treatments increased sharply around 1930; however, their frequency among local patients was far lower than among modern groups experiencing parenteral HIV-1 outbreaks. Recent molecular datings of HIV-1 M fit better the period of maximal resource exploitation and trade links than the period of high injection intensity. We conclude that although local parenteral outbreaks might have occurred, these are unlikely to have caused massive transmission. World War I led to additional, and hitherto unrecognized, risks of HIV-1 emergence. We propose an Enhanced Heterosexual Transmission Hypothesis for the origin of HIV-1 M, featuring at the time and place of its origin a coincidence of favorable co-factors (ape hunting, social disruption, STDs, and mobility) for both cross-species transmission and heterosexual spread. Our hypothesis does not exclude a role for parenteral transmission in the initial viral adaptation.</p></abstract><kwd-group><kwd>HIV</kwd><kwd>SIV</kwd><kwd>Origin of HIV</kwd><kwd>zoonosis</kwd><kwd>Central Africa</kwd><kwd>genital ulcer disease</kwd><kwd>unsterile injections</kwd><kwd>bushmeat</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p>Simian Immunodeficiency Viruses (SIV) have jumped to humans at least thirteen times, leading to four known groups of Human Immunodeficiency Virus (HIV) type 1 (HIV-1) and nine groups of HIV type 2 (HIV-2) [<xref ref-type="bibr" rid="B1-viruses-04-01950">1</xref>,<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B3-viruses-04-01950">3</xref>,<xref ref-type="bibr" rid="B4-viruses-04-01950">4</xref>,<xref ref-type="bibr" rid="B5-viruses-04-01950">5</xref>,<xref ref-type="bibr" rid="B6-viruses-04-01950">6</xref>,<xref ref-type="bibr" rid="B7-viruses-04-01950">7</xref>,<xref ref-type="bibr" rid="B8-viruses-04-01950">8</xref>,<xref ref-type="bibr" rid="B9-viruses-04-01950">9</xref>,<xref ref-type="bibr" rid="B10-viruses-04-01950">10</xref>,<xref ref-type="bibr" rid="B11-viruses-04-01950">11</xref>,<xref ref-type="bibr" rid="B12-viruses-04-01950">12</xref>]. Both the pandemic strain (HIV-1 group M) and a rare variant only found in Cameroon (HIV-1 group N) originated from SIVcpz infecting wild chimpanzees of West Central Africa (<italic>Pan troglodytes troglodytes</italic>) [<xref ref-type="bibr" rid="B1-viruses-04-01950">1</xref>,<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B3-viruses-04-01950">3</xref>,<xref ref-type="bibr" rid="B4-viruses-04-01950">4</xref>,<xref ref-type="bibr" rid="B5-viruses-04-01950">5</xref>]. The rare HIV-1 group P, also found in Cameroon seems to have originated from SIVgor infecting western lowland gorillas (<italic>Gorilla gorilla gorilla</italic>) in the same region [<xref ref-type="bibr" rid="B10-viruses-04-01950">10</xref>,<xref ref-type="bibr" rid="B11-viruses-04-01950">11</xref>]. HIV-1 group O, which infects thousands of people mainly in Cameroon and neighboring countries, has SIVgor as its closest known relative, but an origin from SIVcpz cannot be formally excluded [<xref ref-type="bibr" rid="B1-viruses-04-01950">1</xref>,<xref ref-type="bibr" rid="B13-viruses-04-01950">13</xref>,<xref ref-type="bibr" rid="B14-viruses-04-01950">14</xref>]. All known nine HIV-2 groups are derived from SIVsmm endemic in sooty mangabey monkeys from the West African forests. Only HIV-2 groups A and B generated substantial human epidemics [<xref ref-type="bibr" rid="B4-viruses-04-01950">4</xref>,<xref ref-type="bibr" rid="B5-viruses-04-01950">5</xref>,<xref ref-type="bibr" rid="B6-viruses-04-01950">6</xref>,<xref ref-type="bibr" rid="B7-viruses-04-01950">7</xref>,<xref ref-type="bibr" rid="B8-viruses-04-01950">8</xref>,<xref ref-type="bibr" rid="B9-viruses-04-01950">9</xref>].</p><p>It is widely accepted that the most likely route of simian-to-human transmission of SIV was through bushmeat hunting and handling [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B3-viruses-04-01950">3</xref>,<xref ref-type="bibr" rid="B4-viruses-04-01950">4</xref>,<xref ref-type="bibr" rid="B9-viruses-04-01950">9</xref>,<xref ref-type="bibr" rid="B15-viruses-04-01950">15</xref>,<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>,<xref ref-type="bibr" rid="B17-viruses-04-01950">17</xref>,<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>]. One study reported a prevalence of seroreactivity to SIV of 17% in Central African villagers highly exposed to simian bushmeat, significantly higher than in unexposed individuals [<xref ref-type="bibr" rid="B19-viruses-04-01950">19</xref>]. Other simian retroviruses have found their way into humans through similar bushmeat practices, such as simian foamy virus [<xref ref-type="bibr" rid="B20-viruses-04-01950">20</xref>] and simian T-cell lymphotropic virus (STLV) [<xref ref-type="bibr" rid="B21-viruses-04-01950">21</xref>,<xref ref-type="bibr" rid="B22-viruses-04-01950">22</xref>]. Only a few of such zoonotic infections have turned into the human epidemics of HIV and HTLV.</p><p>Molecular clock analyses were used to estimate the timings of the most recent common ancestor (tMRCA) of epidemic human retroviruses. Estimates of tMRCA for the different HTLV-1 subtypes span between less than 3,000 and about 50,000 years ago [<xref ref-type="bibr" rid="B23-viruses-04-01950">23</xref>,<xref ref-type="bibr" rid="B24-viruses-04-01950">24</xref>]. HTLV-2 crossed to humans between 60,000 and 400,000 years ago [<xref ref-type="bibr" rid="B22-viruses-04-01950">22</xref>,<xref ref-type="bibr" rid="B23-viruses-04-01950">23</xref>,<xref ref-type="bibr" rid="B24-viruses-04-01950">24</xref>]. In contrast, the tMRCAs of all four main epidemic HIV groups (HIV-1 groups M and O and HIV-2 groups A and B) appear to be all very recent and nearly simultaneous in the early 20th century [<xref ref-type="bibr" rid="B6-viruses-04-01950">6</xref>,<xref ref-type="bibr" rid="B25-viruses-04-01950">25</xref>,<xref ref-type="bibr" rid="B26-viruses-04-01950">26</xref>,<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,<xref ref-type="bibr" rid="B28-viruses-04-01950">28</xref>,<xref ref-type="bibr" rid="B29-viruses-04-01950">29</xref>,<xref ref-type="bibr" rid="B30-viruses-04-01950">30</xref>,<xref ref-type="bibr" rid="B31-viruses-04-01950">31</xref>]. Similar research showed that the tMRCA of HIV-1 group M and its closest SIVcpz relative found to date, predates the spread of HIV-1 group M by only a few decades, suggesting that the cross-species transmission of SIVcpz giving rise to HIV-1 group M must have been in late 19th&#x02013;early 20th century. This fact suggests that phenomena new in the 20th century might have constituted the driving factors of HIV emergence. Among the potential factors, it has been noted that bushmeat intensification, forced labour, and smallpox vaccinations performed without proper sterilization were common in colonial Afrique &#x000c9;quatoriale Fran&#x000e7;aise (AEF; a federation of French colonies encompassing French Congo, Gabon, Oubangui-Chari, and Chad), these factors potentially increased human exposure to SIV and risks of human-to-human transmission and viral adaptation [<xref ref-type="bibr" rid="B5-viruses-04-01950">5</xref>].</p><p>Several authors proposed a major role of unsterile injections in HIV origins. One hypothesis proposes that unsterile injections serially transmitting SIV between humans in a chain of 3&#x02013;4 acutely infected people, improved its adaptation to the new host (as happens in experimental serial passage of SIV in macaques and monkeys [<xref ref-type="bibr" rid="B4-viruses-04-01950">4</xref>]). In this hypothesis such serial transmission chains are rare events, but once one happens the resulting adapted virus has long term epidemic potential, even if there is no further transmission immediately after the adaptive event [<xref ref-type="bibr" rid="B4-viruses-04-01950">4</xref>,<xref ref-type="bibr" rid="B32-viruses-04-01950">32</xref>,<xref ref-type="bibr" rid="B33-viruses-04-01950">33</xref>,<xref ref-type="bibr" rid="B34-viruses-04-01950">34</xref>]. The critical injections that might have fostered the origin of the several HIV groups were hypothesized to be either those of the antibiotic era (after ~1950) [<xref ref-type="bibr" rid="B4-viruses-04-01950">4</xref>,<xref ref-type="bibr" rid="B32-viruses-04-01950">32</xref>] or those belonging to the campaigns against human African trypanosomiases (HAT) (which peaked in 1925&#x02013;1945) [<xref ref-type="bibr" rid="B34-viruses-04-01950">34</xref>]. </p><p>Another parenteral hypothesis proposes that unsafe injections used in the treatment of tropical and infectious diseases (e.g., HAT, yaws, syphilis) might have massively transmitted SIV/HIV in rural areas, generating large hubs of infected people, with sexual transmission gaining importance only later on [<xref ref-type="bibr" rid="B17-viruses-04-01950">17</xref>,<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>]. It was proposed that HAT treatments performed in southwestern Oubangui-Chari (now the Central African Republic (CAR)) exponentially transmitted HIV-1 group M among the Mbimou tribe in the 1930s&#x02013;1940s, causing a large proportion of them to die of AIDS [<xref ref-type="bibr" rid="B35-viruses-04-01950">35</xref>]. </p><p>Social changes, and/or increased human mobility [<xref ref-type="bibr" rid="B3-viruses-04-01950">3</xref>], and the onset of urbanization in colonial Africa [<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>] have also been invoked as explanations for HIV emergence. We proposed that a high frequency of genital ulcer diseases (GUD), such as syphilis, chancroid, and lymphogranuloma venereum (LGV), a result of those social changes, and possibly also a relatively low frequency of male circumcision, in nascent colonial cities may have been the triggers of initial HIV transmission and adaptation to humans [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>]. GUD induced genital ulcers can dramatically increase HIV transmission [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>,<xref ref-type="bibr" rid="B36-viruses-04-01950">36</xref>,<xref ref-type="bibr" rid="B37-viruses-04-01950">37</xref>], and our work suggests that the high prevalence of these diseases might have provided crucial &#x0201c;help&#x0201d; for the initial spread of the virus.</p><p>In this article, we will focus on the origin of HIV-1 group M (HIV-1 M). Studies of sera collected in the period 1959&#x02013;1992 (reviewed in [<xref ref-type="bibr" rid="B38-viruses-04-01950">38</xref>]), the history of the early African AIDS cases (reviewed in [<xref ref-type="bibr" rid="B39-viruses-04-01950">39</xref>,<xref ref-type="bibr" rid="B40-viruses-04-01950">40</xref>]), the high genetic diversity exhibited by HIV-1 M in the Democratic Republic of Congo (DRC) compared to other African countries, particularly in Kinshasa [<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,<xref ref-type="bibr" rid="B41-viruses-04-01950">41</xref>,<xref ref-type="bibr" rid="B42-viruses-04-01950">42</xref>], and a recent phylogeographic analysis using HIV-1 M strains from many different DRC locations and from Brazzaville [<xref ref-type="bibr" rid="B43-viruses-04-01950">43</xref>] suggest that, by 1950, Kinshasa was the main human epicenter of the epidemic [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B15-viruses-04-01950">15</xref>,<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>,<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>,<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,<xref ref-type="bibr" rid="B43-viruses-04-01950">43</xref>]. Thus, this city may have been the place where the virus underwent its main initial spread and diversification, whether or not early foci first occurred elsewhere. </p><p>HIV-1 M clusters most closely with SIVcpz currently found in southeast Cameroon [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>], which suggests that the cross-species transmission happened in this part of Africa [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B15-viruses-04-01950">15</xref>]. This motivated us to investigate which factors present in these areas in the early 20th century might have been able to potentially promote SIV zoonotic transmission, sexual or parenteral transmission of the virus between humans, and migration of the virus to major centers. We retrieved colonial reports and archival data about Cameroon and AEF, and additional colonial medical, ethnographic and other literature to compare the different theories of HIV origins with available information from such archives.</p></sec><sec><title>2. Study of Risk Factors</title><sec id="sec2dot1-viruses-04-01950"><title>2.1. The Patchy Prevalence of SIVcpz and SIVgor</title><p>All known HIVs that originated in Central Africa are derived from either SIVcpz or SIVgor. The chances for an HIV-1 epidemic to originate in a particular region within the ranges of the relevant chimpanzee and gorilla subspecies would depend on local SIVcpz/SIVgor prevalence in wild apes, levels of ape bushmeat hunting, and the chance that an infected human carrier would bring the virus to a city hub at or near these areas, where transmission factors were favorable to its initial adaptation and spread. Most regions watered by the navigable branches of the Congo-Oubangui-Sangha fluvial system (which therefore had more contacts with the above cities during the early colonial period) are inhabited by either central chimpanzees (<italic>P.t.troglodytes</italic>), eastern chimpanzees (<italic>P.t.schweinfurthii</italic>), or western lowland gorillas (<italic>G.g.gorilla</italic>), the reservoirs of SIVcpz and SIVgor. SIVcpz seroprevalence is very patchy, with most communities having zero or low seroprevalence, and a minority with a prevalence around 30%&#x02013;60% [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B44-viruses-04-01950">44</xref>,<xref ref-type="bibr" rid="B45-viruses-04-01950">45</xref>]. SIVgor seroprevalence is only 1.6% on average and is zero at most sites [<xref ref-type="bibr" rid="B13-viruses-04-01950">13</xref>]. Ape bushmeat hunting was and is widespread in Central Africa, but its intensity varies across regions [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>,<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>,<xref ref-type="bibr" rid="B47-viruses-04-01950">47</xref>,<xref ref-type="bibr" rid="B48-viruses-04-01950">48</xref>].</p></sec><sec id="sec2dot2-viruses-04-01950"><title>2.2. The Region under Study</title><p>HIV-1 M is most closely related to SIVcpz retrieved from the southeast corner of Cameroon, a region flanked by the Sangha, Ngoko, and Boumba rivers, from the sites MB and LB (<xref ref-type="fig" rid="viruses-04-01950-f001">Figure 1</xref>) [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>]. SIVcpz forms phylogenetic clusters associated with regions separated by rivers and other geographical barriers, which pose obstacles to chimpanzee migration [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>]. This, and the short branches connecting HIV-1 M to SIVcpz collected from this area, justify the assumption that this group likely originated in the area enclosed by the above mentioned rivers [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B15-viruses-04-01950">15</xref>]. Here we will build on this assumption, while recognizing that it would need to be revised, should future evidence indicate that chimpanzee (or its virus) migration was more extensive over the century since the origin of HIV-1 M. In this region, current SIVcpz prevalence in chimpanzees is 20%&#x02013;35%, higher than in chimpanzees from Cameroon and Gabon as a whole [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B44-viruses-04-01950">44</xref>,<xref ref-type="bibr" rid="B49-viruses-04-01950">49</xref>], while hundreds of local gorilla fecal samples did not yield any evidence of SIVgor infection [<xref ref-type="bibr" rid="B13-viruses-04-01950">13</xref>].</p><fig id="viruses-04-01950-f001" position="anchor"><label>Figure 1</label><caption><p>The region of southeast Cameroon and neighboring Afrique &#x000c9;quatoriale Fran&#x000e7;aise (AEF) regions circa 1930. Sources: (1) on the SIV surveys: [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B13-viruses-04-01950">13</xref>,<xref ref-type="bibr" rid="B15-viruses-04-01950">15</xref>]; (2) on other elements: [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>,<xref ref-type="bibr" rid="B52-viruses-04-01950">52</xref>,<xref ref-type="bibr" rid="B53-viruses-04-01950">53</xref>].</p></caption><graphic xlink:href="viruses-04-01950-g001"/></fig></sec><sec id="sec2dot3-viruses-04-01950"><title>2.3. Evolution of Ape Hunting Practices over Time</title><p>Most Central African peoples that share their habitat with apes tend to hunt them, although there are important exceptions [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>,<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>]. For the studied area, we gathered numerous references documenting the hunting of apes throughout the colonial period and beyond, both within the Boumba-Ngoko-Sangha enclosure [<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>,<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>,<xref ref-type="bibr" rid="B55-viruses-04-01950">55</xref>,<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>,<xref ref-type="bibr" rid="B57-viruses-04-01950">57</xref>,<xref ref-type="bibr" rid="B58-viruses-04-01950">58</xref>,<xref ref-type="bibr" rid="B59-viruses-04-01950">59</xref>], and in adjacent regions west of the Boumba [<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>,<xref ref-type="bibr" rid="B57-viruses-04-01950">57</xref>,<xref ref-type="bibr" rid="B60-viruses-04-01950">60</xref>], south of the Ngoko [<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>,<xref ref-type="bibr" rid="B59-viruses-04-01950">59</xref>,<xref ref-type="bibr" rid="B61-viruses-04-01950">61</xref>], and east of the Sangha [<xref ref-type="bibr" rid="B61-viruses-04-01950">61</xref>,<xref ref-type="bibr" rid="B62-viruses-04-01950">62</xref>,<xref ref-type="bibr" rid="B63-viruses-04-01950">63</xref>,<xref ref-type="bibr" rid="B64-viruses-04-01950">64</xref>,<xref ref-type="bibr" rid="B65-viruses-04-01950">65</xref>].</p><p>According to some sources, the Aka and Baka pygmies that inhabit these regions seldom eat ape meat, although they hunt them to supply meat to clients [<xref ref-type="bibr" rid="B59-viruses-04-01950">59</xref>,<xref ref-type="bibr" rid="B65-viruses-04-01950">65</xref>,<xref ref-type="bibr" rid="B66-viruses-04-01950">66</xref>]. However, at least in some of the areas, pygmies eat ape meat frequently [<xref ref-type="bibr" rid="B63-viruses-04-01950">63</xref>,<xref ref-type="bibr" rid="B64-viruses-04-01950">64</xref>]. The non-pygmies of these areas generally eat apes, although this is restricted by certain beliefs: often an animal species is thought to represent the clans&#x02019; ancestors, or to have helped them in the past, this preventing their hunting. For example, gorillas and chimpanzees are not killed by a branch of the Bangantu ethnic group, because they are believed to have helped their ancestors [<xref ref-type="bibr" rid="B67-viruses-04-01950">67</xref>]; some Djem clans regard the gorilla as their totem, and do not hunt these animals [<xref ref-type="bibr" rid="B60-viruses-04-01950">60</xref>]. It should be kept in mind that clans are often more important than ethnic groups as determinants of hunting restrictions [<xref ref-type="bibr" rid="B68-viruses-04-01950">68</xref>]. </p><p>In many of the ethnic groups of the region, women were traditionally forbidden to or strongly discouraged from eating chimpanzee and gorilla meat [<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>,<xref ref-type="bibr" rid="B47-viruses-04-01950">47</xref>,<xref ref-type="bibr" rid="B48-viruses-04-01950">48</xref>,<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>,<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>]. Gorilla meat is generally preferred to chimpanzee meat [<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>,<xref ref-type="bibr" rid="B48-viruses-04-01950">48</xref>,<xref ref-type="bibr" rid="B63-viruses-04-01950">63</xref>,<xref ref-type="bibr" rid="B64-viruses-04-01950">64</xref>].</p><p>In 1907, a French observer noted that the Mbimou people, who live between Yokadouma (Cameroon) and Nola (AEF), &#x0201c;loved&#x0201d; to hunt chimpanzees and gorillas. Colonial concessionary companies corroborated this [<xref ref-type="bibr" rid="B55-viruses-04-01950">55</xref>,<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>]. Chimpanzee hunting for bushmeat was probably practiced in the area around Moloundou in 1910&#x02013;1912, because a German observer remarked that chimpanzee meat was forbidden to women [<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>]. In the 1930s, the hunter Fred Merfield noted that the Menzime hunted gorillas more frequently than the peoples of south-central and southwest Cameroon [<xref ref-type="bibr" rid="B47-viruses-04-01950">47</xref>].</p><p>French and German concessionary companies sold thousands of firearms in the region in exchange for rubber and ivory in the period 1895&#x02013;1910, and observers noted that most local peoples (Bangantu, Konabembe, Menzime, Mbimou) owned firearms [<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>,<xref ref-type="bibr" rid="B47-viruses-04-01950">47</xref>,<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>,<xref ref-type="bibr" rid="B55-viruses-04-01950">55</xref>,<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>,<xref ref-type="bibr" rid="B69-viruses-04-01950">69</xref>]. More than 10,000 had been sold by the French Compagnie Ngoko-Sangha (CNS) in the period 1900&#x02013;1907 [<xref ref-type="bibr" rid="B69-viruses-04-01950">69</xref>]. These were mostly old&#x02011;fashioned muzzle-loaded guns (although modern rifles were also sold), with which the hunting of apes is difficult and unsafe for a lone hunter. However, it was observed that muzzle-loaded guns were used by hunters, jointly with spears and other traditional weapons, to kill gorillas in collective round&#x02011;ups [<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>,<xref ref-type="bibr" rid="B47-viruses-04-01950">47</xref>]. From these descriptions, it is unclear whether muzzle-loaded guns contributed greatly to the efficiency of ape hunting; however, villagers with any type of guns may have been more willing to hunt, which probably led to more ape hunting.</p><p>Ivory collection was intense in this region in the first decade of the 20th century: already by 1912&#x02013;1914 there were worries about the extinction of elephants in the region [<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>]. Rubber collection was forcibly imposed on villagers by colonial companies in exchange for low pay. They had to move deeply into the forests, staying separated from their families for weeks, and this increased reliance on bushmeat [<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>,<xref ref-type="bibr" rid="B57-viruses-04-01950">57</xref>,<xref ref-type="bibr" rid="B70-viruses-04-01950">70</xref>]. The Menzime specialized in supplying bushmeat to rubber collectors and hunted apes very frequently [<xref ref-type="bibr" rid="B47-viruses-04-01950">47</xref>]. In the early to mid-1920s, the lower post-war demand and increased competition from South-American and Asian rubber caused the local rubber prices to collapse [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>]. This caused the foreclosure of most enterprises of the Mouloundou area in 1922&#x02013;1923 [<xref ref-type="bibr" rid="B47-viruses-04-01950">47</xref>,<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>]. However, a new economic development wave centered on coffee and cacao plantations started at that time, and the plantation workers were supplied with bushmeat by specialized hunters [<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>]. Animal skins were procured by concessionary companies and rubber collection continued, albeit reduced. In addition, men working in road construction (more important since the late 1920s) may have been supplied with bushmeat too, since this was common in Central African enterprises [<xref ref-type="bibr" rid="B71-viruses-04-01950">71</xref>,<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>]. These activities probably maintained a high level of human exposures to SIVcpz and SIVgor even after the end of the &#x0201c;rubber and ivory&#x0201d; period. </p><p>From 1916 onwards, the AEF administration introduced measures to protect wildlife, including elephants and gorillas (but not chimpanzees) [<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>]. New hunting laws and permits were enacted in 1929&#x02013;1930, in both AEF [<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>,<xref ref-type="bibr" rid="B73-viruses-04-01950">73</xref>] and Cameroon (report of the French administration of Cameroon to the League of Nations, 1930 [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>]). Chimpanzee hunting became restricted to holders of scientific permits. Gorilla hunting became restricted to holders of either scientific or &#x0201c;<italic>sportif</italic>&#x0201d; (touristic) permits (who were almost always European), and holders of special large game permits (which could be privileged Africans). </p><p>The enforcement of these laws was difficult in interior areas, where colonial administrative personnel visited less frequently. Accordingly, we read numerous descriptions of ape hunting in which the law was violated: Merfield observed collective round-ups of gorillas practiced by the Yaunde and the Menzime in Cameroon, in the late 1920s and 1930s [<xref ref-type="bibr" rid="B47-viruses-04-01950">47</xref>]; Denis observed such practice among the Mbeti (French Congo) in the 1940s [<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>]. In the Belgian Congo, where similar laws protecting apes existed [<xref ref-type="bibr" rid="B74-viruses-04-01950">74</xref>,<xref ref-type="bibr" rid="B75-viruses-04-01950">75</xref>], live infant chimpanzees were being traded in the 1950s [<xref ref-type="bibr" rid="B39-viruses-04-01950">39</xref>,<xref ref-type="bibr" rid="B40-viruses-04-01950">40</xref>]; this implies that their parents had been killed [<xref ref-type="bibr" rid="B39-viruses-04-01950">39</xref>,<xref ref-type="bibr" rid="B76-viruses-04-01950">76</xref>], at a time when colonial administrative control was at its peak.</p><p>With decolonization, in 1960, hunting law enforcement degraded even further, modern firearms became more available, and bushmeat became increasingly commercialized, accelerating the collapse of the chimpanzee and gorilla populations (worldwide, chimpanzees were between one and two million in 1960, and had declined to 170,000&#x02013;300,000 in 2003 [<xref ref-type="bibr" rid="B77-viruses-04-01950">77</xref>,<xref ref-type="bibr" rid="B78-viruses-04-01950">78</xref>,<xref ref-type="bibr" rid="B79-viruses-04-01950">79</xref>]). We can tentatively suggest that ape hunting was less intense in the period 1930&#x02013;1960, when the relevant protective laws were being partly enforced, than either before or after that.</p></sec><sec id="sec2dot4-viruses-04-01950"><title>2.4. Nosocomial Risks</title><sec id="sec2dot4dot1-viruses-04-01950"><title>2.4.1. General Trends</title><p>Parenteral risks such as posed by unsterile injections and vaccinations could have favored initial HIV spread in both rural areas and cities. In this article we attempt to quantify these risks in the rural area under study, while recognizing that quantifying them in the colonial cities more probably associated with early HIV spread (e.g., Kinshasa) is a worthwhile project. </p><p>Several reviews indicate that the broadest (in the sense of number of people covered) healthcare interventions involving injections/inoculations in rural Central Africa up to Word War II were smallpox vaccinations and treatments against HAT and treponemal diseases (yaws and syphilis) [<xref ref-type="bibr" rid="B17-viruses-04-01950">17</xref>,<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>,<xref ref-type="bibr" rid="B34-viruses-04-01950">34</xref>,<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>]. <xref ref-type="fig" rid="viruses-04-01950-f002">Figure 2</xref> displays the annual numbers of these interventions in Cameroon.</p><fig id="viruses-04-01950-f002" position="anchor"><label>Figure 2</label><caption><p>Reported annual numbers of treatments against human African trypanosomiasis (HAT) (only newly diagnosed cases), syphilis and yaws, and of smallpox vaccinations in French-administrated Cameroon, in the period 1920&#x02013;1960. The references are listed in Methods.</p></caption><graphic xlink:href="viruses-04-01950-g002"/></fig></sec><sec id="sec2dot4dot2-viruses-04-01950"><title>2.4.2. Smallpox Vaccinations</title><p>Colonial medical authors had expressed concern about the parenteral risks of smallpox inoculations from very early times. One, writing in 1906, reported that catheters were carefully boiled between inoculations of <italic>Tirailleurs</italic> (the elite African troops) [<xref ref-type="bibr" rid="B80-viruses-04-01950">80</xref>]. In vaccinations of the general African population the standards of safety were probably lower, although several sources of the early 1920s do mention sterilization procedures [<xref ref-type="bibr" rid="B81-viruses-04-01950">81</xref>,<xref ref-type="bibr" rid="B82-viruses-04-01950">82</xref>], such as plunging catheters in a saucer with burning alcohol [<xref ref-type="bibr" rid="B82-viruses-04-01950">82</xref>]. Such &#x0201c;flaming&#x0201d; procedures do effectively kill retroviruses like SIV or HIV; however we do not know how often vaccinations were performed with inadequate or no sterilization procedures.</p><p>Jennerian inoculations were practiced in Cameroon and AEF throughout the colonial period. They were often ineffective, and this prompted medical authorities to revaccinate people often. In the period 1922&#x02013;1940, the annual inoculation rate in the population of French-administrated Cameroon was in the range 12&#x02013;22% [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>], so each person was being inoculated once every 5&#x02013;8 years. In AEF, the frequency was slightly lower [<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>,<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>]. This frequency of parenteral exposures was much lower than in injection treatments (the latter will be reviewed below).</p><p>In the period 1890&#x02013;1910 there were shortages of viable vaccine in interior regions because the heat during the long journey to the interior often caused them to lose effectiveness. Pressed by smallpox epidemics, doctors performed arm-arm inoculations: they collected lymph from the pustule of a recently vaccinated person to vaccinate the next. As was well recognized at the time [<xref ref-type="bibr" rid="B81-viruses-04-01950">81</xref>], this procedure causes a much higher parenteral risk because more lymph is transferred than in normal unsterile catheter reuses. Some of these interventions were done by the French in &#x0201c;Haute Sangha&#x0201d;, which normally designates the region to the north of (and including) Nola [<xref ref-type="bibr" rid="B80-viruses-04-01950">80</xref>,<xref ref-type="bibr" rid="B83-viruses-04-01950">83</xref>,<xref ref-type="bibr" rid="B84-viruses-04-01950">84</xref>]. Lymph was collected from relatively few individuals, each donating to many people, and lymph was gathered from their pustules 4&#x02013;5 days after inoculation [<xref ref-type="bibr" rid="B84-viruses-04-01950">84</xref>,<xref ref-type="bibr" rid="B85-viruses-04-01950">85</xref>,<xref ref-type="bibr" rid="B86-viruses-04-01950">86</xref>]. This practice was, however, less common than the normal method of Jennerian inoculation. </p></sec><sec id="sec2dot4dot3-viruses-04-01950"><title>2.4.3. Yaws and Syphilis Treatments</title><p>In Cameroon, anti-treponemal treatments rose sharply in 1925. They multiplied 10-fold between the early 1920s and the 1950s [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,<xref ref-type="bibr" rid="B87-viruses-04-01950">87</xref>,<xref ref-type="bibr" rid="B88-viruses-04-01950">88</xref>,<xref ref-type="bibr" rid="B89-viruses-04-01950">89</xref>,<xref ref-type="bibr" rid="B90-viruses-04-01950">90</xref>,<xref ref-type="bibr" rid="B91-viruses-04-01950">91</xref>,<xref ref-type="bibr" rid="B92-viruses-04-01950">92</xref>,<xref ref-type="bibr" rid="B93-viruses-04-01950">93</xref>,<xref ref-type="bibr" rid="B94-viruses-04-01950">94</xref>,<xref ref-type="bibr" rid="B95-viruses-04-01950">95</xref>,<xref ref-type="bibr" rid="B96-viruses-04-01950">96</xref>,<xref ref-type="bibr" rid="B97-viruses-04-01950">97</xref>] (<xref ref-type="fig" rid="viruses-04-01950-f002">Figure 2</xref>), <italic>i.e.</italic>, with a peak later than the origin of the more widespread HIV-1 groups (M and O). In forested areas (as in the region where HIV-1 M came from) yaws was more common than syphilis. In the 1920s and 1930s, 90%&#x02013;95% of people treated for yaws were children [<xref ref-type="bibr" rid="B94-viruses-04-01950">94</xref>,<xref ref-type="bibr" rid="B98-viruses-04-01950">98</xref>]&#x02014;less likely to be SIV- or HIV-infected.</p><p>The most important drug used against these diseases was the arsenical compound <italic>neoarsenobenzol</italic> (called <italic>neosalvarsan</italic> or <italic>neo</italic>), available since 1912, soon after its predecessor <italic>arsenobenzol</italic>. It was administered intravenously. Other arsenical compounds, and bismuth and mercury compounds were also used. Bismuth was administered intramuscularly or subcutaneously [<xref ref-type="bibr" rid="B99-viruses-04-01950">99</xref>,<xref ref-type="bibr" rid="B100-viruses-04-01950">100</xref>,<xref ref-type="bibr" rid="B101-viruses-04-01950">101</xref>] and, being better tolerated by Africans than mercury, became increasingly preferred [<xref ref-type="bibr" rid="B102-viruses-04-01950">102</xref>]. Orally administered <italic>stovarsol</italic> was also heavily used. To attempt complete cures of syphilis, prolonged treatment regimens involving many injections (combining an arsenical with other compounds) were recommended [<xref ref-type="bibr" rid="B103-viruses-04-01950">103</xref>]. Accordingly, the best anti-venereal disease hospitals, clinics, and dispensaries in urban centers often administered many injections per patient. For example, in the Institut Policlinique de Dakar, in 1933 and 1934, syphilis patients received an average of 17 and 25 injections per year, respectively; in the Vernes Dispensaries of Madagascar, in 1934, the average was 17 [<xref ref-type="bibr" rid="B94-viruses-04-01950">94</xref>]; in the Croix Rouge du Congo of Leopoldville-East, the averages of injections per syphilis patient per year, in the period 1933&#x02013;1940, were in the range 15&#x02013;24 [<xref ref-type="bibr" rid="B101-viruses-04-01950">101</xref>]. </p><p>However, in less favored dispensaries and in rural areas, much fewer injections were given [<xref ref-type="bibr" rid="B92-viruses-04-01950">92</xref>,<xref ref-type="bibr" rid="B94-viruses-04-01950">94</xref>]. For example, in non-specialized Madagascar dispensaries, in 1934, the average was 3.7 injections per syphilis patient per year, of which 1.25 were of arsenicals [<xref ref-type="bibr" rid="B94-viruses-04-01950">94</xref>]. We refer these Madagascar data because only for this colony the French articles we reviewed provide the figures of injections per patient for "normal" (non-specialized in venereal disease) dispensaries. This is relevant, because the dispensaries existing in the region under study were also non-specialized. Several authors writing about syphilis and yaws treatments in medical <italic>tourn&#x000e9;es</italic> by rural areas of AEF and Cameroon in the 1920s and 1930s, state that the average patient received just one or two <italic>neosalvarsan</italic> injections [<xref ref-type="bibr" rid="B98-viruses-04-01950">98</xref>,<xref ref-type="bibr" rid="B92-viruses-04-01950">92</xref>,<xref ref-type="bibr" rid="B104-viruses-04-01950">104</xref>]. This is corroborated by the administrative reports of Cameroon sent to the League of Nations: in the period 1922&#x02013;1931 the average number of such injections per treponematosis patient per year was in the range 1.0&#x02013;1.9 (or 1.4&#x02013;2.3 counting mercurial and <italic>sulfarsenol</italic> injections) (<xref ref-type="table" rid="viruses-04-01950-t001">Table 1</xref>) [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,<xref ref-type="bibr" rid="B88-viruses-04-01950">88</xref>,<xref ref-type="bibr" rid="B105-viruses-04-01950">105</xref>].</p><table-wrap id="viruses-04-01950-t001" position="float"><object-id pub-id-type="pii">viruses-04-01950-t001_Table 1</object-id><label>Table 1</label><caption><p>Injection treatments against treponematoses in Cameroon, 1922&#x02013;1931. Sources: [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,<xref ref-type="bibr" rid="B88-viruses-04-01950">88</xref>,<xref ref-type="bibr" rid="B105-viruses-04-01950">105</xref>].</p></caption><table frame="hsides" rules="all" style="border: solid thin"><thead><tr><th rowspan="2" align="center" valign="middle" colspan="1">Year</th><th colspan="2" align="center" valign="middle" rowspan="1"># of treponematoses cases</th><th colspan="3" align="center" valign="middle" rowspan="1"># of injections</th><th colspan="2" align="center" valign="middle" rowspan="1"># of injections/patient/year</th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">Syphilis</th><th align="center" valign="middle" rowspan="1" colspan="1">Yaws</th><th align="center" valign="middle" rowspan="1" colspan="1">Neosalvarsan</th><th align="center" valign="middle" rowspan="1" colspan="1">Mercury salts</th><th align="center" valign="middle" rowspan="1" colspan="1">Sulfarsenol</th><th align="center" valign="middle" rowspan="1" colspan="1">Neosalvarsan</th><th align="center" valign="middle" rowspan="1" colspan="1">Others</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1922</td><td align="center" valign="middle" rowspan="1" colspan="1">8,285</td><td align="center" valign="middle" rowspan="1" colspan="1">6,129</td><td align="center" valign="middle" rowspan="1" colspan="1">27,800</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">1.93</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1923</td><td align="center" valign="middle" rowspan="1" colspan="1">8,237</td><td align="center" valign="middle" rowspan="1" colspan="1">6,552</td><td align="center" valign="middle" rowspan="1" colspan="1">20,050</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">1.36</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1927</td><td align="center" valign="middle" rowspan="1" colspan="1">32,303</td><td align="center" valign="middle" rowspan="1" colspan="1">18,930</td><td align="center" valign="middle" rowspan="1" colspan="1">59,200</td><td align="center" valign="middle" rowspan="1" colspan="1">15,274</td><td align="center" valign="middle" rowspan="1" colspan="1">22,310</td><td align="center" valign="middle" rowspan="1" colspan="1">1.16</td><td align="center" valign="middle" rowspan="1" colspan="1">0.73</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1928</td><td align="center" valign="middle" rowspan="1" colspan="1">42,015</td><td align="center" valign="middle" rowspan="1" colspan="1">24,718</td><td align="center" valign="middle" rowspan="1" colspan="1">76,270</td><td align="center" valign="middle" rowspan="1" colspan="1">18,158</td><td align="center" valign="middle" rowspan="1" colspan="1">59,450</td><td align="center" valign="middle" rowspan="1" colspan="1">1.14</td><td align="center" valign="middle" rowspan="1" colspan="1">1.16</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1929</td><td align="center" valign="middle" rowspan="1" colspan="1">40,341</td><td align="center" valign="middle" rowspan="1" colspan="1">30,031</td><td align="center" valign="middle" rowspan="1" colspan="1">75,567</td><td align="center" valign="middle" rowspan="1" colspan="1">20,128</td><td align="center" valign="middle" rowspan="1" colspan="1">4,731</td><td align="center" valign="middle" rowspan="1" colspan="1">1.07</td><td align="center" valign="middle" rowspan="1" colspan="1">0.35</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1930</td><td align="center" valign="middle" rowspan="1" colspan="1">35,693</td><td align="center" valign="middle" rowspan="1" colspan="1">29,701</td><td align="center" valign="middle" rowspan="1" colspan="1">77,728</td><td align="center" valign="middle" rowspan="1" colspan="1">23,085</td><td align="center" valign="middle" rowspan="1" colspan="1">15,591</td><td align="center" valign="middle" rowspan="1" colspan="1">1.19</td><td align="center" valign="middle" rowspan="1" colspan="1">0.59</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1931</td><td align="center" valign="middle" rowspan="1" colspan="1">42,730</td><td align="center" valign="middle" rowspan="1" colspan="1">29,086</td><td align="center" valign="middle" rowspan="1" colspan="1">106,669</td><td align="center" valign="middle" rowspan="1" colspan="1">27,800</td><td align="center" valign="middle" rowspan="1" colspan="1">32,680</td><td align="center" valign="middle" rowspan="1" colspan="1">1.49</td><td align="center" valign="middle" rowspan="1" colspan="1">0.84</td></tr></tbody></table><table-wrap-foot><fn><p>NA: Not available.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2dot4dot4-viruses-04-01950"><title>2.4.4. The HAT Campaigns</title><p>Two drugs constituted the main arsenal against HAT (sleeping sickness) in Central Africa, until the Second World War: <italic>atoxyl</italic>, administered intramuscularly, which had little therapeutic value, and <italic>tryparsamide</italic>, administered intravenously, which permitted cures in advanced disease. Other intravenous drugs were used in the 1930s, but their combined number of injections was considerably lower than that of <italic>tryparsamide</italic>. In AEF, Belgian Congo, and German Kamerun (we will use this spelling to refer to Cameroon under German colonization, 1884&#x02013;1916), <italic>atoxyl </italic>started to be used around 1907&#x02013;1909 [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B106-viruses-04-01950">106</xref>,<xref ref-type="bibr" rid="B107-viruses-04-01950">107</xref>]. Colonial doctors believed that <italic>atoxyl </italic>could clear the peripheral blood from trypanosomes and thus, injecting rural people on a large scale would prevent the spread of the epidemic. They performed numerous &#x0201c;<italic>tourn&#x000e9;es d'atoxylization</italic>&#x0201d; in many rural areas of Central Africa in the two decades following 1907, administering usually one or two injections to each person infected or suspected to be infected [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B108-viruses-04-01950">108</xref>,<xref ref-type="bibr" rid="B109-viruses-04-01950">109</xref>,<xref ref-type="bibr" rid="B110-viruses-04-01950">110</xref>,<xref ref-type="bibr" rid="B111-viruses-04-01950">111</xref>,<xref ref-type="bibr" rid="B112-viruses-04-01950">112</xref>]. Several injection campaigns were performed by the French in Haute Sangha (including Nola) in the period 1907&#x02013;1913 [<xref ref-type="bibr" rid="B83-viruses-04-01950">83</xref>,<xref ref-type="bibr" rid="B109-viruses-04-01950">109</xref>,<xref ref-type="bibr" rid="B112-viruses-04-01950">112</xref>]. Others were performed by the Germans in the Nola region (which was annexed to Kamerun in the period 1911&#x02013;1914 following a Franco-German agreement) and in neighboring southeast Kamerun, where the disease was observed on the banks of the Ngoko [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B113-viruses-04-01950">113</xref>]. These <italic>tourn&#x000e9;es</italic> were very irregular: some interior regions were not visited at all for many years; and, particularly in the 1920s, some regions were visited often, causing some people to receive six and sometimes more injections per year [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B114-viruses-04-01950">114</xref>].</p><p><italic>Tryparsamide </italic>started to be used in the mid-1920s, and was administered in series of weekly intravenous injections (with varying regimens). HAT campaigns peaked earlier than syphilis and yaws treatments, <italic>i.e.</italic>, nearer to the calculated tMRCAs of HIV-1 groups M and O [<xref ref-type="bibr" rid="B26-viruses-04-01950">26</xref>,<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,<xref ref-type="bibr" rid="B28-viruses-04-01950">28</xref>,<xref ref-type="bibr" rid="B29-viruses-04-01950">29</xref>,<xref ref-type="bibr" rid="B30-viruses-04-01950">30</xref>]. In Cameroon, they had a sharp peak in 1926&#x02013;1928 (<xref ref-type="fig" rid="viruses-04-01950-f002">Figure 2</xref>), when Eugene Jamot started more organized campaigns based on mobile teams that visited most of the population [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,<xref ref-type="bibr" rid="B115-viruses-04-01950">115</xref>,<xref ref-type="bibr" rid="B116-viruses-04-01950">116</xref>,<xref ref-type="bibr" rid="B117-viruses-04-01950">117</xref>,<xref ref-type="bibr" rid="B118-viruses-04-01950">118</xref>]. A few years later, similar teams were put in place in AEF [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B119-viruses-04-01950">119</xref>]. Review articles about these organized campaigns of French Cameroon and AEF show that each patient received 15&#x02013;24 injections, spread over a period of treatment of two or more years. More than half of the injections were of the cheaper and non-intravenous <italic>atoxyl </italic>[<xref ref-type="bibr" rid="B115-viruses-04-01950">115</xref>,<xref ref-type="bibr" rid="B116-viruses-04-01950">116</xref>,<xref ref-type="bibr" rid="B120-viruses-04-01950">120</xref>]. </p><p>This suggests that the organized HAT campaigns, during their peak period in Cameroon and AEF (broadly 1926&#x02013;1940), involved considerably higher parenteral risks than syphilis and yaws treatments in the same regions. Probably, the early &#x0201c;<italic>atoxylization</italic>&#x0201d; campaigns (1907&#x02013;1926) posed lower parenteral risks than the more organized ones (which started in 1926): they were irregularly done, each patient received relatively few injections, and these were intramuscular or subcutaneous.</p><p>Colonial health reports mention the number of HAT patients surveyed (newly found ill or old patients revisited). All new patients, and some of the old ones were treated. In 1930, the surveyed HAT patients in AEF received on average only 3.05 injections each (the average of those <italic>effectively treated</italic> was higher; we cannot calculate it because the proportion of surveyed old cases treated was seldom quantified in the reports). This average increased throughout the 1930s (<xref ref-type="table" rid="viruses-04-01950-t002">Table 2</xref>). </p><table-wrap id="viruses-04-01950-t002" position="float"><object-id pub-id-type="pii">viruses-04-01950-t002_Table 2</object-id><label>Table 2</label><caption><p>Injections against human African trypanosomiasis (HAT) in Afrique &#x000c9;quatoriale Fran&#x000e7;aise (AEF). All &#x0201c;new&#x0201d; cases were usually treated with around 12 injections; however, in 1930, this was probably less, given the total number of injections reported. Not all surveyed &#x0201c;old&#x0201d; cases were treated. Sources: [<xref ref-type="bibr" rid="B90-viruses-04-01950">90</xref>,<xref ref-type="bibr" rid="B94-viruses-04-01950">94</xref>,<xref ref-type="bibr" rid="B95-viruses-04-01950">95</xref>,<xref ref-type="bibr" rid="B97-viruses-04-01950">97</xref>]. </p></caption><table frame="hsides" rules="all" style="border: solid thin"><thead><tr><th rowspan="2" align="center" valign="middle" colspan="1">Year</th><th colspan="2" align="center" valign="middle" rowspan="1"># of surveyed HAT cases</th><th rowspan="2" align="center" valign="middle" colspan="1"># of injections performed</th><th colspan="3" align="center" valign="middle" rowspan="1"># of injections per patient per year</th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">New cases</th><th align="center" valign="middle" rowspan="1" colspan="1">Old cases</th><th align="center" valign="middle" rowspan="1" colspan="1">All surveyed cases</th><th align="center" valign="middle" rowspan="1" colspan="1">New cases (all treated)</th><th align="center" valign="middle" rowspan="1" colspan="1">Old cases</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1930</td><td align="center" valign="middle" rowspan="1" colspan="1">12,649</td><td align="center" valign="middle" rowspan="1" colspan="1">34,611</td><td align="center" valign="middle" rowspan="1" colspan="1">144,168</td><td align="center" valign="middle" rowspan="1" colspan="1">3.05</td><td align="center" valign="middle" rowspan="1" colspan="1">6-8?</td><td align="center" valign="middle" rowspan="1" colspan="1">1-2?</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1934</td><td align="center" valign="middle" rowspan="1" colspan="1">13,368</td><td align="center" valign="middle" rowspan="1" colspan="1">42,508</td><td align="center" valign="middle" rowspan="1" colspan="1">254,000</td><td align="center" valign="middle" rowspan="1" colspan="1">4.55</td><td align="center" valign="middle" rowspan="1" colspan="1">~12</td><td align="center" valign="middle" rowspan="1" colspan="1">2.20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1935</td><td align="center" valign="middle" rowspan="1" colspan="1">12,557</td><td align="center" valign="middle" rowspan="1" colspan="1">54,709</td><td align="center" valign="middle" rowspan="1" colspan="1">262,424</td><td align="center" valign="middle" rowspan="1" colspan="1">3.90</td><td align="center" valign="middle" rowspan="1" colspan="1">~12</td><td align="center" valign="middle" rowspan="1" colspan="1">2.75</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1937</td><td align="center" valign="middle" rowspan="1" colspan="1">16,597</td><td align="center" valign="middle" rowspan="1" colspan="1">60,196</td><td align="center" valign="middle" rowspan="1" colspan="1">597,409</td><td align="center" valign="middle" rowspan="1" colspan="1">7.78</td><td align="center" valign="middle" rowspan="1" colspan="1">~12</td><td align="center" valign="middle" rowspan="1" colspan="1">6.62</td></tr></tbody></table></table-wrap></sec><sec id="sec2dot4dot5-viruses-04-01950"><title>2.4.5. The Early 1930s: Intensification of Injection Treatments</title><p>The organized HAT campaigns in Cameroon started in 1926, and the number of newly identified patients peaked in the period 1926&#x02013;1928 (<xref ref-type="fig" rid="viruses-04-01950-f002">Figure 2</xref>). However, this effort did not arrive to the southeast district of Yokadouma (which encompassed the Cameroonian banks of the Ngoko and Sangha river; <xref ref-type="fig" rid="viruses-04-01950-f001">Figure 1</xref>) until 1932, when this area was first visited by the mobile teams [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,<xref ref-type="bibr" rid="B92-viruses-04-01950">92</xref>]. The teams, which visited almost all inhabitants, found 14% of them infected (44% in the southern areas near the Ngoko) [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>]. Each infected person may have been treated with more than 15 injections in the next few years (see above). In addition, the report of Cameroon for that year [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>] states that the district never had continuous medical action before. Thus, the year 1932 brought unprecedented levels of parenteral risks to southeast Cameroon.</p><p>Anti-HAT campaigns in the neighboring AEF regions of Nola and Ouesso peaked after 1929&#x02013;1930, although there was some activity before [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>]. In Nola, there were only 380 new HAT cases treated in 1930, and the number rose sharply after that (<xref ref-type="table" rid="viruses-04-01950-t003">Table 3</xref>). The Mbimou people, who live between Yokadouma and Nola were the main focus but were only systematically treated in the 1930s (<xref ref-type="table" rid="viruses-04-01950-t003">Table 3</xref> and related references). However, according to a reviewer, they were being insufficiently treated at least until 1935 [<xref ref-type="bibr" rid="B121-viruses-04-01950">121</xref>]. Our own research of the relevant AEF reports [<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>] reveals that each surveyed (new or old revisited) HAT patient from Nola (mostly Mbimou) received an average of 4.58 injections in 1933 and 4.59 the following year.</p><table-wrap id="viruses-04-01950-t003" position="float"><object-id pub-id-type="pii">viruses-04-01950-t003_Table 3</object-id><label>Table 3</label><caption><p>Systematic treatments against human African trypanosomiasis (HAT) in southeast Cameroon and neighboring districts of Afrique &#x000c9;quatoriale Fran&#x000e7;aise (AEF), up to 1936. Dashes indicate no systematic activity, according to the reports. Some of the old cases were also treated. Sources: [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>,<xref ref-type="bibr" rid="B87-viruses-04-01950">87</xref>,<xref ref-type="bibr" rid="B88-viruses-04-01950">88</xref>,<xref ref-type="bibr" rid="B89-viruses-04-01950">89</xref>,<xref ref-type="bibr" rid="B90-viruses-04-01950">90</xref>,<xref ref-type="bibr" rid="B91-viruses-04-01950">91</xref>,<xref ref-type="bibr" rid="B92-viruses-04-01950">92</xref>,<xref ref-type="bibr" rid="B93-viruses-04-01950">93</xref>,<xref ref-type="bibr" rid="B94-viruses-04-01950">94</xref>,<xref ref-type="bibr" rid="B95-viruses-04-01950">95</xref>,<xref ref-type="bibr" rid="B96-viruses-04-01950">96</xref>,<xref ref-type="bibr" rid="B97-viruses-04-01950">97</xref>].</p></caption><table frame="hsides" rules="all" style="border: solid thin"><thead><tr><th rowspan="2" align="center" valign="middle" colspan="1">Year</th><th colspan="2" align="center" valign="middle" rowspan="1">Yokadouma sector <sup>a</sup> (Cameroon)</th><th colspan="2" align="center" valign="middle" rowspan="1">Nola sector (AEF) <sup>b</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">Ouesso sector (AEF) <sup>b</sup></th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">New cases</th><th align="center" valign="middle" rowspan="1" colspan="1">Surveyed old cases</th><th align="center" valign="middle" rowspan="1" colspan="1">New cases</th><th align="center" valign="middle" rowspan="1" colspan="1">Surveyed old cases</th><th align="center" valign="middle" rowspan="1" colspan="1">New cases</th><th align="center" valign="middle" rowspan="1" colspan="1">Surveyed old cases</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1927</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1928</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">228</td><td align="center" valign="middle" rowspan="1" colspan="1">222</td><td align="center" valign="middle" rowspan="1" colspan="1">108</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1929</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">77</td><td align="center" valign="middle" rowspan="1" colspan="1">176</td><td align="center" valign="middle" rowspan="1" colspan="1">212</td><td align="center" valign="middle" rowspan="1" colspan="1">242</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1930</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">380</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">154</td><td align="center" valign="middle" rowspan="1" colspan="1">356</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1931</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">594</td><td align="center" valign="middle" rowspan="1" colspan="1">2,371</td><td align="center" valign="middle" rowspan="1" colspan="1">116</td><td align="center" valign="middle" rowspan="1" colspan="1">457</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1932</td><td align="center" valign="middle" rowspan="1" colspan="1">2,928</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">590</td><td align="center" valign="middle" rowspan="1" colspan="1">1,812</td><td align="center" valign="middle" rowspan="1" colspan="1">130</td><td align="center" valign="middle" rowspan="1" colspan="1">957</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1933</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">885</td><td align="center" valign="middle" rowspan="1" colspan="1">3,409</td><td align="center" valign="middle" rowspan="1" colspan="1">177</td><td align="center" valign="middle" rowspan="1" colspan="1">1,632</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1934</td><td align="center" valign="middle" rowspan="1" colspan="1">43</td><td align="center" valign="middle" rowspan="1" colspan="1">2,928</td><td align="center" valign="middle" rowspan="1" colspan="1">1,463</td><td align="center" valign="middle" rowspan="1" colspan="1">2,516</td><td align="center" valign="middle" rowspan="1" colspan="1">184</td><td align="center" valign="middle" rowspan="1" colspan="1">818</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1935</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">1,816</td><td align="center" valign="middle" rowspan="1" colspan="1">7,342</td><td align="center" valign="middle" rowspan="1" colspan="1">b</td><td align="center" valign="middle" rowspan="1" colspan="1">b</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1936</td><td align="center" valign="middle" rowspan="1" colspan="1">74</td><td align="center" valign="middle" rowspan="1" colspan="1">1,036</td><td align="center" valign="middle" rowspan="1" colspan="1">3,464</td><td align="center" valign="middle" rowspan="1" colspan="1">3,721</td><td align="center" valign="middle" rowspan="1" colspan="1">b</td><td align="center" valign="middle" rowspan="1" colspan="1">b</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> Yokadouma was included in the Boumba-Ngoko sector. <sup>b</sup> Ouesso was included in the Ngoko&#x02011;Sangha sector up to 1934, and in the Sangha sector (jointly with Nola) after that.</p></fn></table-wrap-foot></table-wrap><p>Therefore, the early 1930s brought unprecedented levels of parenteral activity to southeast Cameroon and neighboring AEF areas: not only were anti-HAT campaigns systematically performed by then, but the same mobile teams also boosted anti-syphilis and anti-yaws treatment.</p><p>Most calculations of HIV-1 M&#x02019;s tMRCA published recently produced results in which the upper interval of the highest probability distribution falls before 1930 (with a few exceptions) [<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,<xref ref-type="bibr" rid="B30-viruses-04-01950">30</xref>]. This is illustrated in <xref ref-type="fig" rid="viruses-04-01950-f003">Figure 3</xref>, and suggests that HIV-1 M probably originated at a time when parenteral risks in the studied region were considerably smaller than in the 1930s.</p><fig id="viruses-04-01950-f003" position="anchor"><label>Figure 3</label><caption><p>The recent tMRCA calculations of HIV-1 M (with high probability (HPD) distribution intervals), and the timings of systematic treatments against human African trypanosomiasis (HAT) in the districts of Yokadouma (Cameroon) and Nola (Afrique &#x000c9;quatoriale Fran&#x000e7;aise). Sources: (1) on tMRCA calculations: [<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,<xref ref-type="bibr" rid="B30-viruses-04-01950">30</xref>]; (2) on HAT treatments: [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>,<xref ref-type="bibr" rid="B87-viruses-04-01950">87</xref>,<xref ref-type="bibr" rid="B88-viruses-04-01950">88</xref>,<xref ref-type="bibr" rid="B89-viruses-04-01950">89</xref>,<xref ref-type="bibr" rid="B90-viruses-04-01950">90</xref>,<xref ref-type="bibr" rid="B91-viruses-04-01950">91</xref>,<xref ref-type="bibr" rid="B92-viruses-04-01950">92</xref>,<xref ref-type="bibr" rid="B93-viruses-04-01950">93</xref>,<xref ref-type="bibr" rid="B94-viruses-04-01950">94</xref>,<xref ref-type="bibr" rid="B95-viruses-04-01950">95</xref>,<xref ref-type="bibr" rid="B96-viruses-04-01950">96</xref>,<xref ref-type="bibr" rid="B97-viruses-04-01950">97</xref>].</p></caption><graphic xlink:href="viruses-04-01950-g003"/></fig></sec><sec><title>2.4.6. Health Facilities</title><p>During the German period, there was an important medical facility in Moloundou [<xref ref-type="bibr" rid="B122-viruses-04-01950">122</xref>]. In the 1920s and early 1930s, Moloundou and Yokadouma had only dispensaries run by nurses [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>]. In the neighboring AEF areas, only Ouesso and Nola had a doctor each until 1934, whereafter a third medical post, in Berberati, is mentioned in the reports [<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>]. In the 1920s and early 1930s, there were a few nurse-operated dispensaries in Souank&#x000e9; and Semb&#x000e9; (west of Ouesso) and in Berberati and Carnot (north of Nola). In 1931, a new one was set up in Gamboula, at the AEF-Cameroon border [<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>]. During these decades, segregation camps for HAT patients (<italic>hypnoseries</italic>) existed in Ouesso and Nola (the latter since 1909). Leprosariums were set up in Nola and Berberati in the early 1930s. In addition to these facilities, missions provided some healthcare [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>,<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B121-viruses-04-01950">121</xref>]. In these facilities, the number of injections per patient in HAT, syphilis, and yaws treatments was probably higher than in rural villages.</p></sec><sec id="sec2dot4dot7-viruses-04-01950"><title>2.4.7. Comparison with Modern HIV Parenteral Outbreaks</title><p>In an HIV-1 outbreak in Romanian orphanages, children received around 147 injections per year (according to a detailed study based on one of the orphanages) [<xref ref-type="bibr" rid="B123-viruses-04-01950">123</xref>]. Estimates for injection intensity in nosocomial outbreaks in Elista, Russia, and in Lybia give an annualized rate of 40&#x02013;200 and 52, respectively; in both of the latter outbreaks, HIV-1 transmission was probably boosted by the use of venous catheters and lines in many patients; no reliable estimates exist for the other outbreaks [<xref ref-type="bibr" rid="B124-viruses-04-01950">124</xref>]. </p><p>Studies of intravenous drug users (IDU) estimated that they inject themselves around ~700 (300&#x02013;1,800) times a year [<xref ref-type="bibr" rid="B125-viruses-04-01950">125</xref>,<xref ref-type="bibr" rid="B126-viruses-04-01950">126</xref>,<xref ref-type="bibr" rid="B127-viruses-04-01950">127</xref>,<xref ref-type="bibr" rid="B128-viruses-04-01950">128</xref>,<xref ref-type="bibr" rid="B129-viruses-04-01950">129</xref>,<xref ref-type="bibr" rid="B130-viruses-04-01950">130</xref>,<xref ref-type="bibr" rid="B131-viruses-04-01950">131</xref>]. In Western IDUs, explosive HIV-1 spread happened more commonly in the 1980s (with prevalence attaining 15%&#x02013;70%), when they shared needles more frequently and needle exchange programs, methadone, and other harm reduction interventions were still incipient or non-existent [<xref ref-type="bibr" rid="B125-viruses-04-01950">125</xref>,<xref ref-type="bibr" rid="B132-viruses-04-01950">132</xref>,<xref ref-type="bibr" rid="B133-viruses-04-01950">133</xref>,<xref ref-type="bibr" rid="B134-viruses-04-01950">134</xref>,<xref ref-type="bibr" rid="B135-viruses-04-01950">135</xref>,<xref ref-type="bibr" rid="B136-viruses-04-01950">136</xref>]. For IDUs observed at the start, or in early stages, of these interventions the average frequency of needle sharing (counting all individuals including non-sharers) was normally in the range 60&#x02013;245 needle sharing events per year (and much higher counting sharers only) [<xref ref-type="bibr" rid="B125-viruses-04-01950">125</xref>,<xref ref-type="bibr" rid="B131-viruses-04-01950">131</xref>,<xref ref-type="bibr" rid="B132-viruses-04-01950">132</xref>,<xref ref-type="bibr" rid="B133-viruses-04-01950">133</xref>,<xref ref-type="bibr" rid="B137-viruses-04-01950">137</xref>].</p><p>While in some IDU communities the sharing frequency remained similarly high despite interventions [<xref ref-type="bibr" rid="B126-viruses-04-01950">126</xref>,<xref ref-type="bibr" rid="B127-viruses-04-01950">127</xref>], in others the interventions were very successful in reducing the needle sharing frequency to 10&#x02013;30 per year (and sometimes to &#x0003c;10) [<xref ref-type="bibr" rid="B129-viruses-04-01950">129</xref>,<xref ref-type="bibr" rid="B130-viruses-04-01950">130</xref>,<xref ref-type="bibr" rid="B135-viruses-04-01950">135</xref>,<xref ref-type="bibr" rid="B138-viruses-04-01950">138</xref>]. In the latter cases HIV-1 prevalence either is very low, or is persistently stable or declining. For example: (1) in Australia, interventions were very effective, annual needle sharing rate is &#x0003c;10, and HIV-1 prevalence is stable at ~1% [<xref ref-type="bibr" rid="B129-viruses-04-01950">129</xref>]; (2) in Edinburgh&#x02019;s IDUs, after explosive HIV-1 spread in the early 1980s, effective interventions reduced needle sharing rate to &#x0003c;20 per year, and HIV-1 prevalence remained stable around 20% during many years [<xref ref-type="bibr" rid="B138-viruses-04-01950">138</xref>]; (3) a similar pattern was observed in several Dutch cities (estimated annual needle sharing rates of ~23 in Rotterdam and ~14 in Arnhem) [<xref ref-type="bibr" rid="B135-viruses-04-01950">135</xref>], and in Montr&#x000e9;al (estimated annual needle sharing rate of ~27 [<xref ref-type="bibr" rid="B130-viruses-04-01950">130</xref>]; (4) in Vancouver, HIV-1 prevalence was stable at 3&#x02013;4% in the period 1984&#x02013;1994, and annual needle sharing rate was estimated at ~30 [<xref ref-type="bibr" rid="B139-viruses-04-01950">139</xref>]; (5) the IDUs from Bristol, UK, were estimated to share needles 48 times per year and had only 1% HIV-1 prevalence, while those from Teesside, UK, shared needles 14 times per year and had zero HIV-1 prevalence [<xref ref-type="bibr" rid="B140-viruses-04-01950">140</xref>]. Such data seem to suggest that the above sharing frequencies do not enable HIV-1 rapid spread in IDUs.</p><p>Our research indicates that syphilis and yaws patients in Cameroon, in the period 1922&#x02013;1931, were receiving only 1.4&#x02013;2.3 injections per year (<xref ref-type="table" rid="viruses-04-01950-t001">Table 1</xref>); in rural dispensaries, the average per syphilis patient could be twice that number [<xref ref-type="bibr" rid="B94-viruses-04-01950">94</xref>]. In AEF, in the period 1930&#x02013;1935, surveyed HAT patients received 3&#x02013;5 injections per year, and by 1937 this had increased to 7.8 (<xref ref-type="table" rid="viruses-04-01950-t002">Table 2</xref>), although newly found patients would receive around 12 injections in the first year (<xref ref-type="sec" rid="sec2dot4dot4-viruses-04-01950">Section 2.4.4</xref>). In rural <italic>hypnoseries</italic> the average patient could receive more injections but, in the 1930s, the standard treatment was 12 injections. Reviews indicate that patients received 15&#x02013;24, spread over two or more years (<xref ref-type="sec" rid="sec2dot4dot4-viruses-04-01950">Section 2.4.4</xref>). Even in the unlikely scenario of these injections being all unsterile, their frequency was much smaller than either the injection frequency in modern nosocomial outbreaks, or the needle sharing frequency among IDUs (including non-sharers) suffering explosive HIV-1 spread (60&#x02013;245 per year), and was comparable to the sharing frequency among IDUs with low and/or stagnant HIV-1 prevalence. A comparison of the injection intensities in Central African health campaigns, among IDU communities, and in modern HIV outbreaks can be seen in <xref ref-type="fig" rid="viruses-04-01950-f004">Figure 4</xref>.</p></sec></sec><sec id="sec2dot5-viruses-04-01950"><title>2.5. Sexual Promiscuity and Sexually Transmitted Diseases</title><p>In the early 20th century, Central Africa suffered rampant epidemics of STDs, including genital ulcer diseases (GUD), such as syphilis and chancroid, particularly in the nascent colonial cities and socially disrupted semi-rural colonial posts. Syphilis was absent from most forested areas where chimpanzees and gorillas live, up to about 1885, when colonial control of the interior began [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B141-viruses-04-01950">141</xref>,<xref ref-type="bibr" rid="B142-viruses-04-01950">142</xref>,<xref ref-type="bibr" rid="B143-viruses-04-01950">143</xref>,<xref ref-type="bibr" rid="B144-viruses-04-01950">144</xref>,<xref ref-type="bibr" rid="B145-viruses-04-01950">145</xref>], although it was present at the coast [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B146-viruses-04-01950">146</xref>,<xref ref-type="bibr" rid="B147-viruses-04-01950">147</xref>] and in savannah-forest interface regions connected to the Muslim states of the north [<xref ref-type="bibr" rid="B141-viruses-04-01950">141</xref>]. The probable reason for this absence was the absence of commercial sex workers (CSW) with levels of sexual promiscuity comparable to those operating in the West [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>,<xref ref-type="bibr" rid="B147-viruses-04-01950">147</xref>,<xref ref-type="bibr" rid="B148-viruses-04-01950">148</xref>,<xref ref-type="bibr" rid="B149-viruses-04-01950">149</xref>].</p><fig id="viruses-04-01950-f004" position="anchor"><label>Figure 4</label><caption><p>Comparison of injection intensities in the Central African campaigns (first three categories) and relevant modern populations (remaining categories). (ani): annual number of injections; (anns): annual number of needle shares. The seven categories, from left to right, are as follows: (<bold>i</bold>) to (<bold>iii</bold>) Central African data, based on our review (<xref ref-type="table" rid="viruses-04-01950-t001">Table 1</xref> and <xref ref-type="table" rid="viruses-04-01950-t002">Table 2</xref>); (<bold>iv</bold>) available estimates for nosocomial outbreaks (sources: [<xref ref-type="bibr" rid="B123-viruses-04-01950">123</xref>,<xref ref-type="bibr" rid="B124-viruses-04-01950">124</xref>]); (<bold>v</bold>) estimates of needle sharing for IDU groups in which HIV-1 prevalence was either &#x0003c;5% or stagnant since many years previous to observation (sources: [<xref ref-type="bibr" rid="B129-viruses-04-01950">129</xref>,<xref ref-type="bibr" rid="B130-viruses-04-01950">130</xref>,<xref ref-type="bibr" rid="B135-viruses-04-01950">135</xref>,<xref ref-type="bibr" rid="B138-viruses-04-01950">138</xref>,<xref ref-type="bibr" rid="B139-viruses-04-01950">139</xref>,<xref ref-type="bibr" rid="B140-viruses-04-01950">140</xref>]); (<bold>vi</bold>) estimates of needle sharing for IDU groups in which HIV-1 prevalence was &#x0003e;10%, had risen fast in previous years, and the study could observe needle sharing rate at the onset of a needle exchanging program, methadone, or other intervention (known to cause dramatic drops in needle sharing) (sources: [<xref ref-type="bibr" rid="B125-viruses-04-01950">125</xref>,<xref ref-type="bibr" rid="B128-viruses-04-01950">128</xref>,<xref ref-type="bibr" rid="B131-viruses-04-01950">131</xref>,<xref ref-type="bibr" rid="B132-viruses-04-01950">132</xref>,<xref ref-type="bibr" rid="B133-viruses-04-01950">133</xref>,<xref ref-type="bibr" rid="B136-viruses-04-01950">136</xref>,<xref ref-type="bibr" rid="B137-viruses-04-01950">137</xref>]); (<bold>vii</bold>) estimates of annual number of injections (with or without sharing) for IDUs (sources: [<xref ref-type="bibr" rid="B125-viruses-04-01950">125</xref>,<xref ref-type="bibr" rid="B126-viruses-04-01950">126</xref>,<xref ref-type="bibr" rid="B127-viruses-04-01950">127</xref>,<xref ref-type="bibr" rid="B128-viruses-04-01950">128</xref>,<xref ref-type="bibr" rid="B129-viruses-04-01950">129</xref>,<xref ref-type="bibr" rid="B130-viruses-04-01950">130</xref>,<xref ref-type="bibr" rid="B131-viruses-04-01950">131</xref>,<xref ref-type="bibr" rid="B140-viruses-04-01950">140</xref>]). For each category, the range and average between studies are shown.</p></caption><graphic xlink:href="viruses-04-01950-g004"/></fig><p>In the early colonial period, administrative and trading posts were founded, with frequent steamer or railway connections to cities. Although their permanent population was no larger than that of a village, they had a high turnover of predominantly male passers-by, consisting of soldiers, traders, porters, and laborers. As happened in cities, generalized social disruption ensued in the colonial posts and enterprises located in the interior, and sex work and syphilis flourished [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B105-viruses-04-01950">105</xref>,<xref ref-type="bibr" rid="B141-viruses-04-01950">141</xref>,<xref ref-type="bibr" rid="B142-viruses-04-01950">142</xref>,<xref ref-type="bibr" rid="B143-viruses-04-01950">143</xref>,<xref ref-type="bibr" rid="B150-viruses-04-01950">150</xref>].</p><p>Several sources mention the presence of STDs in the region since early colonial times. The Fourneau-Fond&#x000e8;re expedition arrived to Ouesso (a French post since 1891 [<xref ref-type="bibr" rid="B151-viruses-04-01950">151</xref>]) in 1899 with five Europeans, 36 African soldiers, and around 200 porters. Several men contracted blennorrhea and at least one contracted a chancre (of either primary syphilis or chancroid) in Ouesso, after a stay no longer than one month [<xref ref-type="bibr" rid="B152-viruses-04-01950">152</xref>]. According to a contemporaneous reviewer, CSWs generally operated close to colonial military posts [<xref ref-type="bibr" rid="B143-viruses-04-01950">143</xref>]. In the period 1891&#x02013;1902, syphilis was already common in the Sangha posts (Ouesso, Nola, Bania), mainly driven by the movement of troops, and was still absent from interior villages [<xref ref-type="bibr" rid="B143-viruses-04-01950">143</xref>,<xref ref-type="bibr" rid="B152-viruses-04-01950">152</xref>]. Haoussa traders also spread STDs in the region early [<xref ref-type="bibr" rid="B153-viruses-04-01950">153</xref>].</p><p>In the first decade of the 20th century, the French Compagnie Ngoko-Sangha and the German Gesellschaft S&#x000fc;d-Kamerun (GSK) intensified exploitation of local resources in the region, leading to unprecedented movements of people and social disruption. Moloundou was the administrative center of the German southeast Kamerun district, and the main GSK headquarters. The path between Yokadouma and Moloundou became frequented by thousands of soldiers and porters transporting rubber, ivory, and other products. In 1911, the number of soldiers, porters, rowers, and other African workers in the district was 1,500 (mostly young males), hired elsewhere in Cameroon, in Congo, or in other Central African colonies; the non-pygmy native population of the district was around 12,960, of whom 3,716 were adult males and 4,563 were adult females (including old adults) [<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>]. The sex ratio of young adults was then significantly male-biased for a rural area. Many men frequented the socially disrupted colonial posts and did not follow a rural lifestyle. Inevitably, commercial sex work became commonplace [<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>]. The peak intensity of a biased sex ratio and the disruption of the traditional social network probably occurred in the period 1908&#x02013;1916.</p><p>We found limited direct data on the incidence of STDs and sexual promiscuity in the region of study. The high levels of social disruption and biased sex ratio suggest that STDs may have been as incident as in contemporaneous colonial troops stationed in other regions. A review of STD and GUD incidence in French colonial troops from all colonies in the period 1903&#x02013;1906 indicates overall syphilis and chancroid annual incidences in the ranges 3.2%&#x02013;4.1% and 5.1%&#x02013;6.9%, respectively. In the more CSW-ridden Caribbean colonies these incidences were 7.3% and 13.3%, respectively [<xref ref-type="bibr" rid="B154-viruses-04-01950">154</xref>]. Almost all syphilis detected in troops was either primary or secondary; primary syphilis is characterized by a genital chancre and secondary syphilis causes genital ulcers in a substantial fraction of patients [<xref ref-type="bibr" rid="B155-viruses-04-01950">155</xref>].</p><p>The health reports of French Congo show the numbers of <italic>consultants</italic> (treated cases) for syphilis and the population partitioned between adults and children of the Ouesso (or Ngoko-Sangha) district in the period 1932&#x02013;34. The reported syphilis incidence in adults in these three years was 4.8%, 5.2%, and 19.9%, respectively. The same reports show the number of <italic>consultations</italic> for syphilis in the Nola subdivision (which was part of the Haute Sangha district) [<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>]. Assuming the Nola consultations/consultants ratio is the same as in Ouesso, we can estimate the numbers of consultants in Nola; based on that we estimated syphilis incidence in Nola at 10.7% in 1933 and 15.2% in 1934. Part of these cases could be tertiary or serological manifestations of yaws, which were hard to distinguish from syphilis [<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>]. The very high reported incidence in 1934 may reflect an increase in treatments and serological diagnoses [<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>].</p></sec><sec id="sec2dot6-viruses-04-01950"><title>2.6. Travelling and Migration of People to/from the Stanley Pool Cities</title><p>We attempted to obtain information about migration of people from the studied area to cities, or to work in the French railway construction (1921&#x02013;1932) and the Belgian railway upgrade works (1923&#x02013;1931). We collected census/survey tables of colonial cities that partition inhabitants by ethnic/regional origin. These tables appear sporadically in archives, articles, and books. Some were published as supplements to our previous article [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>]. For the period 1927&#x02013;1934, the number of immigrants from either southeast Cameroon or the Nola area recorded in Leopoldville and Brazzaville censuses is negligible. However, these censuses likely missed floating populations and illegal immigrants, and also may have misrepresented the real origin of immigrants, so we cannot conclude that the real number was negligible. Also, we did not obtain similar censuses from before 1927. Additional research is needed to quantify these migrations in more detail.</p><p>During the colonial period the region was economically more dependent on the large southern cities of the Stanley Pool (Leopoldville-West, Leopoldville-East (Kinshasa), and Brazzaville) than on western Cameroon, because of the easy transportation highway provided by the Congo-Sangha river system. Local firms used the Belgian railway between Kinshasa and the Atlantic port of Matadi, available since 1898, to export their products. The French companies used the Belgian railway until 1932, when a second railway connecting Brazzaville to Pointe Noire was completed, diverting most of the region's exports from the Belgian railway [<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B151-viruses-04-01950">151</xref>,<xref ref-type="bibr" rid="B156-viruses-04-01950">156</xref>,<xref ref-type="bibr" rid="B157-viruses-04-01950">157</xref>]. In the period 1899&#x02013;1914 the German connections to Kinshasa were particularly intense. The GSK was exploiting the resources of southeast Kamerun more intensively than its French counterparts in neighboring AEF, and it had large warehouses in Moloundou [<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>,<xref ref-type="bibr" rid="B122-viruses-04-01950">122</xref>,<xref ref-type="bibr" rid="B151-viruses-04-01950">151</xref>,<xref ref-type="bibr" rid="B156-viruses-04-01950">156</xref>]. Both the GSK and the associated Kameruner Schiffahrts-Gesellschaft had steamers navigating between southeast Kamerun and Kinshasa, and Belgian archival documents refer to warehouses and other property owned in Kinshasa by these two German companies [<xref ref-type="bibr" rid="B158-viruses-04-01950">158</xref>]. For example, on the day the First World War broke out, four German steamers were docked in Kinshasa, which illustrates the intensity of the commercial links between the city and southeast Kamerun [<xref ref-type="bibr" rid="B122-viruses-04-01950">122</xref>]. The German administration and enterprises in Moloundou employed men described as &#x0201c;Bangala&#x0201d; [<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>]. This designation could mean they belonged to the Bangala tribe from the Belgian Congo (of which our previous research revealed that many men were in Kinshasa [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>]), or speakers of Lingala, a trade language by then dominant in the Congo basin's colonial posts [<xref ref-type="bibr" rid="B159-viruses-04-01950">159</xref>]; in either case they could well have frequented or inhabited the Pool cities.</p><p>After the mid-1920s the rubber business of the region declined, and coffee and cacao plantations overtook rubber in economic importance in the region (Section 2.3.3). Several important plantations were set up around Nola, Berberati, and at the Sangha banks, more than in southeast Cameroon [<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>]. In the 1930s, these regions probably generated more traffic to and from the southern cities than southeast Cameroon, and after 1932, when the French railway became available, this traffic was probably being increasingly directed to Brazzaville rather than to Kinshasa. In addition, the increasing importance of roads after the 1930s intensified the region's links to western Cameroon, and reduced its reliance on the Stanley Pool. Trade connections between southeast Cameroon and the Pool peaked in the period 1899&#x02013;1923.</p><p>During the First World War, intense military operations occurred in the region. French forces took Nola in October 1914. Franco-Belgian forces conquered Moloundou in December and Yokadouma in January 1915. These forces totaled about 2,000 soldiers and had thousands of porters helping them. They stayed in southeast Cameroon for five months, before resuming the offensive to the west. They &#x0201c;encouraged&#x0201d; (forced?) local people to supply them with food. During these five months and beyond, through February 1916, numerous steamers supplied troops from Brazzaville and Leopoldville [<xref ref-type="bibr" rid="B122-viruses-04-01950">122</xref>]. The numbers of soldiers and porters involved were stressful for a district with about 14,000 native people [<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>], and the sex ratio around the posts where the soldiers were camped became inevitably extremely male-biased. Although the war in Cameroon lasted only 18 months, it involved intense steamer movements to/from the Pool cities, intense soldier and porter movements in the interior [<xref ref-type="bibr" rid="B122-viruses-04-01950">122</xref>,<xref ref-type="bibr" rid="B160-viruses-04-01950">160</xref>], grave food shortages among combatants and reliance on bushmeat [<xref ref-type="bibr" rid="B160-viruses-04-01950">160</xref>,<xref ref-type="bibr" rid="B161-viruses-04-01950">161</xref>]. Deserters formed armed bands that roamed the region for pillage, even after the war [<xref ref-type="bibr" rid="B151-viruses-04-01950">151</xref>]. It should be noted that both the regular troops and the bands of deserters had modern cartridge weapons, with which hunting of apes is far more effective [<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>] than with the muzzle-loaded guns available to most rural hunters. The war operations may have increased human exposure to SIVcpz and SIVgor, sexual promiscuity, and the probability of a zoonotic virus to arrive at the Pool cities.</p><p>During the war, German troops retreated from areas of Gabon and Congo-Brazzaville into Cameroon, and concentrated in Yaound&#x000e9; and Ebolowa, the two larger urban centers that they controlled during most of the war. Invading French troops moved from the same countries into Cameroon and were stationed in the same cities when the war ended. German troops retreated to Equatorial Guinea (a neutral Spanish colony at the time), dragging tens of thousands of civilians with them. Most of these military and civilians moved back into Cameroon (passing by Douala and other cities) soon after [<xref ref-type="bibr" rid="B122-viruses-04-01950">122</xref>,<xref ref-type="bibr" rid="B160-viruses-04-01950">160</xref>]. More than 50,000 people were involved in these movements [<xref ref-type="bibr" rid="B122-viruses-04-01950">122</xref>,<xref ref-type="bibr" rid="B145-viruses-04-01950">145</xref>,<xref ref-type="bibr" rid="B160-viruses-04-01950">160</xref>]. Thus, the war caused an unprecedented transit of people between Cameroon and neighboring regions of Congo-Brazzaville, CAR, Gabon, and Equatorial Guinea, and particularly of highly mobile people, relying on bushmeat while in the forest, and moving from forest areas to Cameroonian cities (Douala, Yaound&#x000e9;, Ebolowa). At least in Douala, CSWs and GUD were abundant [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,<xref ref-type="bibr" rid="B99-viruses-04-01950">99</xref>,<xref ref-type="bibr" rid="B105-viruses-04-01950">105</xref>,<xref ref-type="bibr" rid="B162-viruses-04-01950">162</xref>]. Thus, the unprecedented movements of people associated with the war may have been associated with the origins of the HIV-1 groups M and O, since both are dated from around the same time [<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,<xref ref-type="bibr" rid="B28-viruses-04-01950">28</xref>,<xref ref-type="bibr" rid="B29-viruses-04-01950">29</xref>,<xref ref-type="bibr" rid="B30-viruses-04-01950">30</xref>].</p></sec></sec><sec><title>3. Discussion</title><p>As many authors suggested, HIV-1 M probably started to spread substantially in Kinshasa, whether or not initial foci started in Brazzaville or other towns or colonial posts [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B15-viruses-04-01950">15</xref>,<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>,<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>,<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>]. Even though old samples from other cities have not been available up to date, not only viral genetic diversity including in old samples [<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,<xref ref-type="bibr" rid="B41-viruses-04-01950">41</xref>,<xref ref-type="bibr" rid="B42-viruses-04-01950">42</xref>], but also phylogeographic calculations [<xref ref-type="bibr" rid="B43-viruses-04-01950">43</xref>], and epidemiological data [<xref ref-type="bibr" rid="B38-viruses-04-01950">38</xref>,<xref ref-type="bibr" rid="B39-viruses-04-01950">39</xref>] favor Kinshasa as the initial epicenter of pandemic HIV-1.</p><p>SIVcpz is endemic in southeast Cameroon and the neighboring Nola area (<xref ref-type="fig" rid="viruses-04-01950-f001">Figure 1</xref>), where currently the SIVcpz closest related to HIV-1 M has been found (reported at sites MB, LB, and BY (<xref ref-type="fig" rid="viruses-04-01950-f001">Figure 1</xref>)), with a prevalence over 30% in the MB community, which is higher than the average of either central or eastern chimpanzees [<xref ref-type="bibr" rid="B2-viruses-04-01950">2</xref>,<xref ref-type="bibr" rid="B44-viruses-04-01950">44</xref>,<xref ref-type="bibr" rid="B45-viruses-04-01950">45</xref>]. We show here that ape bushmeat hunting was already widespread in the region in the period 1900&#x02013;1910, probably boosted by massive gun selling in the area. Local clans had a higher cultural inclination to hunt apes than elsewhere in Cameroon. Ape bushmeat hunting was probably more intense in the period 1899&#x02013;1930, when the rubber business peaked, and laws protecting chimpanzees had not been enacted yet. Ape hunting was more common in southeast Cameroon and around Nola than in southwest and south-central Cameroon (<xref ref-type="sec" rid="sec2dot3-viruses-04-01950">Section 2.3</xref>). Considering the &#x0201c;patchiness&#x0201d; of both SIVcpz/SIVgor prevalence and ape bushmeat intensity (<xref ref-type="sec" rid="sec2dot1-viruses-04-01950">Section 2.1</xref>), southeast Cameroon and the neighboring Nola area might have been particularly permissive for cross-species transmission of HIV-1-like viruses. </p><p>We also show that during the period 1899&#x02013;1923, the most likely timing of the origin and initial spread of HIV-1 M, southeast Cameroon and the neighboring Nola area (<xref ref-type="fig" rid="viruses-04-01950-f001">Figure 1</xref>) had intense steamer traffic to/from Kinshasa (<xref ref-type="sec" rid="sec2dot6-viruses-04-01950">Section 2.6</xref>), surpassing neighboring AEF regions, and probably matching many regions of the Belgian Congo in this regard. Both Kinshasa and Brazzaville are located in the Stanley Pool constituting the main attraction and hub for traders, laborers, migrants, and soldiers of the giant fluvial system encompassing the navigable branches of the Congo, Oubangui, Sangha, and relevant tributaries during the colonial period. The trade relations of southeast Kamerun with Kinshasa were intense in the German period (1899&#x02013;1914). At the same time, the social disruption of the region was high, with a substantially male-biased sex ratio in young adults, thousands of soldiers, porters, and workers moving between posts and to/from Kinshasa, and CSWs and STDs were present [<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>,<xref ref-type="bibr" rid="B70-viruses-04-01950">70</xref>]. </p><p>The First World War added specific risk factors that may have helped HIV-1 M to emerge. Although the war lasted only 18 months in Cameroon, thousands of soldiers, armed with modern weapons, and thousands of porters moved in the region of study, relying on bushmeat and confiscating food from local inhabitants, thus forcing them to increase their reliance on bushmeat as well. Armed bands roamed the region. Sexual promiscuity and rape are likely to have happened. Steamer traffic to/from the Stanley Pool cities also intensified [<xref ref-type="bibr" rid="B122-viruses-04-01950">122</xref>,<xref ref-type="bibr" rid="B151-viruses-04-01950">151</xref>]. While we want to focus here on HIV-1 M, the war hypothesis deserves further attention also for the origin and spread of HIV-1 O, which has a tMRCA roughly coinciding with that of HIV-1 M [<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,<xref ref-type="bibr" rid="B28-viruses-04-01950">28</xref>,<xref ref-type="bibr" rid="B29-viruses-04-01950">29</xref>,<xref ref-type="bibr" rid="B30-viruses-04-01950">30</xref>]. </p><p>In currently observed human SIV infections, including among laboratory workers, the viral load is undetectable [<xref ref-type="bibr" rid="B19-viruses-04-01950">19</xref>,<xref ref-type="bibr" rid="B163-viruses-04-01950">163</xref>], suggesting lack of adaptation and transmissibility past acute infection. However, if &#x0201c;nascent HIV&#x0201d;, after the initial cross-species transmission was only transmissible among humans during acute infection, then the origin of HIV-1 M required an initial series of acute transmissions. Either the first human case (e.g., a bushmeat handler) must have carried the virus to a city during the short time frame of his/her acute infection, or there might have been some local human spread of the virus close to its geographic origin, followed by a migration to a city hub. </p><p>In our previous work we showed that, in the early 20th century, Kinshasa had a strongly male&#x02011;biased sex ratio, the presence of CSWs, most women unmarried, a high GUD prevalence, and a lower level of male circumcision than it has today. In Kinshasa the sex ratio was more biased, sex work was more flourishing, and male circumcision was less common than in neighbouring Brazzaville [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>]. We modeled the initial spread in humans of a nascent SIVcpz/HIV-1 M ancestor virus (transmissible only during acute infection) in Kinshasa [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>]. Our simulations show that initial heterosexual spread of such a virus would have been much more probable under the conditions prevailing in the city in the early 20th century&#x02014;particularly a high GUD prevalence [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>,<xref ref-type="bibr" rid="B101-viruses-04-01950">101</xref>]&#x02014;than either in the preceding or in the subsequent periods. In our sensitivity analyses, we let the simulation parameters vary under realistic values, and we tested 51 different scenarios. GUD prevalence appeared to be a key determinant of the magnitude of the simulated epidemics and was crucial to allow for long chains of transmission [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>]. In our simulations, the effects of GUD and acute infection in transmissibility combined in a multiplicative way, a method that has been used in other major published models [<xref ref-type="bibr" rid="B164-viruses-04-01950">164</xref>,<xref ref-type="bibr" rid="B165-viruses-04-01950">165</xref>]. Using an additive model, the effect of GUD for HIV-1 initial spread becomes less dominant [<xref ref-type="bibr" rid="B166-viruses-04-01950">166</xref>]. However, our simulations included, for simplicity, random periods of GUD ulcerations in the affected populations (GUD transmission itself was not explicitly implemented), and thus, the real magnitude of the GUD effect may have been underestimated. We intend to upgrade our models, both the multiplicative and the additive, by implementing explicit transmission of GUD, which might generate strong correlations between GUD and HIV prevalence in the most connected parts of the sexual network and thereby intensify the effect of GUD prevalence on HIV transmission. We did not include the contribution of unsterile injections to the origin and initial spread of HIV-1 in Kinshasa in our model, but we recognize that such contribution is plausible since injection intensity was high in some of the city's health facilities in the 1920s and 1930s [<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>,<xref ref-type="bibr" rid="B101-viruses-04-01950">101</xref>,<xref ref-type="bibr" rid="B167-viruses-04-01950">167</xref>].</p><p>It has been proposed that unsterile injections given in rural Central Africa exponentially amplified HIV-1 to thousands of infections from a single SIVcpz-infected human [<xref ref-type="bibr" rid="B17-viruses-04-01950">17</xref>,<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>,<xref ref-type="bibr" rid="B35-viruses-04-01950">35</xref>], which would assign a major contribution of rural injection campaigns to the origin of HIV-1 M. In this paper, we attempted to assess the injection intensity of such campaigns around the time of the HIV-1 M origin, to have a semi-quantitative appreciation of their possible role in early HIV spread, and to have sound information on which to base future modeling efforts. We found that at present unsterile injections are not capable of sustaining an HIV-1 epidemic without extremely high rates of needle sharing, even though modern HIV-1 is probably more efficient at human-to-human transmission than the initial virus. In the general populations of modern Africa, unsterile injections are still relatively common, and they only account for an estimated 2.5% of all HIV infections [<xref ref-type="bibr" rid="B168-viruses-04-01950">168</xref>]. HIV-1 has spread parenterally only in selected populations, such as IDUs practicing needle sharing and in hospital outbreaks. IDU epidemics are characterized by exposures of &#x0003e;60 unsterile injections per year (<xref ref-type="sec" rid="sec2dot4dot7-viruses-04-01950">Section 2.4.7</xref>). Remarkably, even IDU populations highly infected with the Hepatitis C Virus (HCV), seem to have patchy HIV prevalence, with highly variable prevalence rates among neighboring groups [<xref ref-type="bibr" rid="B126-viruses-04-01950">126</xref>,<xref ref-type="bibr" rid="B127-viruses-04-01950">127</xref>,<xref ref-type="bibr" rid="B129-viruses-04-01950">129</xref>,<xref ref-type="bibr" rid="B130-viruses-04-01950">130</xref>,<xref ref-type="bibr" rid="B140-viruses-04-01950">140</xref>].</p><p>Comparable levels of exposure cannot be documented in early 20th century rural Africa (<xref ref-type="sec" rid="sec2dot4dot7-viruses-04-01950">Section 2.4.7</xref>). With an average injection intensity of around 12 injections per year for newly diagnosed HAT patients and less for old revisited HAT, syphilis, and yaws patients (<xref ref-type="sec" rid="sec2dot4dot3-viruses-04-01950">Section 2.4.3</xref> to <xref ref-type="sec" rid="sec2dot4dot5-viruses-04-01950">Section 2.4.5</xref>), the Central African campaigns might have massively spread HCV [<xref ref-type="bibr" rid="B17-viruses-04-01950">17</xref>,<xref ref-type="bibr" rid="B169-viruses-04-01950">169</xref>] (as happened with anti-schistosomiasis campaigns in Egypt, which had similar injection intensity [<xref ref-type="bibr" rid="B170-viruses-04-01950">170</xref>]), but are unlikely to have spread HIV-1 extensively [<xref ref-type="bibr" rid="B129-viruses-04-01950">129</xref>,<xref ref-type="bibr" rid="B130-viruses-04-01950">130</xref>,<xref ref-type="bibr" rid="B135-viruses-04-01950">135</xref>,<xref ref-type="bibr" rid="B138-viruses-04-01950">138</xref>,<xref ref-type="bibr" rid="B139-viruses-04-01950">139</xref>,<xref ref-type="bibr" rid="B140-viruses-04-01950">140</xref>]. </p><p>During the HAT and other campaigns done in rural Central Africa in the 1920s&#x02013;1940s, people formed a queue waiting for injections or vaccinations [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>]. The hastiness of the procedures would leave little time for appropriate sterilization of syringes and catheters [<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>] and, accordingly, SIV/HIV transmissions may have occurred. However, in such procedures an infected index patient would have been able to transmit the virus to the next person in the row (the first one exposed), but hardly to the second one, because most of his/her blood remaining in the syringe would be injected in the first exposed person, and very little would remain while injecting the second exposed. Thus, the probability of infecting additional people in the queue is likely to exhibit an exponential decline, as has been observed for the probability of recovering HIV-1 from syringes after successive rinses: experiments suggest a 55%&#x02013;80% decline in this probability after the first rinsing with water [<xref ref-type="bibr" rid="B171-viruses-04-01950">171</xref>]. Per shared needle, the probability of transmission is around 0.6%&#x02013;1.4% for intravenous injections and substantially less for intramuscular injections [<xref ref-type="bibr" rid="B123-viruses-04-01950">123</xref>,<xref ref-type="bibr" rid="B125-viruses-04-01950">125</xref>,<xref ref-type="bibr" rid="B168-viruses-04-01950">168</xref>]. Therefore, as a thought experiment, if all people in an entire country were injected once with the same unsterilized syringe, and if there were 100 HIV-infected people before the campaign, assuming a 1% per needle share probability of transmission, the campaign would hardly do more than increase the number of infections from 100 to 101.</p><p>What is the likelihood of parenteral outbreaks of SIV/HIV in campaigns where infected index patients were injected many times (as happens in IDUs and modern hospital outbreaks)? The best candidate environments in the region of study would be the <italic>hypnoseries</italic> (such as in Nola and Ouesso) where the more severe HAT patients might have been interned together and could have received more than the standard number of 12 injections. If an SIV-infected index case entered such a ward, the situation might have mimicked modern nosocomial outbreaks with the virus being able to spread locally, adapt to humans, and possibly initiate an epidemic in a city. This scenario could have produced a local outbreak, but not a massive outbreak to thousands of people [<xref ref-type="bibr" rid="B17-viruses-04-01950">17</xref>,<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>,<xref ref-type="bibr" rid="B35-viruses-04-01950">35</xref>].</p><p>A rural hospital/<italic>hypnoserie</italic> outbreak would be plausible if, in such a rural facility, the frequency of boiling or rinsing of syringes was low, and the injection intensity was much higher than the average for HAT (<xref ref-type="table" rid="viruses-04-01950-t002">Table 2</xref>). The probability of such conditions would have been higher after the early 1930s for several reasons: (1) the first systematic HAT, syphilis, and yaws campaigns started in 1932 in southeast Cameroon, and in 1930 in the Nola sector (<xref ref-type="table" rid="viruses-04-01950-t003">Table 3</xref>; <xref ref-type="sec" rid="sec2dot4dot5-viruses-04-01950">Section 2.4.5</xref>); (2) before that, intravenous drugs such as <italic>tryparsamide</italic> were less commonly used (subcutaneous/intramuscular <italic>atoxyl </italic>predominated). Thus, the parenteral risks in the region of study strongly intensified after 1930&#x02013;32 (<xref ref-type="sec" rid="sec2dot4dot5-viruses-04-01950">Section 2.4.5</xref>). If HIV-1 had spread intensively in rural areas by unsterile injections in the 1930s, it would likely have continued to do so in the 1940s and 1950s, when injection intensity was higher (<xref ref-type="fig" rid="viruses-04-01950-f002">Figure 2</xref>). One would expect the postulated thousands of people so infected [<xref ref-type="bibr" rid="B17-viruses-04-01950">17</xref>,<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>,<xref ref-type="bibr" rid="B35-viruses-04-01950">35</xref>] to have maintained this rural HIV-1 focus in the region for decades. However, the several serological surveys that were made in the area in the period 1975&#x02013;1992 found zero prevalence until 1987, when HIV-1 arrived there with the pandemic wave (reviewed in [<xref ref-type="bibr" rid="B38-viruses-04-01950">38</xref>]).</p><p>Whereas recent datings of the origin of HIV-1 M (corroborated by the use of two &#x0201c;fossil&#x0201d; virus samples from 1959 and 1960) calculated the tMRCA of HIV-1 M in the range 1900&#x02013;1915, with 95% confidence interval 1873&#x02013;1924 [<xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,<xref ref-type="bibr" rid="B30-viruses-04-01950">30</xref>], it cannot be excluded that these dates may still change, for example if heterotachy (differing evolutionary rate between lineages [<xref ref-type="bibr" rid="B30-viruses-04-01950">30</xref>,<xref ref-type="bibr" rid="B172-viruses-04-01950">172</xref>]) results in overestimating the age of HIV-1 M [<xref ref-type="bibr" rid="B30-viruses-04-01950">30</xref>]. In addition, previous datings [<xref ref-type="bibr" rid="B25-viruses-04-01950">25</xref>,<xref ref-type="bibr" rid="B26-viruses-04-01950">26</xref>] included the 1930s in their 95% confidence interval. Further refinement of molecular dating techniques, and the discovery of new HIV-1 M &#x0201c;fossil&#x0201d; viruses may increase the accuracy of tMRCA datings and, when this happens, all arguments will have to be revised in the light of such new findings.</p><p>The hypothesis of HIV having adapted through a parenteral serial passage event [<xref ref-type="bibr" rid="B4-viruses-04-01950">4</xref>,<xref ref-type="bibr" rid="B32-viruses-04-01950">32</xref>,<xref ref-type="bibr" rid="B33-viruses-04-01950">33</xref>,<xref ref-type="bibr" rid="B34-viruses-04-01950">34</xref>] cannot be ruled out, given that many injections and smallpox vaccinations happened in the region of study, even before 1930 (<xref ref-type="sec" rid="sec2dot4dot2-viruses-04-01950">Section 2.4.2</xref> to <xref ref-type="sec" rid="sec2dot4dot4-viruses-04-01950">Section 2.4.4</xref>). However, this is not a unique feature of parenteral serial transmission, and could perhaps more easily have happened by sexual serial transmission (or by a combination of sexual and parenteral transmission). Since the late 1890s there were CSWs, gonococcal urethritis, syphilis, and possibly other GUDs in the colonial posts of the region [<xref ref-type="bibr" rid="B51-viruses-04-01950">51</xref>,<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>,<xref ref-type="bibr" rid="B152-viruses-04-01950">152</xref>] (<xref ref-type="sec" rid="sec2dot5-viruses-04-01950">Section 2.5</xref>). Sex acts involving GUD have higher HIV transmission probability than unsafe intravenous injections: for a female with a genital ulcer, the per-act female-to-male transmission risk was estimated to be 4% if the male is circumcised and 43% if he is uncircumcised [<xref ref-type="bibr" rid="B36-viruses-04-01950">36</xref>,<xref ref-type="bibr" rid="B37-viruses-04-01950">37</xref>], while the male-to-female risk was estimated to be 7% [<xref ref-type="bibr" rid="B37-viruses-04-01950">37</xref>]; these values are substantially higher than the estimates of per-needle share transmission risks, which fall in the range 0.6&#x02013;1.4% [<xref ref-type="bibr" rid="B123-viruses-04-01950">123</xref>,<xref ref-type="bibr" rid="B125-viruses-04-01950">125</xref>].</p><p>The most recent tMRCA calculations fit well with the time of most intense selling of firearms in the region (1900&#x02013;1907), maximal rubber exploitation in the region (1899&#x02013;1923), intense trade relations with Kinshasa (1899&#x02013;1932), First World War (1914&#x02013;1916), the period when chimpanzee hunting was not outlawed (pre-1930), and the period of intense GUD epidemics in Kinshasa [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>]. If the tMRCA calculations are correct, the above factors may have been more important for HIV-1 M origin than unsterile injections, which had a relatively low frequency in the region before 1930&#x02013;1932.</p><p>The coincidence of the above referred factors in a short period of time, together with the high SIVcpz prevalence in the wild, and the local peoples&#x02019; penchant for ape hunting (<xref ref-type="sec" rid="sec2dot3-viruses-04-01950">Section 2.3</xref>), may indicate that the origin of HIV-1 M was opportunistic, more determined by the conjunction of favorable factors and opportunities, than by any (unknown) superiority of the local SIVcpz viruses over others in their <italic>a priori </italic>genetic ability to infect humans. Further biological studies are however needed to clarify this. We are not suggesting here that the studied region was unique, just that the superimposition of the three geographically patchy variables (ape SIV prevalence, ape bushmeat intensity, and intensity of contacts with the Stanley Pool cities) probably implied that, in the whole range of <italic>P.t.troglodytes</italic>, <italic>P.t.schweinfurthii</italic>, and <italic>G.g.gorilla</italic>, few hot spots with comparably high risk of HIV emergence existed, and that the region under study was one of such hot spots. Why epidemic HIV-1 arrived to Kinshasa only from that hot spot and not from others might have been a matter of chance. Our suggestion that local high SIVcpz prevalence (as observed by recent studies) was relevant to explain the location of HIV-1 M origin depends on the assumption that regional differences in SIVcpz prevalence did not change dramatically in the <italic>P.t.troglodytes</italic> range in the last 100 years. Although this assumption is not proven, it is parsimonious, and in the absence of contrary evidence, we consider it reasonable.</p><p>We found no clear evidence of parenteral risk factors having played a decisive role in HIV adaptation and emergence, and we found that intense co-factors potentially favoring HIV heterosexual transmission were present in both the region of study and in the Stanley Pool cities at the likely time of origin. Therefore we propose an Enhanced Heterosexual Transmission Hypothesis for the origin of the several HIV groups: each of these viruses emerged and adapted to humans through heterosexual transmission enhanced by a spatial and temporal coincidence of a high intensity of factors that favor cross-species transmission (SIV prevalence, ape bushmeat intensity), and of the same co-factors of heterosexual transmission that are today observed to contribute the most to the current African epidemic, without the need to invoke additional factors. Since we are proposing a major role for co-factors of heterosexual transmission, which is the overwhelmingly predominant mode of transmission in Africa, our hypothesis follows the principle of parsimony. Our data shows that the coincidence of factors existed for HIV-1 M and we hypothesize that it permitted the virus to emerge by heterosexual transmission. Our hypothesis predicts that similar coincidence is likely to have been a key element in the origin of the other epidemic HIV-1 and HIV-2 groups, as well.</p><p>The Enhanced Heterosexual Transmission Hypothesis rests not only on patterns of sexual behavior, but also on other factors that influence HIV transmission by the heterosexual route. The Four Cities Study [<xref ref-type="bibr" rid="B173-viruses-04-01950">173</xref>] found that differences in HIV prevalence between four African cities (including Yaound&#x000e9;) were best explained by patterns of male circumcision (and not by patterns of sexual promiscuity). The Enhanced Heterosexual Transmission Hypothesis includes that the lower historical prevalence of circumcision in the early 20th century (compared with the current situation) in Central Africa [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>] probably contributed to the emergence of pandemic HIV-1. Furthermore, sexual promiscuity might have played a stronger indirect role than today by fuelling rampant GUD epidemics, which very strongly facilitate the transmission of HIV but are, today, in contrast to the early 20th century, controlled by treatments in spite of high promiscuity.</p><p>Our research shows how varied the risk factors present in the region of origin of HIV-1 M were, and how far we are from knowing the complete picture. Either sexual or parenteral serial transmission could have partially adapted the virus in the studied region. It could have generated a small local epidemic before moving to Kinshasa, or it could have been brought there by a migrant bushmeat handler directly. Further sampling of SIVcpz viruses from many sites within the Boumba-Ngoko-Sangha enclosure and more migration information during the last century from its host, the chimpanzee, could help to establish better where the virus crossed to humans, which in turn could help to test the hypotheses above exposed. Refinement of MRCA dating techniques and new &#x0201c;fossil&#x0201d; viruses could establish more clearly whether increasing parenteral risks after 1932 were accompanied by a radiation and expansion of the virus. Further archival research might help to quantify trade and migration ties to Kinshasa, Brazzaville, and other cities, the intensity of GUDs in the region, and to investigate the possible role of World War I. New simulations could test competing hypotheses. What exactly happened at the origin of HIV-1 M and HIV-1 O is still mostly unknown.</p></sec><sec><title>4. Sources Used</title><p>In addition to the listed sources about HIV, SIV, and other retroviruses, we consulted major reviews about the relevant epidemics of tropical diseases and STDs discussed here (sources: [<xref ref-type="bibr" rid="B17-viruses-04-01950">17</xref>,<xref ref-type="bibr" rid="B18-viruses-04-01950">18</xref>,<xref ref-type="bibr" rid="B34-viruses-04-01950">34</xref>,<xref ref-type="bibr" rid="B39-viruses-04-01950">39</xref>,<xref ref-type="bibr" rid="B40-viruses-04-01950">40</xref>,<xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,<xref ref-type="bibr" rid="B102-viruses-04-01950">102</xref>,<xref ref-type="bibr" rid="B115-viruses-04-01950">115</xref>,<xref ref-type="bibr" rid="B116-viruses-04-01950">116</xref>,<xref ref-type="bibr" rid="B117-viruses-04-01950">117</xref>,<xref ref-type="bibr" rid="B118-viruses-04-01950">118</xref>,<xref ref-type="bibr" rid="B119-viruses-04-01950">119</xref>,<xref ref-type="bibr" rid="B120-viruses-04-01950">120</xref>,<xref ref-type="bibr" rid="B121-viruses-04-01950">121</xref>]). We obtained quantitative data about diseases and their treatments for the whole of Cameroon, AEF, and for the districts of these countries situated in the region of study from:</p><p>(1) Official colonial reports about health, or containing sections about health, and covering also demographic issues. (A) For AEF and Cameroon, period 1920&#x02013;1960, collected in the Archives Nationales d&#x02019;Outre-Mer (ANOM), Aix-en-Provence (France), and in the Institut de M&#x000e9;decine Tropicale du Service de Sant&#x000e9; des Arm&#x000e9;es (IMTSSA), Marseille (France). (B) For Cameroon, we used also the reports from the French administration to the League of Nations [<xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>]. (C) For Kinshasa and the Belgian Congo we consulted the Afrika Archief, Federale Overheidsdients&#x02014;Buitenlandse Zaken, Buitenlandse Handel en Ontwikkelingssamenwerking (FO-BZBHO), Brussels (Belgium).</p><p>(2) We complemented this information with articles in the main colonial and tropical medicine journals (Ann M&#x000e9;d Pharm Coloniales, Ann Hyg M&#x000e9;d Coloniales, Bull Soc Pathol Exotique), and additional articles and books on the subject. Particularly important was a series of annual articles in Ann M&#x000e9;d Pharm Coloniales, covering health data in French colonies and territories under administration in the period 1927&#x02013;1936 [<xref ref-type="bibr" rid="B87-viruses-04-01950">87</xref>,<xref ref-type="bibr" rid="B88-viruses-04-01950">88</xref>,<xref ref-type="bibr" rid="B89-viruses-04-01950">89</xref>,<xref ref-type="bibr" rid="B90-viruses-04-01950">90</xref>,<xref ref-type="bibr" rid="B91-viruses-04-01950">91</xref>,<xref ref-type="bibr" rid="B92-viruses-04-01950">92</xref>,<xref ref-type="bibr" rid="B93-viruses-04-01950">93</xref>,<xref ref-type="bibr" rid="B94-viruses-04-01950">94</xref>,<xref ref-type="bibr" rid="B95-viruses-04-01950">95</xref>,<xref ref-type="bibr" rid="B96-viruses-04-01950">96</xref>,<xref ref-type="bibr" rid="B97-viruses-04-01950">97</xref>].</p><p>We collected primary ethnographic, primatological, and other works to obtain information about chimpanzee and gorilla hunting in the region under study, including legislation [<xref ref-type="bibr" rid="B46-viruses-04-01950">46</xref>,<xref ref-type="bibr" rid="B47-viruses-04-01950">47</xref>,<xref ref-type="bibr" rid="B48-viruses-04-01950">48</xref>,<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>,<xref ref-type="bibr" rid="B55-viruses-04-01950">55</xref>,<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>,<xref ref-type="bibr" rid="B57-viruses-04-01950">57</xref>,<xref ref-type="bibr" rid="B58-viruses-04-01950">58</xref>,<xref ref-type="bibr" rid="B59-viruses-04-01950">59</xref>,<xref ref-type="bibr" rid="B60-viruses-04-01950">60</xref>,<xref ref-type="bibr" rid="B61-viruses-04-01950">61</xref>,<xref ref-type="bibr" rid="B62-viruses-04-01950">62</xref>,<xref ref-type="bibr" rid="B63-viruses-04-01950">63</xref>,<xref ref-type="bibr" rid="B64-viruses-04-01950">64</xref>,<xref ref-type="bibr" rid="B65-viruses-04-01950">65</xref>,<xref ref-type="bibr" rid="B66-viruses-04-01950">66</xref>,<xref ref-type="bibr" rid="B67-viruses-04-01950">67</xref>,<xref ref-type="bibr" rid="B68-viruses-04-01950">68</xref>,<xref ref-type="bibr" rid="B71-viruses-04-01950">71</xref>,<xref ref-type="bibr" rid="B73-viruses-04-01950">73</xref>,<xref ref-type="bibr" rid="B74-viruses-04-01950">74</xref>,<xref ref-type="bibr" rid="B75-viruses-04-01950">75</xref>,<xref ref-type="bibr" rid="B76-viruses-04-01950">76</xref>,<xref ref-type="bibr" rid="B77-viruses-04-01950">77</xref>,<xref ref-type="bibr" rid="B78-viruses-04-01950">78</xref>,<xref ref-type="bibr" rid="B79-viruses-04-01950">79</xref>]. For this region, these sources offer a more detailed picture than the larger set of sources we used in our previous literature survey (applying to Central Africa as a whole), listed in the main and supplementary reference lists published with our previous article [<xref ref-type="bibr" rid="B16-viruses-04-01950">16</xref>]. We complemented these with additional sources about the modern bushmeat crisis and ape population decline.</p><p>We consulted historical and anthropological sources about social, economic, demographic, and military issues, most of which directly cover the region under study [<xref ref-type="bibr" rid="B54-viruses-04-01950">54</xref>,<xref ref-type="bibr" rid="B55-viruses-04-01950">55</xref>,<xref ref-type="bibr" rid="B56-viruses-04-01950">56</xref>,<xref ref-type="bibr" rid="B67-viruses-04-01950">67</xref>,<xref ref-type="bibr" rid="B68-viruses-04-01950">68</xref>,<xref ref-type="bibr" rid="B69-viruses-04-01950">69</xref>,<xref ref-type="bibr" rid="B70-viruses-04-01950">70</xref>,<xref ref-type="bibr" rid="B122-viruses-04-01950">122</xref>,<xref ref-type="bibr" rid="B141-viruses-04-01950">141</xref>,<xref ref-type="bibr" rid="B145-viruses-04-01950">145</xref>,<xref ref-type="bibr" rid="B151-viruses-04-01950">151</xref>,<xref ref-type="bibr" rid="B152-viruses-04-01950">152</xref>,<xref ref-type="bibr" rid="B153-viruses-04-01950">153</xref>,<xref ref-type="bibr" rid="B156-viruses-04-01950">156</xref>,<xref ref-type="bibr" rid="B157-viruses-04-01950">157</xref>,<xref ref-type="bibr" rid="B158-viruses-04-01950">158</xref>,<xref ref-type="bibr" rid="B160-viruses-04-01950">160</xref>,<xref ref-type="bibr" rid="B162-viruses-04-01950">162</xref>].</p><p>We consulted modern sources about IDUs, focusing on their needle sharing behavior, and prevalence of HIV-1 and HCV [<xref ref-type="bibr" rid="B125-viruses-04-01950">125</xref>,<xref ref-type="bibr" rid="B126-viruses-04-01950">126</xref>,<xref ref-type="bibr" rid="B127-viruses-04-01950">127</xref>,<xref ref-type="bibr" rid="B128-viruses-04-01950">128</xref>,<xref ref-type="bibr" rid="B129-viruses-04-01950">129</xref>,<xref ref-type="bibr" rid="B130-viruses-04-01950">130</xref>,<xref ref-type="bibr" rid="B131-viruses-04-01950">131</xref>,<xref ref-type="bibr" rid="B132-viruses-04-01950">132</xref>,<xref ref-type="bibr" rid="B133-viruses-04-01950">133</xref>,<xref ref-type="bibr" rid="B134-viruses-04-01950">134</xref>,<xref ref-type="bibr" rid="B135-viruses-04-01950">135</xref>,<xref ref-type="bibr" rid="B136-viruses-04-01950">136</xref>,<xref ref-type="bibr" rid="B137-viruses-04-01950">137</xref>,<xref ref-type="bibr" rid="B138-viruses-04-01950">138</xref>,<xref ref-type="bibr" rid="B139-viruses-04-01950">139</xref>,<xref ref-type="bibr" rid="B140-viruses-04-01950">140</xref>], and reviews of modern HIV-1 nosocomial outbreaks [<xref ref-type="bibr" rid="B123-viruses-04-01950">123</xref>,<xref ref-type="bibr" rid="B124-viruses-04-01950">124</xref>,<xref ref-type="bibr" rid="B168-viruses-04-01950">168</xref>].</p></sec><sec><title>5. Conclusions</title><p>In this article, we reviewed the factors that may have helped HIV-1 M to emerge from its birthplace in the African rainforest. The cross-species transmission from chimpanzees has been suggested to have taken place in southeast Cameroon or the neighboring AEF areas. Indeed, SIVcpz is far more prevalent in this area than in most other areas of the <italic>P.t.troglodytes</italic> and <italic>P.t.schweinfurthii</italic> range, while SIVgor has not been found there. The conjunction of favorable conditions in a short period of time&#x02014;ape bushmeat hunting intensification, social disruption, nascent cities with commercial sex workers and STDs (including genital ulcer diseases)&#x02014;seem to have coincided with tMRCA estimates for HIV-1 M, suggesting that the origin of the epidemic was opportunistic, probably more associated with these conditions than with a potential predisposition of local SIVcpz over other SIVcpz to infect humans.</p><p>While the parenteral hypothesis of HIV origins still deserves further verification through modeling, we already see two major difficulties. First, the injection treatments in the region intensified sharply only in 1930&#x02013;1932, while the upper confidence intervals of most recently published tMRCA calculations fall before that. Second, local syphilis, yaws, and HAT patients received far fewer injections per year than current IDUs and patients in hospital outbreaks for which good records were kept. Therefore, the strongest version of the parenteral theories, that proposing massive parenteral spread of HIV-1 to thousands of people in rural areas, seems unlikely. A more limited local parenteral outbreak of HIV-1 could have occurred in <italic>hypnoseries</italic> or other health facilities where injection intensity was higher than average, especially after 1932. The hypothesis of HIV-1 adaptation by serial passage involving a short chain of transmissions is plausible and could have happened at any time during colonial domination of the region. This mechanism could have happened by either parenteral or sexual transmission. </p><p>We therefore propose an Enhanced Heterosexual Transmission Hypothesis for the origin of HIV-1 M, by which the emergence of the virus was caused by a coincidence of high intensity of favorable factors for cross-species transmission (SIV prevalence and ape bushmeat hunting), and of factors that are today associated with HIV heterosexual spread in Africa (travel/migration, social disruption, sex work, STDs, GUDs, and possibly lack of male circumcision). While there is no necessity for parenteral transmission in this hypothesis, it does not exclude a role for it in the initial adaptation of SIVcpz to humans.</p></sec></body><back><ack><title>Acknowledgments</title><p>We are grateful to Anne Buv&#x000e9; (Instituut voor Tropische Geneeskunde, Antwerpen, Belgium), Tamara Giles-Vernick (Institut Pasteur, Paris), Nancy Rose Hunt (University of Michigan), Charles Becker (Centre National de Recherche Scientifique, France), Teresa Avelar, and Uwe Schulte-Varendorff (Universit&#x000e4;t Osnabr&#x000fc;ck, Osnabr&#x000fc;ck, Germany) for enlightening discussions. We thank Pierre Dandoy and Rafael Storme (Afrika Archief, Federale Overheidsdients&#x02014;Buitenlandse Zaken, Buitenlandse Handel en Ontwikkelingssamenwerking (FO-BZBHO), Brussels), Evelyne Camara (Archives Nationales d&#x02019;Outre-Mer (ANOM), Aix-en-Provence, France), and Aline Pueyo (Institut de M&#x000e9;decine Tropicale du Service de Sant&#x000e9; des Arm&#x000e9;es (IMTSSA), Marseille, France), for their attention and help to our research in their respective Archives. V.M. acknowledges support from the Hungarian Scientific Research Fund (OTKA NF72791) and a Bolyai J&#x000e1;nos Research Fellowship of the Hungarian Academy of Sciences. C.A. acknowledges support from the Directorate-General for Development Cooperation of the Belgian Government through the Flemish Interuniversity Council (VLIR-UOS Own Initiative ZEIN2010PR376).</p></ack><notes><title>Conflict of Interest</title><p>We declare that no conflict of interest exists. </p></notes><ref-list><title>References and Notes</title><ref id="B1-viruses-04-01950"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Heuverswyn</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Neel</surname><given-names>C.</given-names></name><name><surname>Bailes</surname><given-names>E.</given-names></name><name><surname>Keele</surname><given-names>B.F.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Loul</surname><given-names>S.</given-names></name><name><surname>Butel</surname><given-names>C.</given-names></name><name><surname>Liegeois</surname><given-names>F.</given-names></name><name><surname>Bienvenue</surname><given-names>Y.</given-names></name><etal/></person-group>
<article-title>SIV infection in wild gorillas</article-title>
<source>Nature</source>
<year>2006</year>
<volume>444</volume>
<fpage>164</fpage>
<pub-id pub-id-type="doi">10.1038/444164a</pub-id>
<pub-id pub-id-type="pmid">17093443</pub-id></element-citation></ref><ref id="B2-viruses-04-01950"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keele</surname><given-names>B.F.</given-names></name><name><surname>Van Heuverswyn</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Bailes</surname><given-names>E.</given-names></name><name><surname>Takehisa</surname><given-names>J.</given-names></name><name><surname>Santiago</surname><given-names>M.L.</given-names></name><name><surname>Bibollet-Ruche</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wain</surname><given-names>L.V.</given-names></name><name><surname>Liegeois</surname><given-names>F.</given-names></name><etal/></person-group>
<article-title>Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1</article-title>
<source>Science</source>
<year>2006</year>
<volume>313</volume>
<fpage>523</fpage>
<lpage>526</lpage>
<pub-id pub-id-type="pmid">16728595</pub-id></element-citation></ref><ref id="B3-viruses-04-01950"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hahn</surname><given-names>B.H.</given-names></name><name><surname>Shaw</surname><given-names>G.M.</given-names></name><name><surname>De Cock</surname><given-names>K.M.</given-names></name><name><surname>Sharp</surname><given-names>P.M.</given-names></name></person-group>
<article-title>AIDS as a zoonosis: Scientific and public health implications</article-title>
<source>Science</source>
<year>2000</year>
<volume>287</volume>
<fpage>607</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="doi">10.1126/science.287.5453.607</pub-id>
<pub-id pub-id-type="pmid">10649986</pub-id></element-citation></ref><ref id="B4-viruses-04-01950"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marx</surname><given-names>P.A.</given-names></name><name><surname>Alcabes</surname><given-names>P.G.</given-names></name><name><surname>Drucker</surname><given-names>E.</given-names></name></person-group>
<article-title>Serial human passage of simian immunodeficiency virus by unsterile injections and the emergence of epidemic human immunodeficiency virus in Africa</article-title>
<source>Phil. Trans. R. Soc. Lond. B Biol. Sci.</source>
<year>2001</year>
<volume>356</volume>
<fpage>911</fpage>
<lpage>920</lpage>
<pub-id pub-id-type="doi">10.1098/rstb.2001.0867</pub-id>
<pub-id pub-id-type="pmid">11405938</pub-id></element-citation></ref><ref id="B5-viruses-04-01950"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chitnis</surname><given-names>A.</given-names></name><name><surname>Rawls</surname><given-names>D.</given-names></name><name><surname>Moore</surname><given-names>J.</given-names></name></person-group>
<article-title>Origin of HIV-1 in colonial French Equatorial Africa?</article-title>
<source>AIDS Res. Hum. Retrovir.</source>
<year>2000</year>
<volume>16</volume>
<fpage>5</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1089/088922200309548</pub-id>
<pub-id pub-id-type="pmid">10628811</pub-id></element-citation></ref><ref id="B6-viruses-04-01950"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lemey</surname><given-names>P.</given-names></name><name><surname>Pybus</surname><given-names>O.G.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Saksena</surname><given-names>N.K.</given-names></name><name><surname>Salemi</surname><given-names>M.</given-names></name><name><surname>Vandamme</surname><given-names>A.-M.</given-names></name></person-group>
<article-title>Tracing the origin and history of the HIV-2 epidemic</article-title>
<source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2003</year>
<volume>100</volume>
<fpage>6588</fpage>
<lpage>6592</lpage>
<pub-id pub-id-type="pmid">12743376</pub-id></element-citation></ref><ref id="B7-viruses-04-01950"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>J.</given-names></name><name><surname>Devare</surname><given-names>S.G.</given-names></name><name><surname>Brennan</surname><given-names>C.A.</given-names></name></person-group>
<article-title>Identification of a new HIV-2 subtype based on phylogenetic analysis of full-length genomic sequence</article-title>
<source>AIDS Res. Hum. Retrovir.</source>
<year>2000</year>
<volume>16</volume>
<fpage>925</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="pmid">10875618</pub-id></element-citation></ref><ref id="B8-viruses-04-01950"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Damond</surname><given-names>F.</given-names></name><name><surname>Worobey</surname><given-names>M.</given-names></name><name><surname>Campa</surname><given-names>P.</given-names></name><name><surname>Farfara</surname><given-names>I.</given-names></name><name><surname>Colin</surname><given-names>G.</given-names></name><name><surname>Matheron</surname><given-names>S.</given-names></name><name><surname>Brun-V&#x000e9;zinet</surname><given-names>F.</given-names></name><name><surname>Robertson</surname><given-names>D.L.</given-names></name><name><surname>Simon</surname><given-names>F.</given-names></name></person-group>
<article-title>Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification</article-title>
<source>AIDS Res. Hum. Retrovir.</source>
<year>2004</year>
<volume>20</volume>
<fpage>666</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="pmid">15242544</pub-id></element-citation></ref><ref id="B9-viruses-04-01950"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Santiago</surname><given-names>M.L.</given-names></name><name><surname>Range</surname><given-names>F.</given-names></name><name><surname>Keele</surname><given-names>B.F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Bailes</surname><given-names>E.</given-names></name><name><surname>Bibollet-Ruche</surname><given-names>F.</given-names></name><name><surname>Fruteau</surname><given-names>C.</given-names></name><name><surname>No&#x000eb;</surname><given-names>R.</given-names></name><name><surname>Peeters</surname><given-names>M.</given-names></name><name><surname>Brookfield</surname><given-names>J.F.Y.</given-names></name><etal/></person-group>
<article-title>Smian Immunodeficiency Virus Infection in Free-Ranging Sooty Mangabeys (<italic>Cercocebus atys aty</italic>s) from the Tai Forest, C&#x000f4;te d&#x02019;Ivoire: Implications for the Origin of Epidemic Human Immunodeficiency Virus Type 2</article-title>
<source>J. Virol.</source>
<year>2005</year>
<volume>79</volume>
<fpage>12515</fpage>
<lpage>12527</lpage>
<pub-id pub-id-type="pmid">16160179</pub-id></element-citation></ref><ref id="B10-viruses-04-01950"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Plantier</surname><given-names>J.C.</given-names></name><name><surname>Leoz</surname><given-names>M.</given-names></name><name><surname>Dickerson</surname><given-names>J.E.</given-names></name><name><surname>De Oliveira</surname><given-names>F.</given-names></name><name><surname>Cordonnier</surname><given-names>F.</given-names></name><name><surname>Lem&#x000e9;e</surname><given-names>V.</given-names></name><name><surname>Damond</surname><given-names>F.</given-names></name><name><surname>Robertson</surname><given-names>D.L.</given-names></name><name><surname>Simon</surname><given-names>F.</given-names></name></person-group>
<article-title>A new human immunodeficiency virus derived from gorillas</article-title>
<source>Nat. Med.</source>
<year>2009</year>
<volume>15</volume>
<fpage>871</fpage>
<lpage>872</lpage>
<pub-id pub-id-type="pmid">19648927</pub-id></element-citation></ref><ref id="B11-viruses-04-01950"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vallari</surname><given-names>A.</given-names></name><name><surname>Holzmayer</surname><given-names>V.</given-names></name><name><surname>Harris</surname><given-names>B.</given-names></name><name><surname>Yamaguchi</surname><given-names>J.</given-names></name><name><surname>Ngansop</surname><given-names>C.</given-names></name><name><surname>Makamche</surname><given-names>F.</given-names></name><name><surname>Mbanya</surname><given-names>D.</given-names></name><name><surname>Kaptu&#x000e9;</surname><given-names>L.</given-names></name><name><surname>Ndembi</surname><given-names>N.</given-names></name><name><surname>G&#x000fc;rtler</surname><given-names>L.</given-names></name><etal/></person-group>
<article-title>Confirmation of putative HIV-1 group P in Cameroon</article-title>
<source>J. Virol.</source>
<year>2011</year>
<volume>85</volume>
<fpage>1403</fpage>
<lpage>1407</lpage>
<pub-id pub-id-type="pmid">21084486</pub-id></element-citation></ref><ref id="B12-viruses-04-01950"><label>12.</label><element-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Ayouba</surname><given-names>A.</given-names></name><name><surname>Akoua-Koffi</surname><given-names>C.</given-names></name><name><surname>Adjogoua</surname><given-names>E.</given-names></name><name><surname>Calvignac</surname><given-names>S.</given-names></name><name><surname>Esteban</surname><given-names>A.</given-names></name><name><surname>Locatelli</surname><given-names>S.</given-names></name><name><surname>Delaporte</surname><given-names>E.</given-names></name><name><surname>Leendertz</surname><given-names>F.</given-names></name><name><surname>Peeters</surname><given-names>M.</given-names></name></person-group>
<article-title>Identification of a new HIV-2 lineage in rural C&#x000f4;te d&#x02019;Ivoire: An additional cross-species transmission from SIV<sub>smm</sub> from sooty mangabeys to humans</article-title>
<source>Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections</source>
<conf-loc>Seattle, WA, USA</conf-loc>
<conf-date>5&#x02013;8 March 2012</conf-date>
<comment>Oral presentation 62LB</comment>
</element-citation></ref><ref id="B13-viruses-04-01950"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neel</surname><given-names>C.</given-names></name><name><surname>Etienne</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Takehisa</surname><given-names>J.</given-names></name><name><surname>Rudicell</surname><given-names>R.S.</given-names></name><name><surname>Ndong Bass</surname><given-names>I.</given-names></name><name><surname>Moudindo</surname><given-names>J.</given-names></name><name><surname>Mebenga</surname><given-names>A.</given-names></name><name><surname>Esteban</surname><given-names>A.</given-names></name><name><surname>Van Heuverswyn</surname><given-names>F.</given-names></name><etal/></person-group>
<article-title>Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas</article-title>
<source>J. Virol.</source>
<year>2010</year>
<volume>84</volume>
<fpage>1464</fpage>
<lpage>1476</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.02129-09</pub-id>
<pub-id pub-id-type="pmid">19906908</pub-id></element-citation></ref><ref id="B14-viruses-04-01950"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maucl&#x000e8;re</surname><given-names>P.</given-names></name><name><surname>Loussert-Ajaka</surname><given-names>I.</given-names></name><name><surname>Damond</surname><given-names>F.</given-names></name><name><surname>Fagot</surname><given-names>P.</given-names></name><name><surname>Souqui&#x000e8;res</surname><given-names>S.</given-names></name><name><surname>Lobe</surname><given-names>M.M.</given-names></name><name><surname>Mbopi Keou</surname><given-names>F.-X.</given-names></name><name><surname>Barr&#x000e9;-Sinoussi</surname><given-names>F.</given-names></name><name><surname>Saragosti</surname><given-names>S.</given-names></name><name><surname>Brun-V&#x000e9;zinet</surname><given-names>F.</given-names></name><etal/></person-group>
<article-title>Serological and virological characterization of HIV-1 group O infection in Cameroon</article-title>
<source>AIDS</source>
<year>1997</year>
<volume>11</volume>
<fpage>445</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1097/00002030-199704000-00007</pub-id>
<pub-id pub-id-type="pmid">9084791</pub-id></element-citation></ref><ref id="B15-viruses-04-01950"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharp</surname><given-names>P.M.</given-names></name><name><surname>Hahn</surname><given-names>B.H.</given-names></name></person-group>
<article-title>Origins of HIV and the AIDS pandemic</article-title>
<source>Cold Spring Harb. Perspect. Med.</source>
<year>2011</year>
<volume>1</volume>
<fpage>a006841</fpage>
<pub-id pub-id-type="pmid">22229120</pub-id></element-citation></ref><ref id="B16-viruses-04-01950"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sousa</surname><given-names>J.D.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>V.</given-names></name><name><surname>Lemey</surname><given-names>P.</given-names></name><name><surname>Vandamme</surname><given-names>A.-M.</given-names></name></person-group>
<article-title>High GUD incidence in the early 20th century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains</article-title>
<source>PLoS One</source>
<year>2010</year>
<volume>5</volume>
<fpage>e9936</fpage>
<pub-id pub-id-type="pmid">20376191</pub-id></element-citation></ref><ref id="B17-viruses-04-01950"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>P&#x000e9;pin</surname><given-names>J.</given-names></name><name><surname>Labb&#x000e9;</surname><given-names>A.C.</given-names></name></person-group>
<article-title>Noble goals, unforeseen consequences: Control of tropical diseases in colonial Central Africa and the iatrogenic transmission of blood-borne viruses</article-title>
<source>Trop. Med. Int. Health</source>
<year>2008</year>
<volume>13</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">18578806</pub-id></element-citation></ref><ref id="B18-viruses-04-01950"><label>18.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>P&#x000e9;pin</surname><given-names>J.</given-names></name></person-group>
<source>The Origins of AIDS</source>
<publisher-name>Cambridge University Press</publisher-name>
<publisher-loc>Cambridge, UK</publisher-loc>
<year>2011</year>
</element-citation></ref><ref id="B19-viruses-04-01950"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kalish</surname><given-names>M.L.</given-names></name><name><surname>Wolfe</surname><given-names>N.D.</given-names></name><name><surname>Ndongmo</surname><given-names>C.B.</given-names></name><name><surname>McNicholl</surname><given-names>J.</given-names></name><name><surname>Robbins</surname><given-names>K.E.</given-names></name><name><surname>Aidoo</surname><given-names>M.</given-names></name><name><surname>Fonjungo</surname><given-names>P.N.</given-names></name><name><surname>Alemnji</surname><given-names>G.</given-names></name><name><surname>Zeh</surname><given-names>C.</given-names></name><name><surname>Djoko</surname><given-names>C.F.</given-names></name><etal/></person-group>
<article-title>Central African hunters exposed to simian immunodeficiency virus</article-title>
<source>Emerg. Infect. Dis.</source>
<year>2005</year>
<volume>11</volume>
<fpage>1928</fpage>
<lpage>1930</lpage>
<pub-id pub-id-type="doi">10.3201/eid1112.050394</pub-id>
<pub-id pub-id-type="pmid">16485481</pub-id></element-citation></ref><ref id="B20-viruses-04-01950"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>N.D.</given-names></name><name><surname>Switzer</surname><given-names>W.M.</given-names></name><name><surname>Carr</surname><given-names>J.K.</given-names></name><name><surname>Bhullar</surname><given-names>V.B.</given-names></name><name><surname>Shanmugam</surname><given-names>V.</given-names></name><name><surname>Tamoufe</surname><given-names>U.</given-names></name><name><surname>Prosser</surname><given-names>A.T.</given-names></name><name><surname>Torimiro</surname><given-names>J.N.</given-names></name><name><surname>Wright</surname><given-names>A.</given-names></name><name><surname>Mpoudi-Ngole</surname><given-names>E.</given-names></name><etal/></person-group>
<article-title>Naturally acquired simian retrovirus infections in central African hunters</article-title>
<source>Lancet</source>
<year>2004</year>
<volume>363</volume>
<fpage>932</fpage>
<lpage>937</lpage>
<pub-id pub-id-type="pmid">15043960</pub-id></element-citation></ref><ref id="B21-viruses-04-01950"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>N.D.</given-names></name><name><surname>Heneine</surname><given-names>W.</given-names></name><name><surname>Carr</surname><given-names>J.K.</given-names></name><name><surname>Garcia</surname><given-names>A.D.</given-names></name><name><surname>Shanmugam</surname><given-names>V.</given-names></name><name><surname>Tamoufe</surname><given-names>U.</given-names></name><name><surname>Torimiro</surname><given-names>J.N.</given-names></name><name><surname>Prosser</surname><given-names>A.T.</given-names></name><name><surname>LeBreton</surname><given-names>M.</given-names></name><name><surname>Mpoudi-Ngole</surname><given-names>E.</given-names></name><etal/></person-group>
<article-title>Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters</article-title>
<source>Proc. Nat. Acad. Sci. U. S. A.</source>
<year>2005</year>
<volume>102</volume>
<fpage>7994</fpage>
<lpage>7999</lpage>
</element-citation></ref><ref id="B22-viruses-04-01950"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salemi</surname><given-names>M.</given-names></name><name><surname>Van Dooren</surname><given-names>S.</given-names></name><name><surname>Vandamme</surname><given-names>A.-M.</given-names></name></person-group>
<article-title>Origin and evolution of human and simian T-cell lymphotropic viruses</article-title>
<source>AIDS Rev.</source>
<year>1999</year>
<volume>1</volume>
<fpage>131</fpage>
<lpage>139</lpage>
</element-citation></ref><ref id="B23-viruses-04-01950"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Dooren</surname><given-names>S.</given-names></name><name><surname>Salemi</surname><given-names>M.</given-names></name><name><surname>Vandamme</surname><given-names>A.-M.</given-names></name></person-group>
<article-title>Dating the origin of the african human T-cell lymphotropic virus type-I (HTLV-I) subtypes</article-title>
<source>Mol. Biol. Evol.</source>
<year>2001</year>
<volume>18</volume>
<fpage>661</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="pmid">11264418</pub-id></element-citation></ref><ref id="B24-viruses-04-01950"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salemi</surname><given-names>M.</given-names></name><name><surname>Desmyter</surname><given-names>J.</given-names></name><name><surname>Vandamme</surname><given-names>A.-M.</given-names></name></person-group>
<article-title>Tempo and mode of human and simian T-lymphotropic virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences</article-title>
<source>Mol. Biol. Evol.</source>
<year>2000</year>
<volume>17</volume>
<fpage>374</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a026317</pub-id>
<pub-id pub-id-type="pmid">10723738</pub-id></element-citation></ref><ref id="B25-viruses-04-01950"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salemi</surname><given-names>M.</given-names></name><name><surname>Strimmer</surname><given-names>K.</given-names></name><name><surname>Hall</surname><given-names>W.W.</given-names></name><name><surname>Duffy</surname><given-names>M.</given-names></name><name><surname>Delaporte</surname><given-names>E.</given-names></name><name><surname>Mboup</surname><given-names>S.</given-names></name><name><surname>Peeters</surname><given-names>M.</given-names></name><name><surname>Vandamme</surname><given-names>A.-M.</given-names></name></person-group>
<article-title>Dating the radiation of HIV-1 group M in 1930s using a new method to uncover clock-like molecular evolution</article-title>
<source>FASEB J. Print</source>
<year>2001</year>
<volume>15</volume>
<fpage>276</fpage>
<lpage>278</lpage>
</element-citation></ref><ref id="B26-viruses-04-01950"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Korber</surname><given-names>B.</given-names></name><name><surname>Muldoon</surname><given-names>M.</given-names></name><name><surname>Theiler</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>F.</given-names></name><name><surname>Gupta</surname><given-names>R.</given-names></name><name><surname>Lapedes</surname><given-names>A.</given-names></name><name><surname>Hahn</surname><given-names>B.H.</given-names></name><name><surname>Wolinsky</surname><given-names>S.</given-names></name><name><surname>Bhattacharya</surname><given-names>T.</given-names></name></person-group>
<article-title>Timing the ancestor of the HIV-1 pandemic strains</article-title>
<source>Science</source>
<year>2000</year>
<volume>288</volume>
<fpage>1789</fpage>
<lpage>1796</lpage>
<pub-id pub-id-type="pmid">10846155</pub-id></element-citation></ref><ref id="B27-viruses-04-01950"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Worobey</surname><given-names>M.</given-names></name><name><surname>Gemmel</surname><given-names>M.</given-names></name><name><surname>Teuwen</surname><given-names>D.E.</given-names></name><name><surname>Haselkorn</surname><given-names>T.</given-names></name><name><surname>Kunstman</surname><given-names>K.</given-names></name><name><surname>Bunce</surname><given-names>M.</given-names></name><name><surname>Muyembe</surname><given-names>J.-J.</given-names></name><name><surname>Kabongo</surname><given-names>J.M.M.</given-names></name><name><surname>Kalengayi</surname><given-names>R.M.</given-names></name><name><surname>Van Marck</surname><given-names>E.</given-names></name><etal/></person-group>
<article-title>Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960</article-title>
<source>Nature</source>
<year>2008</year>
<volume>455</volume>
<fpage>661</fpage>
<lpage>665</lpage>
<pub-id pub-id-type="pmid">18833279</pub-id></element-citation></ref><ref id="B28-viruses-04-01950"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lemey</surname><given-names>P.</given-names></name><name><surname>Pybus</surname><given-names>O.G.</given-names></name><name><surname>Rambaut</surname><given-names>A.</given-names></name><name><surname>Drummond</surname><given-names>A.J.</given-names></name><name><surname>Robertson</surname><given-names>D.L.</given-names></name><name><surname>Roques</surname><given-names>P.</given-names></name><name><surname>Worobey</surname><given-names>M.</given-names></name><name><surname>Vandamme</surname><given-names>A.-M.</given-names></name></person-group>
<article-title>The molecular population genetics of HIV-1 group O</article-title>
<source>Genetics</source>
<year>2004</year>
<volume>167</volume>
<fpage>1059</fpage>
<lpage>1068</lpage>
<pub-id pub-id-type="pmid">15280223</pub-id></element-citation></ref><ref id="B29-viruses-04-01950"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wertheim</surname><given-names>J.O.</given-names></name><name><surname>Worobey</surname><given-names>M.</given-names></name></person-group>
<article-title>Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2</article-title>
<source>PLoS Comput. Biol.</source>
<year>2009</year>
<volume>5</volume>
<fpage>e1000377</fpage>
<pub-id pub-id-type="pmid">19412344</pub-id></element-citation></ref><ref id="B30-viruses-04-01950"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wertheim</surname><given-names>J.O</given-names></name><name><surname>Fourment</surname><given-names>M.</given-names></name><name><surname>Kosakovsky Pond</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Inconsistencies in estimating the age of HIV-1 subtypes due to heterotachy</article-title>
<source>Mol. Biol. Evol.</source>
<year>2012</year>
<volume>29</volume>
<fpage>451</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1093/molbev/msr266</pub-id>
<pub-id pub-id-type="pmid">22045998</pub-id></element-citation></ref><ref id="B31-viruses-04-01950"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Faria</surname><given-names>N.R.</given-names></name><name><surname>Hodges-Mameletzis</surname><given-names>I.</given-names></name><name><surname>Silva</surname><given-names>J.C.</given-names></name><name><surname>Rod&#x000e9;s</surname><given-names>B.</given-names></name><name><surname>Erasmus</surname><given-names>S.</given-names></name><name><surname>Paolucci</surname><given-names>S.</given-names></name><name><surname>Ruelle</surname><given-names>J.</given-names></name><name><surname>Pieniazek</surname><given-names>D.</given-names></name><name><surname>Taveira</surname><given-names>N.</given-names></name><name><surname>Trevi&#x000f1;o</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>Pylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A</article-title>
<source>J. Gen. Virol.</source>
<year>2012</year>
<volume>93</volume>
<fpage>889</fpage>
<lpage>899</lpage>
<pub-id pub-id-type="doi">10.1099/vir.0.038638-0</pub-id>
<pub-id pub-id-type="pmid">22190015</pub-id></element-citation></ref><ref id="B32-viruses-04-01950"><label>32.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drucker</surname><given-names>E.</given-names></name><name><surname>Alcabes</surname><given-names>P.G.</given-names></name><name><surname>Marx</surname><given-names>P.A.</given-names></name></person-group>
<article-title>The injection century: Massive unsterile injections and the emergence of human pathogens</article-title>
<source>Lancet</source>
<year>2001</year>
<volume>358</volume>
<fpage>1989</fpage>
<lpage>1992</lpage>
<pub-id pub-id-type="pmid">11747942</pub-id></element-citation></ref><ref id="B33-viruses-04-01950"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verdraeger</surname><given-names>J.</given-names></name></person-group>
<article-title>SIDA: Hypoth&#x000e8;ses sur l'origine et l'&#x000e9;mergence du VIH (in French)</article-title>
<source>Bull. Soc. Pathol. Ex&#x000f3;tique</source>
<year>1995</year>
<volume>88</volume>
<fpage>54</fpage>
<lpage>60</lpage>
</element-citation></ref><ref id="B34-viruses-04-01950"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gisselquist</surname><given-names>D.</given-names></name></person-group>
<article-title>Emergence of HIV type 1 epidemic in the twentieth century: Comparing hypotheses to evidence</article-title>
<source>AIDS Res. Hum. Retrovir.</source>
<year>2003</year>
<volume>19</volume>
<fpage>1071</fpage>
<lpage>1078</lpage>
<pub-id pub-id-type="pmid">14709242</pub-id></element-citation></ref><ref id="B35-viruses-04-01950"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>P&#x000e9;pin</surname><given-names>J.</given-names></name><name><surname>Annie-Claude Labb&#x000e9;</surname><given-names>A.C.</given-names></name><name><surname>Mamadou-Yaya</surname><given-names>F.</given-names></name><name><surname>Mb&#x000e9;lesso</surname><given-names>P.</given-names></name><name><surname>Mbadinga&#x000ef;</surname><given-names>S.</given-names></name><name><surname>Deslandes</surname><given-names>S.</given-names></name><name><surname>Locas</surname><given-names>M.-C.</given-names></name><name><surname>Frost</surname><given-names>E.</given-names></name></person-group>
<article-title>Iatrogenic transmission of human T cell lymphotropic virus type 1 and hepatitis C virus through parenteral treatment and chemoprophylaxis of sleeping sickness in Colonial Equatorial Africa</article-title>
<source>Clin. Inf. Dis.</source>
<year>2010</year>
<volume>51</volume>
<fpage>777</fpage>
<lpage>784</lpage>
</element-citation></ref><ref id="B36-viruses-04-01950"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cameron</surname><given-names>D.W.</given-names></name><name><surname>Simonsen</surname><given-names>J.N.</given-names></name><name><surname>D'Costa</surname><given-names>L.J.</given-names></name><name><surname>Ronald</surname><given-names>A.R.</given-names></name><name><surname>Maitha</surname><given-names>G.M.</given-names></name><name><surname>Gakinya</surname><given-names>M.N.</given-names></name><name><surname>Cheang</surname><given-names>M.</given-names></name><name><surname>Ndinya-Achola</surname><given-names>J.O.</given-names></name><name><surname>Piot</surname><given-names>P.</given-names></name><name><surname>Brunham</surname><given-names>R.C.</given-names></name><etal/></person-group>
<article-title>Female to male transmission of human immunodeficiency virus type 1: Risk factors for seroconversion in men</article-title>
<source>Lancet</source>
<year>1989</year>
<volume>2</volume>
<fpage>403</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="pmid">2569597</pub-id></element-citation></ref><ref id="B37-viruses-04-01950"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hayes</surname><given-names>R.J.</given-names></name><name><surname>Schulz</surname><given-names>K.F.</given-names></name><name><surname>Plummer</surname><given-names>F.A.</given-names></name></person-group>
<article-title>The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa</article-title>
<source>J. Trop. Med. Hyg.</source>
<year>1995</year>
<volume>98</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">7861474</pub-id></element-citation></ref><ref id="B38-viruses-04-01950"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>R&#x000e9;my</surname><given-names>G.</given-names></name></person-group>
<article-title>Image geographique de l&#x02019;infection &#x000e0; VIH-1 en Afrique Centrale: Des descontinuit&#x000e9;s remarquables (in French)</article-title>
<source>Ann. Soc. Belge M&#x000e9;d. Trop.</source>
<year>1993</year>
<volume>73</volume>
<fpage>127</fpage>
<lpage>142</lpage>
</element-citation></ref><ref id="B39-viruses-04-01950"><label>39.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Hooper</surname><given-names>E.</given-names></name></person-group>
<source>The River: A Journey to the Source of HIV and AIDS</source>
<publisher-name>Little, Brown, and Company</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>2000</year>
</element-citation></ref><ref id="B40-viruses-04-01950"><label>40.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hooper</surname><given-names>E.</given-names></name></person-group>
<article-title>Dephlogistication, imperial display, apes, angels, and the return of Monsieur &#x000c9;mile Zola</article-title>
<source>Atti dei Convegni Lincei</source>
<year>2003</year>
<volume>187</volume>
<fpage>27</fpage>
<lpage>230</lpage>
</element-citation></ref><ref id="B41-viruses-04-01950"><label>41.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vidal</surname><given-names>N.</given-names></name><name><surname>Peeters</surname><given-names>M.</given-names></name><name><surname>Mulanga-Kabeya</surname><given-names>C.</given-names></name><name><surname>Nzilambi</surname><given-names>N.</given-names></name><name><surname>Robertson</surname><given-names>D.</given-names></name><name><surname>Ilunga</surname><given-names>W.</given-names></name><name><surname>Sema</surname><given-names>H.</given-names></name><name><surname>Tshimanga</surname><given-names>K.</given-names></name><name><surname>Bongo</surname><given-names>B.</given-names></name><name><surname>Delaporte</surname><given-names>E.</given-names></name></person-group>
<article-title>Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa</article-title>
<source>J. Virol.</source>
<year>2000</year>
<volume>74</volume>
<fpage>10498</fpage>
<lpage>10507</lpage>
<pub-id pub-id-type="pmid">11044094</pub-id></element-citation></ref><ref id="B42-viruses-04-01950"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vidal</surname><given-names>N.</given-names></name><name><surname>Mulanga</surname><given-names>C.</given-names></name><name><surname>Bazepeo</surname><given-names>S.E.</given-names></name><name><surname>Mwamba</surname><given-names>J.K.</given-names></name><name><surname>Tchimpaka</surname><given-names>J.W.</given-names></name><name><surname>Kashi</surname><given-names>M.</given-names></name><name><surname>Mama</surname><given-names>N.</given-names></name><name><surname>Laurent</surname><given-names>C.</given-names></name><name><surname>Lepira</surname><given-names>F.</given-names></name><name><surname>Delaporte</surname><given-names>E.</given-names></name><etal/></person-group>
<article-title>Distribution of HIV-1 variants in the Democratic Republic of Congo suggests increase of subtype C in Kinshasa between 1997 and 2002</article-title>
<source>J. Acquir. Immune Defic. Syndr.</source>
<year>2005</year>
<volume>40</volume>
<fpage>456</fpage>
<lpage>462</lpage>
<pub-id pub-id-type="doi">10.1097/01.qai.0000159670.18326.94</pub-id>
<pub-id pub-id-type="pmid">16280702</pub-id></element-citation></ref><ref id="B43-viruses-04-01950"><label>43.</label><element-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Lemey</surname><given-names>P.</given-names></name></person-group>
<article-title>Early spread of HIV-1 M in the DRC</article-title>
<source>Proceedings of the International Symposium on Simian Viruses and Emerging Diseases in Humans</source>
<conf-loc>Paris, France</conf-loc>
<conf-date>9&#x02013;10 June 2010</conf-date>
<comment>Oral presentation</comment>
</element-citation></ref><ref id="B44-viruses-04-01950"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Heuverswyn</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Bailes</surname><given-names>E.</given-names></name><name><surname>Neel</surname><given-names>C.</given-names></name><name><surname>Lafay</surname><given-names>B.</given-names></name><name><surname>Keele</surname><given-names>B.F.</given-names></name><name><surname>Shaw</surname><given-names>K.S.</given-names></name><name><surname>Takehisa</surname><given-names>J.</given-names></name><name><surname>Kraus</surname><given-names>M.H.</given-names></name><name><surname>Loul</surname><given-names>S.</given-names></name><etal/></person-group>
<article-title>Genetic diversity and phylogeographic clustering of SIVcpz<italic>Ptt </italic>in wild chimpanzees in Cameroon</article-title>
<source>Virology</source>
<year>2007</year>
<volume>368</volume>
<fpage>155</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1016/j.virol.2007.06.018</pub-id>
<pub-id pub-id-type="pmid">17651775</pub-id></element-citation></ref><ref id="B45-viruses-04-01950"><label>45.</label><element-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Ndjango</surname><given-names>J.-B.</given-names></name><name><surname>Learn</surname><given-names>G.</given-names></name><name><surname>Robertson</surname><given-names>J.</given-names></name><name><surname>Takehisa</surname><given-names>J.</given-names></name><name><surname>Bibollet-Ruche</surname><given-names>F.</given-names></name><name><surname>Sharp</surname><given-names>P.</given-names></name><name><surname>Worobey</surname><given-names>M.</given-names></name><name><surname>Shaw</surname><given-names>G.</given-names></name><name><surname>Hahn</surname><given-names>B.</given-names></name></person-group>
<article-title>Molecular epidemiology of simian immunodeficiency virus in Eastern Chimpanzees and Gorillas</article-title>
<source>Proceedings of the 17th Conference on Retroviruses and Opportunistic Infections</source>
<conf-loc>San Francisco, NC, USA</conf-loc>
<conf-date>16&#x02013;19 February 2010</conf-date>
<comment>Poster presentation B-108</comment>
</element-citation></ref><ref id="B46-viruses-04-01950"><label>46.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Peterson</surname><given-names>D.</given-names></name></person-group>
<source>Eating Apes</source>
<publisher-name>University of California Press</publisher-name>
<publisher-loc>Berkeley, CA, USA</publisher-loc>
<year>2003</year>
</element-citation></ref><ref id="B47-viruses-04-01950"><label>47.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Merfield</surname><given-names>F.G.</given-names></name></person-group>
<source>Gorillas Were My Neighbours</source>
<publisher-name>The Company Book Club</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>1957</year>
</element-citation></ref><ref id="B48-viruses-04-01950"><label>48.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meder</surname><given-names>A.</given-names></name></person-group>
<article-title>Gorillas in African culture and medicine</article-title>
<source>Gorilla J.</source>
<year>1999</year>
<volume>18</volume>
<fpage>11</fpage>
<lpage>15</lpage>
</element-citation></ref><ref id="B49-viruses-04-01950"><label>49.</label><element-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Florian Li&#x000e9;geois</surname><given-names>F.</given-names></name><name><surname>Bou&#x000e9;</surname><given-names>V.</given-names></name><name><surname>Locatelli</surname><given-names>S.</given-names></name><name><surname>Butel</surname><given-names>C.</given-names></name><name><surname>Mouinga-Ondeme</surname><given-names>A.</given-names></name><name><surname>Delaporte</surname><given-names>E.</given-names></name><name><surname>Gonzalez</surname><given-names>J.-P.</given-names></name><name><surname>Peeters</surname><given-names>M.</given-names></name><name><surname>Rouet</surname><given-names>F.</given-names></name></person-group>
<article-title>Identification of new divergent SIVcpz <italic>Ptt</italic> strains in wild living chimpanzees in Gabon</article-title>
<source>Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections</source>
<conf-loc>Seattle, WA, USA</conf-loc>
<conf-date>5&#x02013;8 March 2012</conf-date>
<comment>Poster presentation B-109</comment>
</element-citation></ref><ref id="B50-viruses-04-01950"><label>50.</label><element-citation publication-type="book">
<collab>Cameroon</collab>
<source>Rapport annuel adress&#x000e9; par le Gouvernement Fran&#x000e7;ais au Conseil de la Soci&#x000e9;t&#x000e9; des Nations sur l'administration sous mandat du territoire du Cameroun pour l'ann&#x000e9;e[1921 to 1939] (in French)</source>
<publisher-name>Imprimerie G&#x000e9;n&#x000e9;rale Lahure</publisher-name>
<publisher-loc>Paris, France</publisher-loc>
<year>1921</year>
</element-citation></ref><ref id="B51-viruses-04-01950"><label>51.</label><element-citation publication-type="book">
<collab>French Congo</collab>
<source>Rapport annuel du Chef du Service de Sant&#x000e9;, Colonie du Moyen-Congo, Afrique &#x000c9;quatoriale Fran&#x000e7;aise [1930 through 1934] (in French)</source>
<publisher-name>Service de Sant&#x000e9;</publisher-name>
<publisher-loc>Brazzaville, French Congo</publisher-loc>
<year>1930</year>
<comment>IMTSSA, Box 117.</comment>
</element-citation></ref><ref id="B52-viruses-04-01950"><label>52.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Pollacchi</surname><given-names>P.</given-names></name><name><surname>Lyautey</surname><given-names>H.</given-names></name></person-group>
<source>Atlas colonial fran&#x000e7;ais: colonies, protectorats, et pays sous mandat (in French)</source>
<publisher-name>L'Illustration</publisher-name>
<publisher-loc>Paris, France</publisher-loc>
<year>1929</year>
</element-citation></ref><ref id="B53-viruses-04-01950"><label>53.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bruel</surname><given-names>G.</given-names></name></person-group>
<source>La France &#x000c9;quatoriale Africaine: le pays, les habitants, la colonization, les pouvoirs publics (in French)</source>
<publisher-name>Larose &#x000c9;diteur</publisher-name>
<publisher-loc>Paris, France</publisher-loc>
<year>1935</year>
</element-citation></ref><ref id="B54-viruses-04-01950"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koch</surname><given-names>C.W.H.</given-names></name></person-group>
<article-title>Die St&#x000e4;mme des Bezirks Molundu: in Sprachlicher, Geschichtlicher und V&#x000f6;lkerkundlicher Beziehung (in German)</article-title>
<source>B&#x000e4;ssler-Archiv: Beitr&#x000e4;ge zu V&#x000f6;lkerkunde</source>
<year>1913</year>
<volume>3</volume>
<fpage>257</fpage>
<lpage>312</lpage>
</element-citation></ref><ref id="B55-viruses-04-01950"><label>55.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giles-Vernick</surname><given-names>T.</given-names></name></person-group>
<article-title>We wander like birds: Migration, indigeneity, and the fabrication of frontiers in the Sangha River Basin of Equatorial Africa</article-title>
<source>Environ. Hist.</source>
<year>1999</year>
<volume>4</volume>
<fpage>168</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.2307/3985302</pub-id>
</element-citation></ref><ref id="B56-viruses-04-01950"><label>56.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Giles-Vernick</surname><given-names>T.</given-names></name></person-group>
<source>Cutting the Vines of the Past: Environmental Histories of the Central African Rain Forest</source>
<publisher-name>University Press of Virginia</publisher-name>
<publisher-loc>Charlottesville, VA, USA</publisher-loc>
<year>2002</year>
</element-citation></ref><ref id="B57-viruses-04-01950"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Despois</surname><given-names>J.</given-names></name></person-group>
<article-title>Les genres de vie des populations de la for&#x000ea;t dans le Cameroun oriental (in French)</article-title>
<source>Ann. G&#x000e9;ographie</source>
<year>1946</year>
<volume>55</volume>
<fpage>19</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.3406/geo.1946.12706</pub-id>
</element-citation></ref><ref id="B58-viruses-04-01950"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hattori</surname><given-names>S.</given-names></name></person-group>
<article-title>Nature conservation and hunter-gatherer&#x02019;s life in Cameroonian rainforest</article-title>
<source>Afr. Study Monogr.</source>
<year>2005</year>
<volume>29</volume>
<fpage>41</fpage>
<lpage>51</lpage>
</element-citation></ref><ref id="B59-viruses-04-01950"><label>59.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>K&#x000f6;hler</surname><given-names>A.</given-names></name></person-group>
<article-title>Of Apes and men: Baka and Bantu attitudes to wildlife and the making of eco-goodies and baddies</article-title>
<source>Conservat. Soc.</source>
<year>2005</year>
<volume>3</volume>
<fpage>407</fpage>
<lpage>435</lpage>
</element-citation></ref><ref id="B60-viruses-04-01950"><label>60.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allys</surname><given-names>P.</given-names></name></person-group>
<article-title>Monographie de la tribu des Dzems (Ngoko-Sangha) (in French)</article-title>
<source>Bull. Soc. Rech. Congolaises</source>
<year>1930</year>
<volume>11</volume>
<fpage>3</fpage>
<lpage>21</lpage>
</element-citation></ref><ref id="B61-viruses-04-01950"><label>61.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ballif</surname><given-names>N.</given-names></name></person-group>
<source>Les Pygm&#x000e9;es de la Grande For&#x000ea;t (in French)</source>
<publisher-name>L&#x02019;Harmattan</publisher-name>
<publisher-loc>Paris, France</publisher-loc>
<year>1992</year>
</element-citation></ref><ref id="B62-viruses-04-01950"><label>62.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Darr&#x000e9;</surname><given-names>E.</given-names></name><name><surname>Le Bourhis</surname><given-names>A.</given-names></name></person-group>
<article-title>Notes sur la tribu Bomitaba (in French)</article-title>
<source>Bull. Soc. Rech. Congolaises</source>
<year>1925</year>
<volume>5</volume>
<fpage>15</fpage>
<lpage>38</lpage>
</element-citation></ref><ref id="B63-viruses-04-01950"><label>63.</label><element-citation publication-type="thesis">
<person-group person-group-type="author"><name><surname>Blake</surname><given-names>S.</given-names></name></person-group>
<article-title>A reconnaissance survey in the Likouala swamps of northern Congo and its implications for conservation</article-title>
<comment>M.Sc. thesis, University of Edinburgh, Edinburgh, UK, 1993.</comment>
</element-citation></ref><ref id="B64-viruses-04-01950"><label>64.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kano</surname><given-names>T.</given-names></name><name><surname>Asato</surname><given-names>R.</given-names></name></person-group>
<article-title>Hunting pressure on chimpanzees and gorillas in the Motaba river area, northeastern Congo</article-title>
<source>Afr. Study Monogr.</source>
<year>1994</year>
<volume>15</volume>
<fpage>143</fpage>
<lpage>162</lpage>
</element-citation></ref><ref id="B65-viruses-04-01950"><label>65.</label><element-citation publication-type="thesis">
<person-group person-group-type="author"><name><surname>Lewis</surname><given-names>J.</given-names></name></person-group>
<article-title>Forest hunther-gatherers and their world: A study of the Mbendjele Yaka pygmies of Congo-Brazzaville and their secular and religious activities and representations</article-title>
<comment>Ph.D. thesis, Department of Social Anthropology, London School of Economics and Political Science, London, UK, 2002.</comment>
</element-citation></ref><ref id="B66-viruses-04-01950"><label>66.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lalouel</surname><given-names>J.</given-names></name></person-group>
<article-title>Les Babinga du Bas-Oubangui. Contribution &#x000e0; l'&#x000e9;tude ethnographique des N&#x000e9;grilles, Bak&#x000e0; et Bayak&#x000e0; (in French)</article-title>
<source>Bull. et M&#x000e9;moires de la Soc. d'Anthrop. de Paris</source>
<year>1950</year>
<volume>1</volume>
<fpage>175</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.3406/bmsap.1950.2870</pub-id>
</element-citation></ref><ref id="B67-viruses-04-01950"><label>67.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giles-Vernick</surname><given-names>T.</given-names></name><name><surname>Rupp</surname><given-names>S.</given-names></name></person-group>
<article-title>Visions of apes, reflections on change: Telling tales of great apes in Equatorial Africa</article-title>
<source>Afr. Studies Rev.</source>
<year>2006</year>
<volume>49</volume>
<fpage>51</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1353/arw.2006.0067</pub-id>
</element-citation></ref><ref id="B68-viruses-04-01950"><label>68.</label><element-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Giles-Vernick</surname><given-names>T.</given-names></name></person-group>
<article-title>Apes and Humans in the Sangha basin, 1890&#x02013;1920</article-title>
<source>Proceedings of the International Symposium on Simian Viruses and Emerging Diseases in Humans</source>
<conf-loc>Paris, France</conf-loc>
<conf-date>9&#x02013;10 June 2010</conf-date>
<comment>Oral presentation</comment>
</element-citation></ref><ref id="B69-viruses-04-01950"><label>69.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coquery-Vidrovitch</surname><given-names>C.</given-names></name></person-group>
<article-title>La Haute-Sangha au Temps des Compagnies Concessionnaires (in French)</article-title>
<source>Yale F&#x00026;ES Bull.</source>
<year>1999</year>
<volume>102</volume>
<fpage>78</fpage>
<lpage>90</lpage>
</element-citation></ref><ref id="B70-viruses-04-01950"><label>70.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Timberg</surname><given-names>C.</given-names></name><name><surname>Halperin</surname><given-names>D.</given-names></name></person-group>
<source>Tinderbox: How the West Sparked the AIDS Epidemic and How the World Can Finally Overcome It</source>
<publisher-name>The Penguin Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2012</year>
</element-citation></ref><ref id="B71-viruses-04-01950"><label>71.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fargeot</surname><given-names>C.</given-names></name></person-group>
<article-title>La Chasse Commerciale et le N&#x000e9;goce de la Venaison en Afrique Centrale Foresti&#x000e8;re (in French)</article-title>
<source>Game Wildl. Sci.</source>
<year>2004</year>
<volume>21</volume>
<fpage>817</fpage>
<lpage>833</lpage>
</element-citation></ref><ref id="B72-viruses-04-01950"><label>72.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Headrick</surname><given-names>R.</given-names></name></person-group>
<source>Colonialism, Health and Illness in French Equatorial Africa, 1885&#x02013;1935</source>
<publisher-name>African Studies Associated Press</publisher-name>
<publisher-loc>Atlanta, GA, USA</publisher-loc>
<year>1994</year>
</element-citation></ref><ref id="B73-viruses-04-01950"><label>73.</label><element-citation publication-type="book">
<article-title>Soci&#x000e9;t&#x000e9; d'&#x000c9;ditions G&#x000e9;ographiques, Maritimes et Coloniales</article-title>
<source>Guide des Colonies Fran&#x000e7;aises: Afrique Fran&#x000e7;aise: Afrique Occidentale Fran&#x000e7;aise, Afrique &#x000c9;quatoriale Fran&#x000e7;aise, Togo et Cameroun (in French)</source>
<publisher-name>Soci&#x000e9;t&#x000e9; d'&#x000c9;ditions G&#x000e9;ographiques, Maritimes et Coloniales</publisher-name>
<publisher-loc>Paris, France</publisher-loc>
<year>1931</year>
</element-citation></ref><ref id="B74-viruses-04-01950"><label>74.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Frechkop</surname><given-names>S.</given-names></name></person-group>
<source>Mammif&#x000e8;res et oiseaux prot&#x000e9;g&#x000e9;s au Congo Belge (in French)</source>
<publisher-name>Institut des Parcs Nationaux du Congo Belge</publisher-name>
<publisher-loc>Brussels, Belgium</publisher-loc>
<year>1936</year>
</element-citation></ref><ref id="B75-viruses-04-01950"><label>75.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Frechkop</surname><given-names>S.</given-names></name></person-group>
<source>Animaux Prot&#x000e9;g&#x000e9;s au Congo Belge et dans le Territoire sous Mandat du Ruanda-Urundi (in French)</source>
<publisher-name>Institut des Parcs Nationaux du Congo Belge</publisher-name>
<publisher-loc>Brussels, Belgium</publisher-loc>
<year>1941</year>
</element-citation></ref><ref id="B76-viruses-04-01950"><label>76.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gagneux</surname><given-names>P.</given-names></name><name><surname>Gonder</surname><given-names>M.K.</given-names></name><name><surname>Goldberg</surname><given-names>T.L.</given-names></name><name><surname>Morin</surname><given-names>P.A.</given-names></name></person-group>
<article-title>Gene flow in wild chimpanzee populations: what genetic data tell us about chimpanzee movement over space and time</article-title>
<source>Phil. Trans. R. Soc. Lond. B Biol. Sci.</source>
<year>2001</year>
<volume>356</volume>
<fpage>889</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="doi">10.1098/rstb.2001.0865</pub-id>
<pub-id pub-id-type="pmid">11405936</pub-id></element-citation></ref><ref id="B77-viruses-04-01950"><label>77.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Walsh</surname><given-names>P.D.</given-names></name><name><surname>Abernethy</surname><given-names>K.A.</given-names></name><name><surname>Bermejo</surname><given-names>M.</given-names></name><name><surname>Beyersk</surname><given-names>R.</given-names></name><name><surname>De Wachter</surname><given-names>P.</given-names></name><name><surname>Akou</surname><given-names>M.E.</given-names></name><name><surname>Huijbregts</surname><given-names>B.</given-names></name><name><surname>Mambounga</surname><given-names>D.I.</given-names></name><name><surname>Toham</surname><given-names>A.K.</given-names></name><name><surname>Kilbourn</surname><given-names>A.M.</given-names></name><etal/></person-group>
<article-title>Catastrophic ape decline in western equatorial Africa</article-title>
<source>Nature</source>
<year>2003</year>
<volume>422</volume>
<fpage>611</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="doi">10.1038/nature01566</pub-id>
<pub-id pub-id-type="pmid">12679788</pub-id></element-citation></ref><ref id="B78-viruses-04-01950"><label>78.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bailey</surname><given-names>N.D.</given-names></name></person-group>
<collab>Bushmeat Crisis Task Force</collab>
<source>Bushmeat Crisis Task Force. Effects of Bushmeat Hunting on Populations of African Great Apes: Summary Document</source>
<publisher-name>Bushmeat Crisis Task Force</publisher-name>
<publisher-loc>Silver Spring, MD, USA</publisher-loc>
<year>2001</year>
</element-citation></ref><ref id="B79-viruses-04-01950"><label>79.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Butynsky</surname><given-names>T.M.</given-names></name></person-group>
<article-title>The robust chimpanzee <italic>Pan troglodytes</italic>: Taxonomy, distribution, abundance and conservation status</article-title>
<source>Status Survey and Conservation Action Plan: West African Chimpanzees</source>
<person-group person-group-type="editor"><name><surname>Kormos</surname><given-names>R.</given-names></name><name><surname>Boesch</surname><given-names>C.</given-names></name><name><surname>Bakarr</surname><given-names>M.I.</given-names></name><name><surname>Butynski</surname><given-names>T.M.</given-names></name></person-group>
<publisher-name>IUCN/SSC Primate Specialist Group</publisher-name>
<publisher-loc>Gland, Switzerland and Cambridge, UK</publisher-loc>
<year>2003</year>
<fpage>5</fpage>
<lpage>12</lpage>
</element-citation></ref><ref id="B80-viruses-04-01950"><label>80.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Goyon</surname><given-names>J.</given-names></name></person-group>
<article-title>Variole et vaccinations dans le Haut Oubangui (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon.</source>
<year>1996</year>
<volume>9</volume>
<fpage>117</fpage>
<lpage>125</lpage>
</element-citation></ref><ref id="B81-viruses-04-01950"><label>81.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jouveau-Dubreil</surname><given-names>H.</given-names></name></person-group>
<article-title>Service de la vaccine &#x000e0; l'Institut Pasteur de Tchen-Tou (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1921</year>
<volume>19</volume>
<fpage>64</fpage>
<lpage>77</lpage>
</element-citation></ref><ref id="B82-viruses-04-01950"><label>82.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Legendre</surname><given-names>J.</given-names></name></person-group>
<article-title>Les &#x000e9;pingles pour la vaccination antivariolique en s&#x000e9;rie (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1924</year>
<volume>22</volume>
<fpage>412</fpage>
<lpage>413</lpage>
</element-citation></ref><ref id="B83-viruses-04-01950"><label>83.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aubert</surname><given-names>P.</given-names></name></person-group>
<article-title>Mission dans la Haute-Sangha: &#x000e9;tude de la dysenterie, de la trypanosomiase humaine, <italic>etc.</italic> (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon. </source>
<year>1911</year>
<volume>14</volume>
<fpage>782</fpage>
<lpage>816</lpage>
</element-citation></ref><ref id="B84-viruses-04-01950"><label>84.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heckenroth</surname><given-names>F.F.</given-names></name></person-group>
<article-title>La vaccine dans la Haute-Sangha (Congo Fran&#x000e7;ais) (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon. </source>
<year>1909</year>
<volume>12</volume>
<fpage>402</fpage>
<lpage>414</lpage>
</element-citation></ref><ref id="B85-viruses-04-01950"><label>85.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bouillez</surname><given-names>M. </given-names></name></person-group>
<article-title>Vaccine et vaccination au Tchad, secteur m&#x000e9;dical de Bokoro (27 f&#x000e9;vrier&#x02013;28 novembre 1907) (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon. </source>
<year>1908</year>
<volume>11</volume>
<fpage>475</fpage>
<lpage>487</lpage>
</element-citation></ref><ref id="B86-viruses-04-01950"><label>86.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lecompte</surname><given-names>A.</given-names></name></person-group>
<article-title>Rapport sur les op&#x000e9;rations de vaccination pratiqu&#x000e9;es dans l'Ogoou&#x000e9; (Congo Fran&#x000e7;ais) en 1896&#x02013;1897 (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon.</source>
<year>1899</year>
<volume>2</volume>
<fpage>98</fpage>
<lpage>103</lpage>
</element-citation></ref><ref id="B87-viruses-04-01950"><label>87.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rousseau</surname><given-names>P.</given-names></name></person-group>
<article-title>Les maladies transmissibles observ&#x000e9;es dans les colonies fran&#x000e7;aises et territoires sous mandat pendant l&#x02019;ann&#x000e9;e 1927 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1929</year>
<volume>27</volume>
<fpage>145</fpage>
<lpage>246</lpage>
</element-citation></ref><ref id="B88-viruses-04-01950"><label>88.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hermant</surname><given-names>P.</given-names></name></person-group>
<article-title>Les maladies transmissibles observ&#x000e9;es dans les colonies fran&#x000e7;aises et territoires sous mandat pendant l&#x02019;ann&#x000e9;e 1928 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1931</year>
<volume>29</volume>
<fpage>5</fpage>
<lpage>138</lpage>
</element-citation></ref><ref id="B89-viruses-04-01950"><label>89.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ledentu</surname><given-names>G.</given-names></name></person-group>
<article-title>Les maladies transmissibles observ&#x000e9;es dans les colonies fran&#x000e7;aises et territoires sous mandat pendant l&#x02019;ann&#x000e9;e 1929 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1931</year>
<volume>29</volume>
<fpage>661</fpage>
<lpage>849</lpage>
</element-citation></ref><ref id="B90-viruses-04-01950"><label>90.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lef&#x000e8;vre</surname><given-names>R.</given-names></name></person-group>
<article-title>Les maladies transmissibles observ&#x000e9;es dans les colonies fran&#x000e7;aises et territoires sous mandat pendant l&#x02019;ann&#x000e9;e 1930 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm.</source>
<year>1932</year>
<volume>30</volume>
<fpage>296</fpage>
<lpage>569</lpage>
<page-range>296&#x02013;405 and 546&#x02013;569.</page-range>
</element-citation></ref><ref id="B91-viruses-04-01950"><label>91.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marque</surname><given-names>E.</given-names></name></person-group>
<article-title>Les maladies transmissibles observ&#x000e9;es dans les colonies fran&#x000e7;aises et territoires sous mandat pendant l'ann&#x000e9;e 1931 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1933</year>
<volume>31</volume>
<fpage>123</fpage>
<lpage>323</lpage>
</element-citation></ref><ref id="B92-viruses-04-01950"><label>92.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grosfillez</surname><given-names>J.</given-names></name></person-group>
<article-title>Les principales maladies observ&#x000e9;es dans les colonies fran&#x000e7;aises et territoires sous mandat en 1932 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon. </source>
<year>1934</year>
<volume>32</volume>
<fpage>153</fpage>
<lpage>268</lpage>
</element-citation></ref><ref id="B93-viruses-04-01950"><label>93.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ledentu</surname><given-names>G.</given-names></name></person-group>
<article-title>Les maladies transmissibles observ&#x000e9;es dans les colonies fran&#x000e7;aises et territoires sous mandat pendant l&#x02019;ann&#x000e9;e 1933 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon. </source>
<year>1935</year>
<volume>33</volume>
<fpage>552</fpage>
<lpage>816</lpage>
</element-citation></ref><ref id="B94-viruses-04-01950"><label>94.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ledentu</surname><given-names>G.</given-names></name></person-group>
<article-title>Les maladies transmissibles observ&#x000e9;es dans les colonies fran&#x000e7;aises et territoires sous mandat pendant l'ann&#x000e9;e 1934 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1936</year>
<volume>34</volume>
<fpage>474</fpage>
<lpage>749</lpage>
</element-citation></ref><ref id="B95-viruses-04-01950"><label>95.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ledentu</surname><given-names>G.</given-names></name><name><surname>Peltier</surname><given-names>M.</given-names></name></person-group>
<article-title>Les maladies transmissibles observ&#x000e9;es dans les colonies fran&#x000e7;aises et territoires sous mandat pendant l&#x02019;ann&#x000e9;e 1935 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1937</year>
<volume>35</volume>
<fpage>748</fpage>
<lpage>1335</lpage>
<page-range>748&#x02013;928 and 1207&#x02013;1335.</page-range>
</element-citation></ref><ref id="B96-viruses-04-01950"><label>96.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vogel</surname><given-names>E.</given-names></name><name><surname>Le Rouzic</surname><given-names>J.</given-names></name></person-group>
<article-title>Les maladies transmissibles observ&#x000e9;es dans les colonies fran&#x000e7;aises et territoires sous mandat pendant l'ann&#x000e9;e 1936 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon. </source>
<year>1938</year>
<volume>36</volume>
<fpage>352</fpage>
<lpage>725</lpage>
<page-range>352&#x02013;520 and 633&#x02013;725.</page-range>
</element-citation></ref><ref id="B97-viruses-04-01950"><label>97.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vogel</surname><given-names>E.</given-names></name><name><surname>Riou</surname><given-names>M.</given-names></name></person-group>
<article-title>Les maladies &#x000e9;pid&#x000e9;miques, end&#x000e9;miques, et sociales dans les colonies fran&#x000e7;aises pendant l&#x02019;ann&#x000e9;e 1937 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1939</year>
<volume>37</volume>
<fpage>257</fpage>
<lpage>551</lpage>
</element-citation></ref><ref id="B98-viruses-04-01950"><label>98.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Clapier</surname><given-names>N.</given-names></name></person-group>
<article-title>L'end&#x000e9;mie pianique sur le Bas-Oubangui: essai de lutte anti-pianique, 1920 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1921</year>
<volume>19</volume>
<fpage>319</fpage>
<lpage>334</lpage>
</element-citation></ref><ref id="B99-viruses-04-01950"><label>99.</label><element-citation publication-type="book">
<collab>Cameroon</collab>
<source>Rapport du Service de Sant&#x000e9;, Division du Wouri, Territoire du Cameroun (in French)</source>
<publisher-name>Service de Sant&#x000e9;</publisher-name>
<publisher-loc>Douala, Cameroon</publisher-loc>
<year>1935</year>
<comment>IMTSSA, Box 481.</comment>
</element-citation></ref><ref id="B100-viruses-04-01950"><label>100.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Dupuy</surname><given-names>L.</given-names></name></person-group>
<source>Rapport sur le Service de l'Assistance M&#x000e9;dicale aux Indig&#x000e8;nes du For&#x000e9;ami pour l'exercice 1931 (in French)</source>
<publisher-name>For&#x000e9;ami</publisher-name>
<publisher-loc>Brussels, Belgium</publisher-loc>
<year>1932</year>
</element-citation></ref><ref id="B101-viruses-04-01950"><label>101.</label><element-citation publication-type="book">
<collab>Croix Rouge du Congo</collab>
<source>Rapport annuel [1928 through 1954] (in French)</source>
<publisher-name>Croix Rouge de Belgique</publisher-name>
<publisher-loc>Brussels, Belgium</publisher-loc>
<fpage>1928</fpage>
<lpage>1954</lpage>
</element-citation></ref><ref id="B102-viruses-04-01950"><label>102.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Janssens</surname><given-names>P.G.</given-names></name><name><surname>Yaws</surname><given-names>M.A.</given-names></name></person-group>
<source>Health in Central Africa since 1885: Past, Present and Future</source>
<person-group person-group-type="editor"><name><surname>Janssens</surname><given-names>P.G.</given-names></name><name><surname>Kivits</surname><given-names>M.</given-names></name><name><surname>Vuylsteke</surname><given-names>J.</given-names></name></person-group>
<publisher-name>Fondation Roi Baudouin</publisher-name>
<publisher-loc>Brussels, Belgium</publisher-loc>
<year>1997</year>
<fpage>1829</fpage>
<lpage>1839</lpage>
</element-citation></ref><ref id="B103-viruses-04-01950"><label>103.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Vernier</surname><given-names>P.</given-names></name></person-group>
<source>&#x000c9;pidemiologie V&#x000e9;n&#x000e9;rienne en Afrique Noire Fran&#x000e7;aise (in French)</source>
<publisher-name>Imprimerie Bi&#x000e8;re</publisher-name>
<publisher-loc>Bordeaux, France</publisher-loc>
<year>1950</year>
</element-citation></ref><ref id="B104-viruses-04-01950"><label>104.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tournier</surname><given-names>E.</given-names></name></person-group>
<article-title>Le traitement du pian par les injections sous-cutan&#x000e9;es de novars&#x000e9;nobenzol (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1922</year>
<volume>20</volume>
<fpage>37</fpage>
<lpage>39</lpage>
</element-citation></ref><ref id="B105-viruses-04-01950"><label>105.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Letonturier</surname><given-names>L.P.</given-names></name></person-group>
<article-title>Rapport sur le fonctionnement du service de sant&#x000e9; au Cameroun pendant l&#x02019;ann&#x000e9;e 1923 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1924</year>
<volume>22</volume>
<fpage>396</fpage>
<lpage>408</lpage>
</element-citation></ref><ref id="B106-viruses-04-01950"><label>106.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Broden</surname><given-names>A.</given-names></name><name><surname>Rodhain</surname><given-names>J.</given-names></name></person-group>
<source>Rapport sur les Travaux Faits au Laboratoire de la Soci&#x000e9;t&#x000e9; Belge d'&#x000c9;tudes Coloniales &#x000e0; l'H&#x000f4;pital des Noirs et au Lazaret pour Trypanosomi&#x000e9;s (in French)</source>
<publisher-name>Soci&#x000e9;t&#x000e9; Belge d'&#x000c9;tudes Coloniales</publisher-name>
<publisher-loc>Brussels, Belgium</publisher-loc>
<year>1908</year>
</element-citation></ref><ref id="B107-viruses-04-01950"><label>107.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bauche</surname><given-names>M.</given-names></name></person-group>
<article-title>Trypanosomen und Tinbeef&#x02014;Medizinisches Wissen um Schlafkrankheit zwischen Kamerun und Deutschland, 1910&#x02013;1914</article-title>
<source>Beitr&#x000e4;ge zur I. K&#x000f6;lner Afrikawissenschaftlichen Nachwuchstagung (in German)</source>
<person-group person-group-type="editor"><name><surname>Seifert</surname><given-names>M.</given-names></name><name><surname>Egert</surname><given-names>M.</given-names></name><name><surname>Heerbaart</surname><given-names>F.</given-names></name><name><surname>Kolossa</surname><given-names>K.</given-names></name><name><surname>Limanski</surname><given-names>M.</given-names></name><name><surname>Mumin</surname><given-names>M.</given-names></name><name><surname>Rodekuhr</surname><given-names>P.A.</given-names></name><name><surname>Rous</surname><given-names>S.</given-names></name><name><surname>Stankowski</surname><given-names>S.</given-names></name><name><surname>Thanassoula</surname><given-names>M.</given-names></name></person-group>
<publisher-name>Universit&#x000e4;t K&#x000f6;ln</publisher-name>
<publisher-loc>K&#x000f6;ln, Germany</publisher-loc>
<year>2005</year>
<fpage>1</fpage>
<lpage>19</lpage>
</element-citation></ref><ref id="B108-viruses-04-01950"><label>108.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kerandel</surname><given-names>J.</given-names></name></person-group>
<article-title>Note sur la mission du Haut Logone (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon.</source>
<year>1909</year>
<volume>12</volume>
<fpage>107</fpage>
<lpage>114</lpage>
</element-citation></ref><ref id="B109-viruses-04-01950"><label>109.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heckenroth</surname><given-names>F.F.</given-names></name></person-group>
<article-title>R&#x000e9;sum&#x000e9; de 68 observations de trypanosomiase humaine dans la Haute-Sangha (Congo) (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon.</source>
<year>1910</year>
<volume>13</volume>
<fpage>663</fpage>
<lpage>669</lpage>
</element-citation></ref><ref id="B110-viruses-04-01950"><label>110.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heckenroth</surname><given-names>F.F.</given-names></name></person-group>
<article-title>Tourn&#x000e9;e m&#x000e9;dicale effectu&#x000e9;e sur le Congo et l'Oubangui (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon.</source>
<year>1913</year>
<volume>16</volume>
<fpage>104</fpage>
<lpage>144</lpage>
</element-citation></ref><ref id="B111-viruses-04-01950"><label>111.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ouzilleau</surname><given-names>F.</given-names></name></person-group>
<article-title>Rapport sur la tourn&#x000e9;e m&#x000e9;dicale effectu&#x000e9;e en pays Yakoma du 23 mars au 3 avril 1912 (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon.</source>
<year>1912</year>
<volume>15</volume>
<fpage>819</fpage>
<lpage>827</lpage>
</element-citation></ref><ref id="B112-viruses-04-01950"><label>112.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Montfort</surname><given-names>F.</given-names></name></person-group>
<article-title>Contribution &#x000e0; l'&#x000e9;tude de la r&#x000e9;partition et de la prophylaxie de la trypanosomiase humaine dans la Haute Sangha (avril-mai 1911) (in French)</article-title>
<source>Ann Hyg M&#x000e9;d. Colon.</source>
<year>1912</year>
<volume>15</volume>
<fpage>593</fpage>
<lpage>613</lpage>
</element-citation></ref><ref id="B113-viruses-04-01950"><label>113.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>P.</given-names></name></person-group>
<article-title>Die Geschichte der Schlafkrankheit in Kamerun und ihre Lehren (in German)</article-title>
<source>Med. Microbiol. Immunol.</source>
<year>1916</year>
<volume>81</volume>
<fpage>69</fpage>
<lpage>137</lpage>
</element-citation></ref><ref id="B114-viruses-04-01950"><label>114.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boy&#x000e9;</surname><given-names>L.</given-names></name></person-group>
<article-title>Fonctionnement technique des secteurs de prophylaxie de la maladie du sommeil dans l'Afrique &#x000c9;quatoriale Fran&#x000e7;aise pendant l'ann&#x000e9;e 1921 (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon. </source>
<year>1922</year>
<volume>20</volume>
<fpage>194</fpage>
<lpage>216</lpage>
</element-citation></ref><ref id="B115-viruses-04-01950"><label>115.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jamot</surname><given-names>E.</given-names></name></person-group>
<article-title>La maladie du sommeil au Cameroun en janvier 1929 (in French)</article-title>
<source>Bull. Soc. Pathol. Ex&#x000f3;tique </source>
<year>1929</year>
<volume>22</volume>
<fpage>473</fpage>
<lpage>496</lpage>
</element-citation></ref><ref id="B116-viruses-04-01950"><label>116.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jamot</surname><given-names>E.</given-names></name></person-group>
<article-title>La Maladie du Sommeil au Cameroun (in French)</article-title>
<source>Africa: J. Int. Afr. Institute</source>
<year>1930</year>
<volume>3</volume>
<fpage>161</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="doi">10.2307/1155796</pub-id>
</element-citation></ref><ref id="B117-viruses-04-01950"><label>117.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ollivier</surname><given-names>G.</given-names></name><name><surname>Legros</surname><given-names>D.</given-names></name></person-group>
<article-title>Trypanosomiase humaine africaine: Historique de la th&#x000e9;rapeutique et de ses &#x000e9;checs (in French)</article-title>
<source>Trop. Med. Int. Health</source>
<year>2001</year>
<volume>6</volume>
<fpage>855</fpage>
<lpage>863</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-3156.2001.00753.x</pub-id>
<pub-id pub-id-type="pmid">11703839</pub-id></element-citation></ref><ref id="B118-viruses-04-01950"><label>118.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Millous</surname><given-names>P.</given-names></name></person-group>
<article-title>La lutte contre les maladies sociales au Cameroun en 1934 (in French)</article-title>
<source>Africa: J. Int. Afr. Institute</source>
<year>1935</year>
<volume>8</volume>
<fpage>171</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.2307/3180506</pub-id>
</element-citation></ref><ref id="B119-viruses-04-01950"><label>119.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muraz</surname><given-names>G.</given-names></name><name><surname>Vaisseau</surname><given-names>G.</given-names></name></person-group>
<article-title>De divers types d'ars&#x000e9;no-r&#x000e9;sistance dans les traitements actuels (A.E.F.) de la trypanosomiase humaine (in French)</article-title>
<source>Bull. Soc. Pathol. Ex&#x000f3;tique </source>
<year>1932</year>
<volume>25</volume>
<fpage>260</fpage>
<lpage>280</lpage>
</element-citation></ref><ref id="B120-viruses-04-01950"><label>120.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vamos</surname><given-names>S. </given-names></name></person-group>
<article-title>Traitement de trypanosom&#x000e9;s dans un secteur du Moyen-Chari (A.E.F.): &#x000e9;tude de 3,705 observations (in French)</article-title>
<source>Bull. Soc. Pathol. Ex&#x000f3;tique</source>
<year>1936</year>
<volume>29</volume>
<fpage>1015</fpage>
<lpage>1022</lpage>
</element-citation></ref><ref id="B121-viruses-04-01950"><label>121.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lotte</surname><given-names>A.J.</given-names></name></person-group>
<article-title>Historique du foyer de trypanosomiase de Nola (in French)</article-title>
<source>Bull. Soc. Pathol. Ex&#x000f3;tique</source>
<year>1953</year>
<volume>46</volume>
<fpage>374</fpage>
<lpage>386</lpage>
</element-citation></ref><ref id="B122-viruses-04-01950"><label>122.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Aym&#x000e9;rich</surname><given-names>J.</given-names></name></person-group>
<source>La Conqu&#x000ea;te du Cameroun: 1<sup>er</sup> Ao&#x000fb;t 1914 &#x02013; 20 F&#x000e9;vrier 1916 (in French)</source>
<publisher-name>Payot</publisher-name>
<publisher-loc>Paris, France</publisher-loc>
<year>1933</year>
</element-citation></ref><ref id="B123-viruses-04-01950"><label>123.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gisselquist</surname><given-names>D.P.</given-names></name></person-group>
<article-title>Estimating HIV-1 transmission efficiency through unsafe medical injections</article-title>
<source>Int. J. Sex. Transm. Dis. AIDS</source>
<year>2002</year>
<volume>13</volume>
<fpage>152</fpage>
<lpage>159</lpage>
</element-citation></ref><ref id="B124-viruses-04-01950"><label>124.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gisselquist</surname><given-names>D.P.</given-names></name><name><surname>Upham</surname><given-names>G.</given-names></name><name><surname>Potterat</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Efficiency of human immunodeficiency virus transmission through injections and other medical procedures: Evidence, estimates, and unfinished busines</article-title>
<source>Infect. Control Hosp. Epidemiol.</source>
<year>2006</year>
<volume>27</volume>
<fpage>944</fpage>
<lpage>952</lpage>
<pub-id pub-id-type="pmid">16941321</pub-id></element-citation></ref><ref id="B125-viruses-04-01950"><label>125.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>E.H.</given-names></name><name><surname>Heimer</surname><given-names>R.</given-names></name></person-group>
<article-title>A model-based estimate of HIV infectivity via needle sharing</article-title>
<source>J. Acq. Imm. Deficien. Syndr.</source>
<year>1992</year>
<volume>5</volume>
<fpage>1116</fpage>
<lpage>1118</lpage>
</element-citation></ref><ref id="B126-viruses-04-01950"><label>126.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vickerman</surname><given-names>P.</given-names></name><name><surname>Hickman</surname><given-names>M.</given-names></name><name><surname>Judd</surname><given-names>A.</given-names></name></person-group>
<article-title>Modelling the impact of hepatitis C transmission of reducing syringe sharing: London case study</article-title>
<source>Int. J. Epidemiol.</source>
<year>2007</year>
<volume>36</volume>
<fpage>396</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="doi">10.1093/ije/dyl276</pub-id>
<pub-id pub-id-type="pmid">17218325</pub-id></element-citation></ref><ref id="B127-viruses-04-01950"><label>127.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vickerman</surname><given-names>P.</given-names></name><name><surname>Platt</surname><given-names>L.</given-names></name><name><surname>Hawkes</surname><given-names>S.</given-names></name></person-group>
<article-title>Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan</article-title>
<source>Sex. Transm. Inf.</source>
<year>2009</year>
<volume>85</volume>
<fpage>ii23</fpage>
<lpage>ii30</lpage>
</element-citation></ref><ref id="B128-viruses-04-01950"><label>128.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lott</surname><given-names>D.C.</given-names></name><name><surname>Strain</surname><given-names>E.C.</given-names></name><name><surname>Brooner</surname><given-names>R.K.</given-names></name><name><surname>Bigelow</surname><given-names>G.E.</given-names></name><name><surname>Johnson</surname><given-names>R.E.</given-names></name></person-group>
<article-title>HIV risk behaviors during pharmacologic treatment for opioid dependence: A comparison of levomethadyl acetate, buprenorphine, and methadone</article-title>
<source>J. Subst. Abuse Treat.</source>
<year>2006</year>
<volume>31</volume>
<fpage>187</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1016/j.jsat.2006.04.005</pub-id>
<pub-id pub-id-type="pmid">16919747</pub-id></element-citation></ref><ref id="B129-viruses-04-01950"><label>129.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kwon</surname><given-names>J.A.</given-names></name><name><surname>Iversen</surname><given-names>J.</given-names></name><name><surname>Maher</surname><given-names>L.</given-names></name><name><surname>Law</surname><given-names>M.G.</given-names></name><name><surname>Wilson</surname><given-names>D.P.</given-names></name></person-group>
<article-title>The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: A model-based analysis</article-title>
<source>J. Acquir. Immune Defic. Syndr.</source>
<year>2009</year>
<volume>51</volume>
<fpage>462</fpage>
<lpage>469</lpage>
<pub-id pub-id-type="pmid">19387355</pub-id></element-citation></ref><ref id="B130-viruses-04-01950"><label>130.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jutras-Aswad</surname><given-names>D.</given-names></name><name><surname>Zang</surname><given-names>G.</given-names></name><name><surname>Bruneau</surname><given-names>J.</given-names></name></person-group>
<article-title>Cannabis use correlates of syringe sharing among injection drug users</article-title>
<source>Amer. J. Addictions</source>
<year>2010</year>
<volume>19</volume>
<fpage>231</fpage>
<lpage>237</lpage>
</element-citation></ref><ref id="B131-viruses-04-01950"><label>131.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kipke</surname><given-names>M.D.</given-names></name><name><surname>Unger</surname><given-names>J.B.</given-names></name><name><surname>Palmer</surname><given-names>R.F.</given-names></name><name><surname>Edgington</surname><given-names>R.</given-names></name></person-group>
<article-title>Drug use, needle sharing, and HIV risk among injection drug-using street youth</article-title>
<source>Subst. Use Misuse</source>
<year>1996</year>
<volume>31</volume>
<fpage>1167</fpage>
<lpage>1187</lpage>
<pub-id pub-id-type="doi">10.3109/10826089609063971</pub-id>
<pub-id pub-id-type="pmid">8853236</pub-id></element-citation></ref><ref id="B132-viruses-04-01950"><label>132.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ball</surname><given-names>J.C.</given-names></name><name><surname>Lange</surname><given-names>W.R.</given-names></name><name><surname>Myers</surname><given-names>C.P.</given-names></name><name><surname>Friedman</surname><given-names>S.R.</given-names></name></person-group>
<article-title>Reducing the risk of AIDS through methadone maintenance treatment</article-title>
<source>J. Health Soc. Behav.</source>
<year>1988</year>
<volume>29</volume>
<fpage>214</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="pmid">3241064</pub-id></element-citation></ref><ref id="B133-viruses-04-01950"><label>133.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caussy</surname><given-names>D.</given-names></name><name><surname>Weiss</surname><given-names>S.H.</given-names></name><name><surname>Blattner</surname><given-names>W.A.</given-names></name><name><surname>French</surname><given-names>J.</given-names></name><name><surname>Cantor</surname><given-names>K.P.</given-names></name><name><surname>Ginzburg</surname><given-names>H.</given-names></name><name><surname>Altman</surname><given-names>R.</given-names></name><name><surname>Goedert</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs</article-title>
<source>AIDS Res. Hum. Retrovir.</source>
<year>1990</year>
<volume>6</volume>
<fpage>1459</fpage>
<lpage>1467</lpage>
<pub-id pub-id-type="pmid">1964060</pub-id></element-citation></ref><ref id="B134-viruses-04-01950"><label>134.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chaisson</surname><given-names>R.E.</given-names></name><name><surname>Moss</surname><given-names>A.R.</given-names></name><name><surname>Onishi</surname><given-names>R.</given-names></name><name><surname>Osmond</surname><given-names>D.</given-names></name><name><surname>Carlson</surname><given-names>J.R.</given-names></name></person-group>
<article-title>Human Immunodeficiency Virus Infection in Heterosexual Intravenous Drug Users in San Francisco</article-title>
<source>Amer. J. Public Health</source>
<year>1987</year>
<volume>77</volume>
<fpage>169</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="pmid">3467596</pub-id></element-citation></ref><ref id="B135-viruses-04-01950"><label>135.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kretzschmar</surname><given-names>M.</given-names></name><name><surname>Wiessing</surname><given-names>L.G.</given-names></name></person-group>
<article-title>Modelling the spread of HIV in social networks of injecting drug users</article-title>
<source>AIDS</source>
<year>1998</year>
<volume>12</volume>
<fpage>801</fpage>
<lpage>811</lpage>
<pub-id pub-id-type="doi">10.1097/00002030-199807000-00017</pub-id>
<pub-id pub-id-type="pmid">9619813</pub-id></element-citation></ref><ref id="B136-viruses-04-01950"><label>136.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allen</surname><given-names>D.M.</given-names></name><name><surname>Onorato</surname><given-names>I.M.</given-names></name><name><surname>Green</surname><given-names>T.A.</given-names></name></person-group>
<article-title>HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989</article-title>
<source>Amer. J. Public Health</source>
<year>1992</year>
<volume>82</volume>
<fpage>541</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="doi">10.2105/AJPH.82.4.541</pub-id>
<pub-id pub-id-type="pmid">1312310</pub-id></element-citation></ref><ref id="B137-viruses-04-01950"><label>137.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Irala</surname><given-names>J.</given-names></name><name><surname>Bigelow</surname><given-names>C.</given-names></name><name><surname>McCusker</surname><given-names>J.</given-names></name><name><surname>Hindin</surname><given-names>R.</given-names></name><name><surname>Zheng</surname><given-names>U.</given-names></name></person-group>
<article-title>Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population</article-title>
<source>Amer. J. Epidemiol.</source>
<year>1996</year>
<volume>143</volume>
<fpage>725</fpage>
<lpage>732</lpage>
<pub-id pub-id-type="pmid">8651235</pub-id></element-citation></ref><ref id="B138-viruses-04-01950"><label>138.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peters</surname><given-names>A.</given-names></name><name><surname>Davies</surname><given-names>T.</given-names></name><name><surname>Richardson</surname><given-names>A.</given-names></name></person-group>
<article-title>Multi-site samples of injecting drug users in Edinburgh: prevalence and correlates of risky injecting practices</article-title>
<source>Addiction</source>
<year>1998</year>
<volume>93</volume>
<fpage>253</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="pmid">9624726</pub-id></element-citation></ref><ref id="B139-viruses-04-01950"><label>139.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raboud</surname><given-names>J.M.</given-names></name><name><surname>Boily</surname><given-names>M.C.</given-names></name><name><surname>Rajeswaran</surname><given-names>J.</given-names></name><name><surname>O&#x02019;Shaughnessy</surname><given-names>M.V.</given-names></name><name><surname>Schechter</surname><given-names>M.T.</given-names></name></person-group>
<article-title>The impact of needle-exchange programs on the spread of HIV among injection drug users: A simulation study</article-title>
<source>J. Urban Health</source>
<year>2003</year>
<volume>80</volume>
<fpage>302</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="pmid">12791806</pub-id></element-citation></ref><ref id="B140-viruses-04-01950"><label>140.</label><element-citation publication-type="webpage">
<person-group person-group-type="author"><name><surname>Vickerman</surname><given-names>P.</given-names></name><name><surname>Miners</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>J.</given-names></name></person-group>
<article-title>Assessing the cost-effectiveness of interventions linked to needle and syringe programmes for injecting drug users: An economic modelling report. National Institute for Health and Clinical Excellence. Report published online, 2008</article-title>
<date-in-citation>(accessed on 14 June 2012)</date-in-citation>
<comment>Available online:<ext-link ext-link-type="uri" xlink:href="http://www.nice.org.uk/nicemedia/pdf/NSPEconomicmodellingFullreportJune08.pdf">http://www.nice.org.uk/nicemedia/pdf/NSPEconomicmodellingFullreportJune08.pdf</ext-link></comment>
</element-citation></ref><ref id="B141-viruses-04-01950"><label>141.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Retel-Laurentin</surname><given-names>A.</given-names></name></person-group>
<source>Un Pays &#x000e0; la D&#x000e9;rive: une Societ&#x000e9; en R&#x000e9;gression D&#x000e9;mographique: les Nzakara de l&#x02019;Est Centrafricain (in French)</source>
<publisher-name>Jean-Pierre Delarge</publisher-name>
<publisher-loc>Paris, France</publisher-loc>
<year>1979</year>
</element-citation></ref><ref id="B142-viruses-04-01950"><label>142.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mouchet</surname><given-names>R.</given-names></name></person-group>
<article-title>Yaws and syphilis among natives of the Belgian Congo</article-title>
<source>Kenya Med. J.</source>
<year>1926</year>
<volume>3</volume>
<fpage>242</fpage>
<lpage>245</lpage>
</element-citation></ref><ref id="B143-viruses-04-01950"><label>143.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kermorgant</surname><given-names>A.</given-names></name></person-group>
<article-title>Aper&#x000e7;u sur les maladies v&#x000e9;n&#x000e9;riennes dans les colonies fran&#x000e7;aises (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon.</source>
<year>1903</year>
<volume>6</volume>
<fpage>428</fpage>
<lpage>460</lpage>
</element-citation></ref><ref id="B144-viruses-04-01950"><label>144.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Egerton</surname><given-names>F.C.</given-names></name></person-group>
<source>African Majesty: A Record of Refuge at the Court of the King of Bangangt&#x000e9; in the French Cameroons</source>
<publisher-name>George Routledge &#x00026; Sons</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>1938</year>
</element-citation></ref><ref id="B145-viruses-04-01950"><label>145.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gray</surname><given-names>C.</given-names></name></person-group>
<source>Colonial Rule and Crisis in Equatorial Africa: Southern Gabon ca. 1850&#x02013;1940</source>
<publisher-name>The University of Rochester Press</publisher-name>
<publisher-loc>Rochester, NY, USA</publisher-loc>
<year>2002</year>
</element-citation></ref><ref id="B146-viruses-04-01950"><label>146.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patterson</surname><given-names>K.D.</given-names></name></person-group>
<article-title>The vanishing Mpongwe: European contact and demographic change in the Gabon river</article-title>
<source>J. Afr. Hist.</source>
<year>1975</year>
<volume>16</volume>
<fpage>217</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1017/S0021853700001134</pub-id>
</element-citation></ref><ref id="B147-viruses-04-01950"><label>147.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Phillips</surname><given-names>R.</given-names></name></person-group>
<article-title>Heterogeneous imperialism and the regulation of sexuality in British West Africa</article-title>
<source>J. Hist. Sexuality</source>
<year>2005</year>
<volume>14</volume>
<fpage>291</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="doi">10.1353/sex.2006.0029</pub-id>
</element-citation></ref><ref id="B148-viruses-04-01950"><label>148.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Van Wing</surname><given-names>J.</given-names></name></person-group>
<source>&#x000c9;tudes Bakongo: Sociologie, Religion et Magie (in French)</source>
<publisher-name>Van Campenhout</publisher-name>
<publisher-loc>Brussels, Belgium</publisher-loc>
<year>1938</year>
</element-citation></ref><ref id="B149-viruses-04-01950"><label>149.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trezenem</surname><given-names>E.</given-names></name></person-group>
<article-title>Notes ethnographiques sur les tribus Fan du Moyen-Ogoou&#x000e9; (in French)</article-title>
<source>J. Soc. Africanistes</source>
<year>1936</year>
<volume>6</volume>
<fpage>65</fpage>
<lpage>93</lpage>
</element-citation></ref><ref id="B150-viruses-04-01950"><label>150.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Georgelin</surname><given-names>D.</given-names></name></person-group>
<article-title>Notes m&#x000e9;dicales sur le Gabon: les facteurs de d&#x000e9;population (in French)</article-title>
<source>Ann. M&#x000e9;d. Pharm. Colon.</source>
<year>1920</year>
<volume>19</volume>
<fpage>58</fpage>
<lpage>64</lpage>
</element-citation></ref><ref id="B151-viruses-04-01950"><label>151.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Robineau</surname><given-names>C.</given-names></name></person-group>
<article-title>Contribution &#x000e0; l'histoire du Congo: la domination europ&#x000e9;enne et l'example de Souank&#x000e9; (1900-1960) (in French)</article-title>
<source>Cahiers d'&#x000c9;tudes Africaines</source>
<year>1967</year>
<volume>7</volume>
<fpage>300</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="doi">10.3406/cea.1967.3099</pub-id>
</element-citation></ref><ref id="B152-viruses-04-01950"><label>152.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spire</surname><given-names>D.</given-names></name></person-group>
<article-title>Rapport m&#x000e9;dicale de la mission Fourneau (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon. </source>
<year>1902</year>
<volume>5</volume>
<fpage>353</fpage>
<lpage>379</lpage>
</element-citation></ref><ref id="B153-viruses-04-01950"><label>153.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berny</surname><given-names>P.</given-names></name></person-group>
<article-title>La l&#x000e8;pre en Haute-Sangha (in French)</article-title>
<source>Bull. Soc. Rech. Congolaises</source>
<year>1933</year>
<volume>18</volume>
<fpage>37</fpage>
<lpage>55</lpage>
</element-citation></ref><ref id="B154-viruses-04-01950"><label>154.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kermorgant</surname><given-names>A. </given-names></name></person-group>
<article-title>Maladies end&#x000e9;miques, &#x000e9;pid&#x000e9;miques et contagieuses qui ont regn&#x000e9; dans les colonies fran&#x000e7;aises en 1906 (in French)</article-title>
<source>Ann. Hyg. M&#x000e9;d. Colon. </source>
<year>1908</year>
<volume>11</volume>
<fpage>334</fpage>
<lpage>380</lpage>
</element-citation></ref><ref id="B155-viruses-04-01950"><label>155.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Adler</surname><given-names>M.</given-names></name><name><surname>French</surname><given-names>P.</given-names></name></person-group>
<article-title>Syphilis-clinical features, diagnosis, and management</article-title>
<source>ABC of Sexually Transmitted Infections</source>
<edition>5th</edition>
<person-group person-group-type="editor"><name><surname>Adler</surname><given-names>M.</given-names></name><name><surname>Cowan</surname><given-names>F.</given-names></name><name><surname>French</surname><given-names>P.</given-names></name><name><surname>Mitchell</surname><given-names>H.</given-names></name><name><surname>Richens</surname><given-names>J.</given-names></name></person-group>
<publisher-name>BMJ Publishing Group</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>2004</year>
<fpage>49</fpage>
<lpage>55</lpage>
</element-citation></ref><ref id="B156-viruses-04-01950"><label>156.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Coquery-Vidrovitch</surname><given-names>C.</given-names></name></person-group>
<source>Le Congo au temps des grandes compagnies concessionaires, 1898-1930 (in French)</source>
<publisher-name>Mouton &#x00026; Co et EPHE</publisher-name>
<publisher-loc>Paris, France</publisher-loc>
<year>1972</year>
</element-citation></ref><ref id="B157-viruses-04-01950"><label>157.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>E.</given-names></name></person-group>
<source>Neu-Kamerun: Reiseerlebnisse und wirtschaftspolitische Untersuchungen (in German)</source>
<publisher-name>Ernst Siegfried Mittler und Sohn</publisher-name>
<publisher-loc>Berlin, Germany</publisher-loc>
<year>1913</year>
</element-citation></ref><ref id="B158-viruses-04-01950"><label>158.</label><element-citation publication-type="other">
<collab>Belgian Congo</collab>
<comment>Letter from the Comissaire du District du Moyen Congo to the Chef du Service des Terres &#x000e0; L&#x000e9;opoldville, dated from November 12, 1918 (in French). District du Moyen Congo: Leopoldville, Belgian Congo, 1918. Afrika Archief (FO-BZBHO, Brussels), Series GG, Folder GG 16586.</comment>
</element-citation></ref><ref id="B159-viruses-04-01950"><label>159.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Samarin</surname><given-names>W.J.</given-names></name></person-group>
<article-title>Protestant missions and the history of Lingala</article-title>
<source>J. Relig. Af.</source>
<year>1986</year>
<volume>16</volume>
<fpage>138</fpage>
<lpage>163</lpage>
</element-citation></ref><ref id="B160-viruses-04-01950"><label>160.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Schulte-Varendorff</surname><given-names>U.</given-names></name></person-group>
<source>Krieg in Kamerun: Die deutsche Kolonie im Ersten Weltkrieg (in German)</source>
<publisher-name>Berlin</publisher-name>
<publisher-loc>Christoph Links Verlag: Berlin, Germany</publisher-loc>
<year>2011</year>
</element-citation></ref><ref id="B161-viruses-04-01950"><label>161.</label><element-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Schulte-Varendorff</surname><given-names>U. </given-names></name></person-group>
<comment>Universit&#x000e4;t Osnabr&#x000fc;ck, Osnabr&#x000fc;ck, Germany. Personal communication, 2012.</comment>
</element-citation></ref><ref id="B162-viruses-04-01950"><label>162.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schler</surname><given-names>L.</given-names></name></person-group>
<article-title>Ambiguous spaces: The struggle over African identities and urban communities in colonial Douala, 1914&#x02013;45</article-title>
<source>J. Afr. Hist.</source>
<year>2003</year>
<volume>44</volume>
<fpage>51</fpage>
<lpage>72</lpage>
</element-citation></ref><ref id="B163-viruses-04-01950"><label>163.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khabbaz</surname><given-names>R.M.</given-names></name><name><surname>Heneine</surname><given-names>W.</given-names></name><name><surname>George</surname><given-names>J.R.</given-names></name><name><surname>Parekh</surname><given-names>B.</given-names></name><name><surname>Rowe</surname><given-names>T.</given-names></name><name><surname>Woods</surname><given-names>T.</given-names></name><name><surname>Switzer</surname><given-names>W.M.</given-names></name><name><surname>McClure</surname><given-names>H.M.</given-names></name><name><surname>Murphey-Corb</surname><given-names>M.</given-names></name><name><surname>Folks</surname><given-names>T.M.</given-names></name></person-group>
<article-title>Bief report: Infection of a laboratory worker with simian immunodeficiency virus</article-title>
<source>New Engl. J. Med.</source>
<year>1994</year>
<volume>330</volume>
<fpage>172</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199401203300304</pub-id>
<pub-id pub-id-type="pmid">8264739</pub-id></element-citation></ref><ref id="B164-viruses-04-01950"><label>164.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Korenromp</surname><given-names>E.L.</given-names></name><name><surname>Bakker</surname><given-names>R.</given-names></name><name><surname>de Vlas</surname><given-names>S.J.</given-names></name><name><surname>Gray</surname><given-names>R.H.</given-names></name><name><surname>Wawer</surname><given-names>M.J.</given-names></name><name><surname>Serwadda</surname><given-names>D.</given-names></name><name><surname>Sewankambo</surname><given-names>N.K.</given-names></name><name><surname>Habbema</surname><given-names>J.D.F.</given-names></name></person-group>
<article-title>HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial</article-title>
<source>AIDS</source>
<year>2002</year>
<volume>16</volume>
<fpage>2209</fpage>
<lpage>2218</lpage>
<pub-id pub-id-type="pmid">12409743</pub-id></element-citation></ref><ref id="B165-viruses-04-01950"><label>165.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Orroth</surname><given-names>K.K.</given-names></name><name><surname>Freeman</surname><given-names>E.E.</given-names></name><name><surname>Bakker</surname><given-names>R.</given-names></name><name><surname>Buv&#x000e9;</surname><given-names>A.</given-names></name><name><surname>Glynn</surname><given-names>J.R.</given-names></name><name><surname>Boily</surname><given-names>M.-C.</given-names></name><name><surname>White</surname><given-names>R.G.</given-names></name><name><surname>Habbema</surname><given-names>J.D.F.</given-names></name><name><surname>Hayes</surname><given-names>R.J.</given-names></name></person-group>
<article-title>Understanding the differences between contrasting HIV epidemics in east and west Africa: Results from a simulation model of the Four Cities Study</article-title>
<source>Sex. Transm. Infect.</source>
<year>2007</year>
<volume>83</volume>
<fpage>i5</fpage>
<lpage>i16</lpage>
<pub-id pub-id-type="pmid">17405781</pub-id></element-citation></ref><ref id="B166-viruses-04-01950"><label>166.</label><element-citation publication-type="other">
<person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>V.</given-names></name></person-group>
<comment>E&#x000f6;tv&#x000f6;s Lor&#x000e1;nd University, Budapest, Hungary. Unpublished computer simulations, 2012.</comment>
</element-citation></ref><ref id="B167-viruses-04-01950"><label>167.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van den Branden</surname><given-names>F.</given-names></name><name><surname>Van Hoof</surname><given-names>L.</given-names></name></person-group>
<article-title>Rapport sur le fonctionnement du Laboratoire de L&#x000e9;opoldville pendant l'ann&#x000e9;e 1923 (in French)</article-title>
<source>Ann. Soc. Belge M&#x000e9;d. Trop.</source>
<year>1924</year>
<volume>4</volume>
<fpage>231</fpage>
<lpage>245</lpage>
</element-citation></ref><ref id="B168-viruses-04-01950"><label>168.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmid</surname><given-names>G.P.</given-names></name><name><surname>Buv&#x000e9;</surname><given-names>A.</given-names></name><name><surname>Mugyenyi</surname><given-names>P.</given-names></name><name><surname>Garnett</surname><given-names>G.P.</given-names></name><name><surname>Hayes</surname><given-names>R.J.</given-names></name><name><surname>Williams</surname><given-names>B.G.</given-names></name><name><surname>Calleja</surname><given-names>J.G.</given-names></name><name><surname>De Cock</surname><given-names>K.M.</given-names></name><name><surname>Whitworth</surname><given-names>J.A.</given-names></name><name><surname>Kapiga</surname><given-names>S.H.</given-names></name><etal/></person-group>
<article-title>Transmission of HIV infection in sub-Saharan Africa and effect of elimination of unsafe injections</article-title>
<source>Lancet</source>
<year>2004</year>
<volume>363</volume>
<fpage>482</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="pmid">14962531</pub-id></element-citation></ref><ref id="B169-viruses-04-01950"><label>169.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Njouom</surname><given-names>R.</given-names></name><name><surname>Nerrienet</surname><given-names>E.</given-names></name><name><surname>Dubois</surname><given-names>M.</given-names></name><name><surname>Lachenal</surname><given-names>G.</given-names></name><name><surname>Rousset</surname><given-names>D.</given-names></name><name><surname>Vessi&#x000e8;re</surname><given-names>A.</given-names></name><name><surname>Ayouba</surname><given-names>A.</given-names></name><name><surname>Pasquier</surname><given-names>C.</given-names></name><name><surname>Pouillot</surname><given-names>R.</given-names></name></person-group>
<article-title>The hepatitis C virus epidemic in Cameroon: Genetic evidence for rapid transmission between 1920 and 1960</article-title>
<source>Inf. Gen. Evol.</source>
<year>2007</year>
<volume>7</volume>
<fpage>361</fpage>
<lpage>367</lpage>
<pub-id pub-id-type="doi">10.1016/j.meegid.2006.10.003</pub-id>
</element-citation></ref><ref id="B170-viruses-04-01950"><label>170.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frank</surname><given-names>C.</given-names></name><name><surname>Mohamed</surname><given-names>M.K.</given-names></name><name><surname>Strickland</surname><given-names>G.T.</given-names></name><name><surname>Lavanchy</surname><given-names>D.</given-names></name><name><surname>Arthur</surname><given-names>R.R.</given-names></name><name><surname>Magder</surname><given-names>L.S.</given-names></name><name><surname>El Khoby</surname><given-names>T.</given-names></name><name><surname>Abdel-Wahab</surname><given-names>Y.</given-names></name><name><surname>Ohn</surname><given-names>E.S.A.</given-names></name><name><surname>Anwar</surname><given-names>W.</given-names></name><etal/></person-group>
<article-title>The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. </article-title>
<source>Lancet</source>
<year>2000</year>
<volume>355</volume>
<fpage>887</fpage>
<lpage>891</lpage>
<pub-id pub-id-type="pmid">10752705</pub-id></element-citation></ref><ref id="B171-viruses-04-01950"><label>171.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abdala</surname><given-names>N.</given-names></name><name><surname>Gleghorn</surname><given-names>A.A.</given-names></name><name><surname>Carney</surname><given-names>J.M.</given-names></name><name><surname>Heimer</surname><given-names>R.</given-names></name></person-group>
<article-title>Can HIV-1-contaminated syringes be disinfected?</article-title>
<source>J. Acquir. Immune Defic. Syndr.</source>
<year>2001</year>
<volume>28</volume>
<fpage>487</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="pmid">11744839</pub-id></element-citation></ref><ref id="B172-viruses-04-01950"><label>172.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>A.B.</given-names></name><name><surname>Vandamme</surname><given-names>A.-M.</given-names></name><name><surname>Lemey</surname><given-names>P.</given-names></name></person-group>
<article-title>Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution</article-title>
<source>J. Virol.</source>
<year>2009</year>
<volume>83</volume>
<fpage>12917</fpage>
<lpage>12924</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.01022-09</pub-id>
<pub-id pub-id-type="pmid">19793809</pub-id></element-citation></ref><ref id="B173-viruses-04-01950"><label>173.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Buv&#x000e9;</surname><given-names>A.</given-names></name><name><surname>Cara&#x000eb;l</surname><given-names>M.</given-names></name><name><surname>Hayes</surname><given-names>R.J.</given-names></name><name><surname>Auvert</surname><given-names>B.</given-names></name><name><surname>Ferry</surname><given-names>B.</given-names></name><name><surname>Robinson</surname><given-names>N.J.</given-names></name><name><surname>Anagonou</surname><given-names>S.</given-names></name><name><surname>Kanhonou</surname><given-names>L.</given-names></name><name><surname>Laourou</surname><given-names>M.</given-names></name><name><surname>Abega</surname><given-names>S.</given-names></name><etal/></person-group>
<article-title>The multicentre study on factors determining the differential spread of HIV in four African cities: Summary and conclusions</article-title>
<source>AIDS</source>
<year>2001</year>
<volume>15</volume>
<fpage>S127</fpage>
<lpage>S131</lpage>
</element-citation></ref></ref-list></back></article>